===============================================================================
=
 NURSEPATH COPYRIGHT REGISTRATION
 IPOPHL DOCUMENTATION
===============================================================================
=
TITLE: NursePath: Clinical Learning Progressive Web Application
AUTHOR: Rance Adriel M. Pascua
DATE: April 8, 2026
VERSION: 1.1
CATEGORY: Class N Computer Program
REGISTRATION INTENT: Copyright Protection & Intellectual Property Establishment
===============================================================================
=
 COVER PAGE
===============================================================================
=
 NURSEPATH
 Clinical Learning PWA - Version 1.1
 A Progressive Web Application for
 Academic Nursing Education Support
 AUTHOR: Rance Adriel M. Pascua
 DEVELOPMENT PERIOD: 2025-2026
 INSTITUTION: Universidad de Dagupan
 PROGRAM: Bachelor of Science in Nursing
 Submitted to: IPOPHL (Intellectual Property
 Office of the Philippines)
 Category: Class N - Computer Program
 Registration Date: April 8, 2026
===============================================================================
=
 EXECUTIVE SUMMARY
===============================================================================
=
NursePath is a Progressive Web Application (PWA) developed as an academic
learning tool for nursing students. The application provides interactive
calculators and study references that reinforce clinical concepts through
offline-capable technology.
CORE FUNCTIONALITY:
• IV Flow Rate Calculator (mL/hr and gtt/min formulas)
• Age of Gestation (AOG) & Estimated Date of Delivery (EDD) Calculator
• Body Mass Index (BMI) Calculator
• Vital Signs Reference Database (age-adjusted ranges)
• OTC Medication Study Reference (34 medications with Philippine brands)
• Offline Service Worker Implementation
TECHNICAL ARCHITECTURE:
• Runtime: Vanilla JavaScript (no frameworks)
• Styling: Inlined Tailwind CSS
• Offline Support: Service Worker Cache-First Strategy
• Deployment: Vercel PWA
• Data Persistence: localStorage
KEY INTELLECTUAL PROPERTY COMPONENTS:
1. Complete PWA implementation with Service Worker logic
2. Proprietary vital signs assessment algorithm
3. Custom medication database with condition-specific safety ratings
4. Interactive UI/UX design with responsive calculations
5. Medical education content curation and verification
===============================================================================
=
 PROJECT DOCUMENTATION
===============================================================================
=
--- SOURCE CODE: README.md (Technical Manual) ---
# NursePath: An Academic Learning Companion for Nursing Students
<p align="center">
 <img src="image-512.png" alt="NursePath Logo" width="120" height="120">
</p>
<p align="center">
 <strong>A Study Aid for Reinforcing Clinical Concepts in Nursing Education</strong>
</p>
<p align="center">
 <em>Version 1.1 | February 2026 | Faculty Review Phase</em>
</p>
---
## Executive Summary
**NursePath** is a Progressive Web Application (PWA) developed as an **academic learning tool** for
nursing students. The application serves as a digital study companion that reinforces textbook concepts taught
in the classroom.
This project addresses two educational objectives:
1. **Concept Reinforcement** — Provides interactive examples of drug dosage calculations and IV flow rate
formulas that mirror textbook exercises, helping students practice and internalize mathematical nursing
concepts.
2. **Reference Accessibility** — Offers a searchable compilation of commonly discussed OTC medications
and vital signs ranges, serving as a portable study reference similar to pocket nursing guides.
The application operates entirely offline after initial installation, making it convenient for studying in various
environments including libraries, dormitories, or areas with limited connectivity.
**Important:** This is a learning reinforcement tool, not a clinical resource. All content reflects standard
nursing textbook material and is intended to support classroom instruction, not replace it.

---

## Acknowledgements & Licensing

**Copyright Ownership**
I, Rance Adriel M. Pascua, hereby declare and affirm that I am the sole author, lead developer, and exclusive copyright owner of the entire source code, proprietary algorithms, and application architecture embodied in the *NursePath* Progressive Web Application (Class N - Computer Program).

**Non-Exclusive Academic License**
By this declaration, I grant Universidad de Dagupan a formal, royalty-free, non-exclusive academic license to utilize *NursePath* strictly for internal educational purposes, academic case studies, faculty performance reviews, and Commission on Higher Education (CHED) accreditation demonstrations or acknowledgements. This limited license grant does not constitute, and shall in no event be construed as, a transfer, assignment, or waiver of any intellectual property rights, commercial ownership, or proprietary interest in the software to the institution or any third party.

**Institutional Acknowledgements**
I extend my profound gratitude to the Universidad de Dagupan, specifically the Bachelor of Science in Nursing (BSN) Program, for providing the robust academic framework and supportive clinical learning environment where the foundational concepts of this project were established.

**Special Acknowledgement**
Special recognition and utmost appreciation are directed to my Guiding Clinical Instructor, Sir Edberg De Guzman II. His invaluable mentorship, administrative support, and clinical oversight throughout the project's conceptualization, faculty review phases, and this subsequent intellectual property registration process have been directly instrumental to its realization.

---
## Features
### 🧭 Navigation
- Simple navigation bar for easy access to different sections
- Smooth scrolling between study modules
- Color-coded sections for quick identification
### 💉 IV Flow Rate Practice Calculator
- Demonstrates **mL/hr** calculations for infusion scenarios
- Shows **gtt/min** (drops per minute) formula applications
- Supports standard drop factors: 10, 15, 20, and 60 gtt/mL
- Helps students verify their manual calculation practice
### 🤰 AOG & EDD Study Calculator
- Demonstrates **Age of Gestation (AOG)** calculation methods
- Shows **Estimated Date of Delivery (EDD)** using Naegele's Rule
- Displays trimester information for maternal nursing coursework
- Lists common pregnancy milestones discussed in OB nursing classes
### 💊 OTC Medications Study Reference
- **34 commonly discussed OTC medications** with Philippine brand names
- Quick reference and detailed information tabs
- Includes information typically covered in pharmacology classes:
 - Drug classifications and mechanisms
 - Common uses and contraindications
 - Side effects and interactions
- Searchable by condition, brand name, or generic name
- DOH-recognized Philippine herbal medicines included
### 📊 Vital Signs Reference Guide
- Age-adjusted normal ranges from nursing textbooks
- Categorization examples (Normal, Low, High)
- Covers pediatric through geriatric ranges
- Pregnancy-related values for OB nursing studies
### ⚖️ BMI Calculator
- Standard BMI formula demonstration
- WHO category classifications
### 📴 Offline Availability
- Works without internet after first load
- Convenient for studying anywhere
---
## Technical Information
### Development Approach
This application was developed using **AI-Assisted Programming**, combining the developer's nursing
education background with AI coding assistance.
| Component | Responsibility |
|-----------|----------------|
| **Content Selection & Requirements** | Rance Adriel M. Pascua, BSN Student |
| **Formula Verification** | Rance Adriel M. Pascua, BSN Student |
| **Feature Planning** | Rance Adriel M. Pascua, BSN Student |
| **Code Implementation** | Assisted by Claude (Anthropic) |
| **Testing & Review** | Rance Adriel M. Pascua, BSN Student |
### Technology
- **Frontend:** HTML5, CSS3, JavaScript
- **Styling:** Tailwind CSS (inlined)
- **Offline Support:** Service Worker
- **Hosting:** Vercel
---
## Content Sources
All educational content in NursePath is derived from standard nursing textbooks and educational resources:
- **Brunner & Suddarth's Textbook of Medical-Surgical Nursing** (14th Edition)
- **Kozier & Erb's Fundamentals of Nursing** (11th Edition)
- **Lippincott's Nursing Drug Guide**
- **Philippine National Drug Formulary**
- **Pillitteri's Maternal & Child Health Nursing**
- **WHO BMI Classification Guidelines**
- **DOH Traditional Medicine Guidelines**
---
## Current Status
| Phase | Status | Description |
|-------|--------|-------------|
| Development | ✅ Complete | Features implemented |
| Internal Testing | ✅ Complete | Basic functionality verified |
| **Faculty Review** | 🔄 **In Progress** | Seeking instructor feedback |
| Student Feedback | ⏳ Pending | Peer review from classmates |
---
## Access Information
### For Faculty Reviewers
**Demo Access:** Automatically unlocked on load
This code is valid for 30 days and functions offline after initial access.
---
## Contact Information
**Developer:** Rance Adriel M. Pascua
**Program:** Bachelor of Science in Nursing
**Institution:** Universidad de Dagupan
**Email:** adrielrancepascua@gmail.com
**Academic Year:** 2025-2026
---
## Usage Terms
This application is a student academic project. See the [LICENSE](LICENSE.txt) file for terms of use.
**Summary:** This is a student-developed educational tool provided for academic review. The content
reflects standard nursing textbook material and is intended as a study aid only.
===============================================================================
=
 --- COMPLETE SOURCE CODE FILE ---
 index.html
 --- CATEGORY: Class N Computer Program ---
===============================================================================
=
FULL SOURCE CODE LISTING: index.html The following 2,700+ lines constitute the complete original
source code, inclusive of UI logic, clinical algorithms, and database structures.
<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="UTF-8">
<meta name="viewport" content="width=device-width, initial-scale=1.0, maximum-scale=5.0,
user-scalable=yes, viewport-fit=cover">
<meta name="theme-color" content="#0f172a">
<meta name="description" content="NursePath - Academic Simulation & Clinical Reference
Tool for student nurses. Practice vital signs interpretation, dosage calculations, and
clinical reasoning in a controlled educational environment.">
<meta name="apple-mobile-web-app-capable" content="yes">
<meta name="apple-mobile-web-app-status-bar-style" content="black-translucent">
<meta name="apple-mobile-web-app-title" content="NursePath">
<meta name="application-name" content="NursePath">
<meta name="msapplication-TileColor" content="#0f172a">
<meta name="msapplication-config" content="browserconfig.xml">
<meta name="format-detection" content="telephone=no">
<meta name="mobile-web-app-capable" content="yes">
<title>NursePath - Academic Simulation & Reference Tool</title>
<!-- CRITICAL: Force dark mode immediately to prevent white flash -->
<style>
/* Dark mode foundation - loads FIRST */
html, body {
background-color: #020617 !important;
color: #e2e8f0 !important;
font-family: -apple-system, BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif;
}
* { box-sizing: border-box; }
/* Prevent ANY white backgrounds */
div, section, main, aside, article, header, footer, nav {
background-color: transparent;
}
</style>
<link rel="manifest" href="manifest.json">
<link rel="icon" type="image/png" sizes="32x32" href="data:image/svg+xml,<svg
xmlns='http://www.w3.org/2000/svg' viewBox='0 0 192 192'><rect fill='%230f172a' width='192'
height='192'/><text x='50%' y='50%' font-size='120' font-weight='bold' fill='%2306b6d4'
text-anchor='middle' dy='.35em'>Rx</text></svg>">
<link rel="apple-touch-icon" href="data:image/svg+xml,<svg
xmlns='http://www.w3.org/2000/svg' viewBox='0 0 180 180'><rect fill='%230f172a' width='180'
height='180' rx='40'/><text x='50%' y='50%' font-size='100' font-weight='bold'
fill='%2306b6d4' text-anchor='middle' dy='.35em'>Rx</text></svg>">
<!-- OFFLINE-FIRST: Inlined CSS (no CDN) -->
<style>
* { margin: 0; padding: 0; box-sizing: border-box; }
html { background: #020617 !important; color: #e2e8f0; font-family: -apple-system,
BlinkMacSystemFont, 'Segoe UI', Roboto, sans-serif; scroll-behavior: smooth; }
body { background: #020617 !important; color: #e2e8f0; min-height: 100vh; padding-top:
env(safe-area-inset-top); padding-left: env(safe-area-inset-left); padding-right:
env(safe-area-inset-right); padding-bottom: env(safe-area-inset-bottom); overflow-x: hidden; }
/* Tab content visibility */
.tab-content.hidden { display: none !important; }
.hidden { display: none !important; }
/* Text overflow prevention */
p, span, div, h1, h2, h3, h4, h5, h6, label, td, th, li { word-wrap: break-word;
overflow-wrap: break-word; max-width: 100%; }
.max-w-7xl { max-width: 80rem; margin: 0 auto; }
.mx-auto { margin-left: auto; margin-right: auto; }
.p-3 { padding: 0.75rem; }
.p-4 { padding: 1rem; }
.p-5 { padding: 1.25rem; }
.p-6 { padding: 1.5rem; }
.px-4 { padding-left: 1rem; padding-right: 1rem; }
.py-2 { padding-top: 0.5rem; padding-bottom: 0.5rem; }
.py-3 { padding-top: 0.75rem; padding-bottom: 0.75rem; }
.py-6 { padding-top: 1.5rem; padding-bottom: 1.5rem; }
.mb-2 { margin-bottom: 0.5rem; }
.mb-3 { margin-bottom: 0.75rem; }
.mb-4 { margin-bottom: 1rem; }
.mb-6 { margin-bottom: 1.5rem; }
.mt-0 { margin-top: 0; }
.mt-0.5 { margin-top: 0.125rem; }
.mt-1 { margin-top: 0.25rem; }
.mt-8 { margin-top: 2rem; }
.mt-12 { margin-top: 3rem; }
.gap-0 { gap: 0; }
.gap-2 { gap: 0.5rem; }
.gap-3 { gap: 0.75rem; }
.gap-6 { gap: 1.5rem; }
.space-y-1 > * + * { margin-top: 0.25rem; }
.space-y-2 > * + * { margin-top: 0.5rem; }
.space-y-3 > * + * { margin-top: 0.75rem; }
.space-y-4 > * + * { margin-top: 1rem; }
.space-y-6 > * + * { margin-top: 1.5rem; }
.w-full { width: 100%; }
.w-1\/3 { width: 33.333%; }
.h-full { height: 100%; }
.min-h-screen { min-height: 100vh; }
.min-h-\[120px\] { min-height: 120px; }
.min-h-\[240px\] { min-height: 240px; }
.max-h-\[420px\] { max-height: 420px; overflow-y: auto; }
.max-h-\[600px\] { max-height: 600px; overflow-y: auto; }
.h-\[600px\] { height: 600px; overflow-y: auto; }
.text-left { text-align: left; }
.text-center { text-align: center; }
.text-right { text-align: right; }
.inline-block { display: inline-block; }
.flex { display: flex; }
.flex-col { flex-direction: column; }
.flex-wrap { flex-wrap: wrap; }
.items-center { align-items: center; }
.items-start { align-items: flex-start; }
.justify-between { justify-content: space-between; }
.justify-center { justify-content: center; }
.gap-0 { gap: 0; }
.grid { display: grid; }
.grid-cols-1 { grid-template-columns: 1fr; }
.grid-cols-2 { grid-template-columns: repeat(2, minmax(0, 1fr)); }
.grid-cols-3 { grid-template-columns: repeat(3, minmax(0, 1fr)); }
.grid-cols-4 { grid-template-columns: repeat(4, minmax(0, 1fr)); }
.grid-cols-5 { grid-template-columns: repeat(5, minmax(0, 1fr)); }
.md\:grid-cols-2 { grid-template-columns: repeat(2, minmax(0, 1fr)); }
.md\:grid-cols-3 { grid-template-columns: repeat(3, minmax(0, 1fr)); }
.md\:grid-cols-4 { grid-template-columns: repeat(4, minmax(0, 1fr)); }
.md\:grid-cols-5 { grid-template-columns: repeat(5, minmax(0, 1fr)); }
.lg\:col-span-1 { grid-column: span 1; }
.lg\:col-span-4 { grid-column: span 4; }
.lg\:grid-cols-5 { grid-template-columns: repeat(5, minmax(0, 1fr)); }
.sticky { position: sticky; }
.lg\:sticky { position: sticky; top: 24px; }
.rounded-xl { border-radius: 0.875rem; }
.rounded-2xl { border-radius: 1rem; }
.rounded-lg { border-radius: 0.5rem; }
.rounded-full { border-radius: 9999px; }
.border { border: 1px solid; }
.border-b { border-bottom: 1px solid; }
.border-b-2 { border-bottom: 2px solid; }
.border-l-4 { border-left: 4px solid; }
.border-slate-600 { border-color: #1e293b !important; }
.border-slate-700 { border-color: #1e293b !important; }
.border-blue-500 { border-color: #1e4a7a; }
.border-blue-700 { border-color: #1d4ed8; }
.border-cyan-500 { border-color: #0e4a5c; }
.border-emerald-500 { border-color: #064e3b; }
.border-red-900 { border-color: #7f1d1d; }
.border-slate-700-50 { border-color: rgba(30, 41, 59, 0.5) !important; }
.border-blue-500-30 { border-color: rgba(30, 74, 122, 0.3); }
.border-cyan-500-30 { border-color: rgba(14, 74, 92, 0.3); }
.border-emerald-500-30 { border-color: rgba(6, 78, 59, 0.3); }
.border-blue-700-50 { border-color: rgba(29, 78, 216, 0.5); }
.bg-slate-900 { background-color: #0f172a !important; }
.bg-slate-800 { background-color: #1e293b !important; }
.bg-slate-700 { background-color: #334155 !important; }
.bg-slate-950 { background-color: #020617 !important; }
.bg-red-700 { background-color: #b91c1c !important; }
.bg-blue-600 { background-color: #2563eb; }
.bg-blue-500 { background-color: #3b82f6; }
.bg-emerald-600 { background-color: #059669; }
.bg-emerald-500 { background-color: #10b981; }
.bg-slate-700-30 { background-color: rgba(51, 65, 85, 0.4) !important; }
.bg-slate-900-70 { background-color: rgba(15, 23, 42, 0.85) !important; }
.bg-slate-800-50 { background-color: rgba(30, 41, 59, 0.6) !important; }
.bg-slate-700-20 { background-color: rgba(51, 65, 85, 0.3) !important; }
.bg-slate-900-60 { background-color: rgba(15, 23, 42, 0.75) !important; }
.bg-blue-900-30 { background-color: rgba(30, 58, 138, 0.4) !important; }
/* Gradient backgrounds with dark tones */
.bg-gradient-to-br { background: linear-gradient(135deg, #1e293b 0%, #0f172a 100%)
!important; }
.hover\:bg-slate-700 { cursor: pointer; }
.hover\:bg-slate-700:hover { background-color: rgba(51, 65, 85, 0.7); }
.hover\:from-blue-500 { cursor: pointer; }
.hover\:from-blue-500:hover { background: linear-gradient(to right, #3b82f6, #0284c7);
}
.hover\:from-emerald-500 { cursor: pointer; }
.hover\:from-emerald-500:hover { background: linear-gradient(to right, #10b981,
#059669); }
.text-white { color: #ffffff; }
.text-slate-100 { color: #f1f5f9; }
.text-slate-300 { color: #cbd5e1; }
.text-slate-400 { color: #94a3b8; }
.text-slate-500 { color: #64748b; }
.text-slate-600 { color: #475569; }
.text-slate-700 { color: #334155; }
.text-cyan-400 { color: #22d3ee; }
.text-cyan-300 { color: #06b6d4; }
.text-blue-400 { color: #60a5fa; }
.text-blue-300 { color: #93c5fd; }
.text-blue-500 { color: #3b82f6; }
.text-red-500 { color: #ef4444; }
.text-red-400 { color: #f87171; }
.text-red-700 { color: #b91c1c; }
.text-orange-500 { color: #f97316; }
.text-amber-400 { color: #fbbf24; }
.text-amber-300 { color: #fcd34d; }
.text-green-400 { color: #4ade80; }
.text-green-500 { color: #22c55e; }
.text-yellow-400 { color: #facc15; }
.text-emerald-400 { color: #34d399; }
.text-blue-400 { color: #60a5fa; }
.font-bold { font-weight: 700; }
.font-black { font-weight: 900; }
.font-semibold { font-weight: 600; }
.text-xs { font-size: 0.75rem; }
.text-sm { font-size: 0.875rem; }
.text-lg { font-size: 1.125rem; }
.text-xl { font-size: 1.25rem; }
.text-2xl { font-size: 1.5rem; }
.text-3xl { font-size: 1.875rem; }
.text-4xl { font-size: 2.25rem; }
.text-\[9px\] { font-size: 9px; }
.text-\[10px\] { font-size: 10px; }
.text-\[11px\] { font-size: 11px; }
.text-\[12px\] { font-size: 12px; }
.text-\[14px\] { font-size: 14px; }
.text-\[120px\] { font-size: 120px; }
.text-\[280px\] { font-size: 280px; }
.text-\[3xl\] { font-size: 1.875rem; }
.text-\[2xl\] { font-size: 1.5rem; }
.uppercase { text-transform: uppercase; }
.lowercase { text-transform: lowercase; }
.italic { font-style: italic; }
.tracking-widest { letter-spacing: 0.1em; }
.tracking-wider { letter-spacing: 0.05em; }
.no-underline { text-decoration: none; }
.opacity-50 { opacity: 0.5; }
.shadow-xl { box-shadow: 0 20px 25px -5px rgba(0, 0, 0, 0.1); }
.shadow-2xl { box-shadow: 0 25px 50px -12px rgba(0, 0, 0, 0.25); }
.shadow-lg { box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1); }
.shadow-blue-900-30 { box-shadow: 0 10px 15px -3px rgba(30, 58, 138, 0.3); }
.shadow-emerald-900-30 { box-shadow: 0 10px 15px -3px rgba(4, 120, 87, 0.3); }
input, select, textarea { min-height: 44px; min-width: 44px; padding: 12px; font-size:
16px; border: 1px solid #334155; background: #0f172a; color: #e2e8f0; border-radius: 0.75rem;
-webkit-appearance: none; appearance: none; }
input:focus, select:focus, textarea:focus { outline: none; border-color: #3b82f6;
box-shadow: 0 0 0 2px rgba(59, 130, 246, 0.3); }
button { min-height: 44px; min-width: 44px; padding: 12px; cursor: pointer; border:
none; border-radius: 0.875rem; font-weight: 700; transition: all 0.3s; user-select: none;
-webkit-user-select: none; -webkit-touch-callout: none; }
button:active { transform: scale(0.98); }
.transition { transition: all 0.3s; }
.transition-all { transition: all 0.3s; }
.pr-2 { padding-right: 0.5rem; }
mark { background: #fbbf24; color: #000; padding: 0; }
.bg-gradient-to-r { background-image: linear-gradient(to right,
var(--tw-gradient-stops)); }
.from-blue-400 { --tw-gradient-stops: #60a5fa, var(--tw-gradient-to, rgba(96, 165,
250, 0)); }
.to-cyan-400 { --tw-gradient-to: #22d3ee; }
.from-blue-600 { --tw-gradient-stops: #2563eb, var(--tw-gradient-to, rgba(37, 99, 235,
0)); }
.to-blue-500 { --tw-gradient-to: #3b82f6; }
.from-blue-500 { --tw-gradient-stops: #3b82f6, var(--tw-gradient-to, rgba(59, 130,
246, 0)); }
.to-blue-400 { --tw-gradient-to: #60a5fa; }
.from-emerald-600 { --tw-gradient-stops: #059669, var(--tw-gradient-to, rgba(5, 150,
105, 0)); }
.to-emerald-500 { --tw-gradient-to: #10b981; }
.from-emerald-500 { --tw-gradient-stops: #10b981, var(--tw-gradient-to, rgba(16, 185,
129, 0)); }
.to-emerald-400 { --tw-gradient-to: #34d399; }
.from-slate-800 { --tw-gradient-stops: #1e293b, var(--tw-gradient-to, rgba(30, 41, 59,
0)); }
.to-slate-900 { --tw-gradient-to: #0f172a; }
.bg-clip-text { background-clip: text; -webkit-background-clip: text; }
.text-transparent { color: transparent; }
.pr-4 { padding-right: 1rem; }
@media (max-width: 768px) { .md\:text-\[11px\] { font-size: 11px; } .md\:gap-3 { gap:
0.75rem; } .md\:p-4 { padding: 1rem; } .md\:p-6 { padding: 1.5rem; } .md\:mb-8 {
margin-bottom: 2rem; } .md\:text-3xl { font-size: 1.875rem; } .md\:text-4xl { font-size:
2.25rem; } }
@media (min-width: 768px) { .sm\:p-4 { padding: 1rem; } .sm\:mb-8 { margin-bottom:
2rem; } .sm\:text-sm { font-size: 0.875rem; } .sm\:text-3xl { font-size: 1.875rem; } .sm\:mr-2
{ margin-right: 0.5rem; } .sm\:mr-3 { margin-right: 0.75rem; } .sm\:gap-2 { gap: 0.5rem; }
.sm\:gap-3 { gap: 0.75rem; } .sm\:flex-row { flex-direction: row; } .sm\:items-center {
align-items: center; } }
@media (min-width: 1024px) { .lg\:col-span-1 { grid-column: span 1; } .lg\:col-span-4
{ grid-column: span 4; } }
</style>
<style>
/* Mobile-first safe area for notches */
body {
padding-top: env(safe-area-inset-top);
padding-left: env(safe-area-inset-left);
padding-right: env(safe-area-inset-right);
padding-bottom: env(safe-area-inset-bottom);
}
/* Ensure tappable elements are at least 44x44px */
button, a.btn, select, input[type="submit"], input[type="button"],
input[type="number"], input[type="text"], input[type="date"] {
min-height: 44px;
min-width: 44px;
padding: 12px !important;
}
/* Mobile Optimizations */
@media (max-width: 768px) {
/* Force 16px inputs to prevent iOS zoom */
input, select, textarea {
font-size: 16px !important;
min-height: 48px !important;
}
/* Stack all grids on mobile */
.grid, .grid.lg\:grid-cols-5, .grid.grid-cols-2, .md\:grid-cols-2,
.md\:grid-cols-4, .md\:grid-cols-5 {
grid-template-columns: 1fr 1fr !important;
gap: 8px !important;
}
/* Container padding */
.max-w-7xl, .container {
padding-left: 10px !important;
padding-right: 10px !important;
}
/* Smaller gaps */
.gap-6, .gap-3 {
gap: 10px !important;
}
/* Card padding on mobile */
.bg-gradient-to-br, .card, .p-6, .p-5, .p-4 {
padding: 14px !important;
border-radius: 14px !important;
}
/* Smaller text on mobile */
h1, .text-3xl, .text-4xl { font-size: 1.4rem !important; }
h2, .text-2xl { font-size: 1.15rem !important; }
h3, .text-xl, .text-lg { font-size: 1rem !important; }
/* Full width on mobile - single column for some sections */
.md\:grid-cols-2 {
grid-template-columns: 1fr !important;
}
/* Buttons */
button {
padding: 12px 16px !important;
font-size: 14px !important;
min-height: 48px !important;
}
/* Hide OTC sidebar on mobile */
aside.lg\:col-span-1 {
display: none !important;
}
/* Labels smaller */
label, .text-\[9px\], .text-\[10px\] {
font-size: 9px !important;
}
/* Diagnosis box */
#dx-box {
min-height: 70px !important;
padding: 12px !important;
}
/* Prevent text overflow */
p, span, div, h1, h2, h3, h4, label {
word-wrap: break-word !important;
overflow-wrap: break-word !important;
}
}
/* Better sidebar for tablets and up */
@media (min-width: 1024px) {
.lg\:sticky {
position: sticky;
top: 24px;
}
}
/* OTC Detail container - always visible on desktop */
@media (min-width: 768px) {
#otc-detail-container {
display: block !important;
}
}
/* Improve card readability on mobile */
.rounded-xl {
border-radius: 0.875rem;
}
/* Prevent text selection on buttons for better tap experience */
button, input[type="button"], input[type="submit"] {
user-select: none;
-webkit-user-select: none;
-webkit-touch-callout: none;
}
/* iOS specific: improve form input appearance */
input, select, textarea {
-webkit-appearance: none;
appearance: none;
border-radius: 0.75rem;
}
/* Custom select arrow on iOS */
select {
background-image: url("data:image/svg+xml,%3Csvg
xmlns='http://www.w3.org/2000/svg' width='12' height='8' viewBox='0 0 12 8'%3E%3Cpath
fill='%2394a3b8' d='M1 1l5 5 5-5'/%3E%3C/svg%3E");
background-repeat: no-repeat;
background-position: right 12px center;
padding-right: 36px;
}
</style>
</head>
<body class="bg-slate-950 text-slate-100 font-sans min-h-screen" style="background-color:
#020617 !important;">
<!-- ACCESS CODE LOCK OVERLAY -->
<div id="accessLockOverlay" style="position: fixed; inset: 0; background:
linear-gradient(135deg, #020617 0%, #0f172a 50%, #1e293b 100%); z-index: 99999; display: flex;
align-items: center; justify-content: center; padding: 20px;">
<div style="background: #0f172a; border: 2px solid #06b6d4; border-radius: 20px;
padding: 40px 30px; max-width: 400px; width: 100%; text-align: center; box-shadow: 0 25px 50px
rgba(0,0,0,0.5);">
<!-- Logo -->
<div style="display: none; width: 80px; height: 80px; background:
linear-gradient(135deg, #06b6d4, #0891b2); border-radius: 20px; margin: 0 auto 20px; display:
flex; align-items: center; justify-content: center; font-size: 36px; font-weight: bold; color:
white;">Rx</div>
<h1 style="color: #06b6d4; font-size: 28px; font-weight: bold; margin-bottom:
8px;">NursePath</h1>
<p style="color: #94a3b8; font-size: 14px; margin-bottom: 30px;">Academic
Simulation Tool</p>
<!-- Lock Icon -->
<div style="font-size: 48px; margin-bottom: 20px;">🔐</div>
<h2 style="color: white; font-size: 20px; margin-bottom: 10px;">Access Code
Required</h2>
<p style="color: #64748b; font-size: 13px; margin-bottom: 25px;">Enter your access
code to unlock the app</p>
<!-- Code Input -->
<input type="text" id="accessCodeInput" placeholder="Enter access code"
style="width: 100%; padding: 16px; font-size: 16px; text-align: center;
background: #1e293b; border: 2px solid #334155; border-radius: 12px; color: white;
margin-bottom: 15px; text-transform: uppercase; letter-spacing: 2px;"
onkeypress="if(event.key==='Enter') verifyAccessCode()">
<!-- Error Message -->
<p id="accessError" style="color: #ef4444; font-size: 13px; margin-bottom: 15px;
display: none;">Invalid code. Please try again.</p>
<!-- Submit Button -->
<button onclick="verifyAccessCode()"
style="width: 100%; padding: 16px; font-size: 16px; font-weight: 600;
background: linear-gradient(135deg, #06b6d4, #0891b2); color: white; border: none;
border-radius: 12px; cursor: pointer; margin-bottom: 20px; transition: all 0.3s;">
🔓 Unlock App
</button>
<p style="color: #475569; font-size: 11px;">Demo version for academic
evaluation<br>Contact developer for access code</p>
</div>
</div>
<!-- SIMULATION MODE AGREEMENT OVERLAY -->
<div id="simulationModeOverlay" style="display: none; position: fixed; inset: 0;
background: rgba(0,0,0,0.95); z-index: 10000; justify-content: center; align-items: center;
padding: 20px;">
<div style="background: linear-gradient(135deg, #1e293b, #0f172a); border-radius:
20px; padding: 40px; max-width: 500px; width: 100%; text-align: center; border: 2px solid
#f59e0b; box-shadow: 0 25px 50px -12px rgba(0,0,0,0.5);">
<!-- Warning Icon -->
<div style="font-size: 60px; margin-bottom: 20px;">⚠️</div>
<!-- Title -->
<h2 style="font-size: 24px; font-weight: bold; color: #f59e0b; margin-bottom:
15px; text-transform: uppercase; letter-spacing: 2px;">
Simulation Mode
</h2>
<!-- Disclaimer Text -->
<div style="background: #0f172a; border-radius: 12px; padding: 20px;
margin-bottom: 25px; border: 1px solid #334155;">
<p style="color: #e2e8f0; font-size: 15px; line-height: 1.7; text-align:
left;">
This is a <strong style="color: #f59e0b;">simulation-only reference
tool</strong> designed for academic purposes.
</p>
<p style="color: #94a3b8; font-size: 13px; line-height: 1.6; margin-top: 15px;
text-align: left;">
By proceeding, I agree to:
</p>
<ul style="color: #94a3b8; font-size: 13px; line-height: 1.8; text-align:
left; margin-top: 10px; padding-left: 20px;">
<li>✓ Verify <strong>ALL outputs</strong> with a Clinical Instructor</li>
<li>✓ Cross-reference with my <strong>prescribed textbooks</strong></li>
<li>✓ <strong>NOT use</strong> this for actual patient care
decisions</li>
</ul>
</div>
<!-- Agreement Button -->
<button onclick="acceptSimulationMode()"
style="width: 100%; padding: 16px; font-size: 16px; font-weight: 600;
background: linear-gradient(135deg, #f59e0b, #d97706); color: #0f172a; border: none;
border-radius: 12px; cursor: pointer; transition: all 0.3s; text-transform: uppercase;
letter-spacing: 1px;">
📚 I Understand — Enter Simulation Mode
</button>
<p style="color: #475569; font-size: 11px; margin-top: 15px;">
This agreement is valid for 24 hours
</p>
</div>
</div>
<!-- Access Code Verification Script -->
<script>
// MASTER CODE - Change this for your dean demo
const MASTER_CODE = '202526';
const STORAGE_KEY = 'nursepath_access';
const SIMULATION_KEY = 'nursepath_simulation_agreed';
const UNLOCK_DURATION = 30 * 24 * 60 * 60 * 1000; // 30 days in milliseconds
const SIMULATION_DURATION = 24 * 60 * 60 * 1000; // 24 hours in milliseconds
// Check if simulation mode agreement is valid
function checkSimulationAgreement() {
const stored = localStorage.getItem(SIMULATION_KEY);
if (stored) {
try {
const data = JSON.parse(stored);
const now = Date.now();
if (data.agreed && data.expires > now) {
return true; // Agreement still valid
} else {
localStorage.removeItem(SIMULATION_KEY);
}
} catch (e) {
localStorage.removeItem(SIMULATION_KEY);
}
}
return false;
}
// Accept simulation mode agreement
function acceptSimulationMode() {
const agreementData = {
agreed: true,
expires: Date.now() + SIMULATION_DURATION,
agreedAt: new Date().toISOString()
};
localStorage.setItem(SIMULATION_KEY, JSON.stringify(agreementData));
// Hide overlay with animation
const overlay = document.getElementById('simulationModeOverlay');
overlay.style.opacity = '0';
overlay.style.transition = 'opacity 0.5s ease';
setTimeout(() => {
overlay.style.display = 'none';
}, 500);
}
// Check if already unlocked (works offline!)
function checkAccess() {
// Automatically grant access without requiring password
const unlockData = {
granted: true,
expires: Date.now() + UNLOCK_DURATION,
unlockedAt: new Date().toISOString()
};
localStorage.setItem(STORAGE_KEY, JSON.stringify(unlockData));
// Hide access overlay
document.getElementById('accessLockOverlay').style.display = 'none';
// Now check simulation agreement
if (!checkSimulationAgreement()) {
document.getElementById('simulationModeOverlay').style.display = 'flex';
}
return true;
}
// Verify the entered code
function verifyAccessCode() {
const input = document.getElementById('accessCodeInput');
const error = document.getElementById('accessError');
const code = input.value.trim().toUpperCase();
if (code === MASTER_CODE) {
// Success! Store unlock with 30-day expiry
const unlockData = {
granted: true,
expires: Date.now() + UNLOCK_DURATION,
unlockedAt: new Date().toISOString()
};
localStorage.setItem(STORAGE_KEY, JSON.stringify(unlockData));
// Hide overlay with animation
const overlay = document.getElementById('accessLockOverlay');
overlay.style.opacity = '0';
overlay.style.transition = 'opacity 0.5s ease';
setTimeout(() => {
overlay.style.display = 'none';
// Show simulation agreement after access is granted
if (!checkSimulationAgreement()) {
document.getElementById('simulationModeOverlay').style.display =
'flex';
}
}, 500);
error.style.display = 'none';
} else {
// Wrong code
error.style.display = 'block';
input.style.borderColor = '#ef4444';
input.value = '';
input.focus();
// Shake animation
input.style.animation = 'shake 0.5s';
setTimeout(() => input.style.animation = '', 500);
}
}
// Check on page load
checkAccess();
// Focus input if overlay is visible
if (document.getElementById('accessLockOverlay').style.display !== 'none') {
setTimeout(() => document.getElementById('accessCodeInput').focus(), 100);
}
</script>
<style>
@keyframes shake {
0%, 100% { transform: translateX(0); }
25% { transform: translateX(-10px); }
75% { transform: translateX(10px); }
}
</style>
<div class="bg-amber-600 text-white py-2 px-4 text-[10px] md:text-[11px] font-bold
text-center tracking-widest uppercase border-b-2 border-amber-800 sticky top-0 z-50
shadow-lg">
📚 SIMULATION MODE • Verify with Faculty & Textbooks • Academic Reference Only
</div>
<!-- SVG Icon Helper (no Font Awesome) -->
<svg style="display:none;">
<defs>
<symbol id="icon-stethoscope" viewBox="0 0 24 24"><path fill="currentColor" d="M12
2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm-1
15h2v2h-2zm0-10h2v8h-2zm3-3h2v6h-2zm-6 3h2v6H7z"/></symbol>
<symbol id="icon-heart" viewBox="0 0 24 24"><path fill="currentColor" d="M20.84
4.61a5.5 5.5 0 0 0-7.78 0L12 5.67l-1.06-1.06a5.5 5.5 0 0 0-7.78 7.78l1.06 1.06L12
21.23l7.78-7.78 1.06-1.06a5.5 5.5 0 0 0 0-7.78z"/></symbol>
<symbol id="icon-droplet" viewBox="0 0 24 24"><path fill="currentColor" d="M12
2.69l5.66 5.66a8 8 0 1 1-11.32 0z"/></symbol>
<symbol id="icon-scale" viewBox="0 0 24 24"><path fill="currentColor" d="M13
6.3V5a2 2 0 1 0-4 0v1.3M4 14h16M5 9h14a2 2 0 0 1 2 2v9a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2v-9a2 2 0
0 1 2-2z"/></symbol>
<symbol id="icon-pills" viewBox="0 0 24 24"><path fill="currentColor" d="M19
6h-2V4a2 2 0 0 0-2-2h-6a2 2 0 0 0-2 2v2H5a2 2 0 0 0-2 2v12a2 2 0 0 0 2 2h14a2 2 0 0 0 2-2V8a2
2 0 0 0-2-2zm-7 12a3 3 0 1 1 0-6 3 3 0 0 1 0 6z"/></symbol>
<symbol id="icon-wind" viewBox="0 0 24 24"><path fill="currentColor" d="M9.59
4.59A2 2 0 1 1 7.98 6.98H12m4 0a2 2 0 1 1-3.59 2.59H6m7 9a2 2 0 1 1-3.59 2.59M6 13a2 2 0 1
1-3.59-2.59M20 2a2 2 0 1 1-3.59 2.59"/></symbol>
<symbol id="icon-chart" viewBox="0 0 24 24"><path fill="currentColor" d="M3
3v18h18m-2-17V7h-4m-5 0v10h-4m5-5v5h-4"/></symbol>
<symbol id="icon-check" viewBox="0 0 24 24"><path fill="currentColor" d="M20 6L9
17l-5-5"/></symbol>
<symbol id="icon-calculator" viewBox="0 0 24 24"><path fill="currentColor" d="M4
6h16v2H4V6zm0 4h16v2H4v-2zm0 4h16v2H4v-2zm0 4h16v2H4v-2zM4 2h16a2 2 0 0 1 2 2v16a2 2 0 0 1-2
2H4a2 2 0 0 1-2-2V4a2 2 0 0 1 2-2z"/></symbol>
<symbol id="icon-capsules" viewBox="0 0 24 24"><path fill="currentColor" d="M8 2a6
6 0 0 1 6 6v8a6 6 0 0 1-12 0V8a6 6 0 0 1 6-6zm8 0a6 6 0 0 1 0 12v-6a6 6 0 0
0-6-6h6z"/></symbol>
<symbol id="icon-exclamation" viewBox="0 0 24 24"><path fill="currentColor" d="M12
2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1
15h-2v-2h2v2zm0-4h-2V7h2v6z"/></symbol>
</defs>
</svg>
<!-- Icon Component (replace i.fa-solid with svg) -->
<script>
function svg(iconId, classList='') {
return `<svg class="inline ${classList}" width="1em" height="1em" viewBox="0 0 24
24"><use href="#${iconId}"/></svg>`;
}
// Map Font Awesome icons to inline SVG
function getIconSvg(faIcon) {
const iconMap = {
'fa-exclamation-triangle': '<svg class="inline mr-2 text-yellow-400"
width="1em" height="1em" viewBox="0 0 24 24" fill="currentColor"><path d="M1 21h22L12 2 1
21zm12-3h-2v-2h2v2zm0-4h-2v-4h2v4z"/></svg>',
'fa-arrow-down': '<svg class="inline mr-2 text-yellow-400" width="1em"
height="1em" viewBox="0 0 24 24" fill="currentColor"><path d="M7 10l5 5 5-5z"/></svg>',
'fa-arrow-up': '<svg class="inline mr-2 text-yellow-400" width="1em"
height="1em" viewBox="0 0 24 24" fill="currentColor"><path d="M7 14l5-5 5 5z"/></svg>',
'fa-arrow-up-long': '<svg class="inline mr-2 text-yellow-400" width="1em"
height="1em" viewBox="0 0 24 24" fill="currentColor"><path d="M7 14l5-5 5 5M12 21V3"/></svg>',
'fa-snowflake': '<svg class="inline mr-2 text-yellow-400" width="1em"
height="1em" viewBox="0 0 24 24" fill="currentColor"><path d="M20.79 13.12l-1.07-1.07-1.41
1.41L17.64 11H13v-1h5.64l1.07-1.07-1.41-1.41 1.07-1.07L23 12l-2.21 2.12M2.21 10.88L3.28
12l-2.21 2.12 1.07 1.07 1.41-1.41L6.36 13H11v1H5.36l-1.07 1.07 1.41 1.41-1.07 1.07L1
12l1.21-1.12M12 2c5.52 0 10 4.48 10 10s-4.48 10-10 10S2 17.52 2 12 6.48 2 12 2m0-2C6.48 0 2
4.48 2 10s4.48 10 10 10 10-4.48 10-10S17.52 0 12 0z"/></svg>',
'fa-fire': '<svg class="inline mr-2 text-yellow-400" width="1em" height="1em"
viewBox="0 0 24 24" fill="currentColor"><path d="M13.5.67s.74 2.65.74 4.8c0 2.06-1.35
3.73-3.41 3.73-2.07 0-3.63-1.67-3.63-3.73l.03-.36C5.21 7.51 4 10.3 4 13c0 4.08 3.32 8 7.5
8s7.5-3.92 7.5-8C19 9.86 17.55 7.54 16 5.65"/></svg>',
'fa-thermometer': '<svg class="inline mr-2 text-yellow-400" width="1em"
height="1em" viewBox="0 0 24 24" fill="currentColor"><path d="M5 13c0 3.86 3.14 7 7 7s7-3.14
7-7M12 2v9m0 0v9m7-4h-3m-8 0H2"/></svg>',
'fa-heart': '<svg class="inline mr-2 text-yellow-400" width="1em" height="1em"
viewBox="0 0 24 24" fill="currentColor"><path d="M20.84 4.61a5.5 5.5 0 0 0-7.78 0L12
5.67l-1.06-1.06a5.5 5.5 0 0 0-7.78 7.78l1.06 1.06L12 21.23l7.78-7.78 1.06-1.06a5.5 5.5 0 0 0
0-7.78z"/></svg>'
};
return iconMap[faIcon] || '<svg class="inline mr-2 text-yellow-400" width="1em"
height="1em" viewBox="0 0 24 24" fill="currentColor"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10
10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8
8z"/></svg>';
}
</script>
<div class="max-w-7xl mx-auto p-3 sm:p-4 md:p-6">
<header class="mb-4 sm:mb-6 text-center">
<h1 class="text-2xl sm:text-3xl md:text-4xl font-black text-transparent
bg-clip-text bg-gradient-to-r from-blue-400 to-cyan-400 mb-2">
<svg class="inline mr-2 sm:mr-3" width="1.2em" height="1.2em" viewBox="0 0 24
24" fill="currentColor"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2
12 2zm-1 15h2v2h-2zm0-10h2v8h-2zm3-3h2v6h-2zm-6 3h2v6H7z"/></svg>NursePath Simulation Tool
</h1>
<p class="text-slate-400 text-xs sm:text-sm">Vital Signs Simulation • Reference
Interpreter • IV Calculator • Drug Reference</p>
</header>
<!-- TAB NAVIGATION -->
<nav id="quick-nav" class="sticky top-0 z-50 mb-6 bg-slate-900/95 backdrop-blur-sm
rounded-xl border border-slate-700 p-3 shadow-lg">
<div class="flex flex-wrap items-center justify-center gap-2 sm:gap-3">
<span class="text-[10px] text-slate-500 uppercase font-bold mr-2 hidden
sm:inline">Sections:</span>
<!-- Main Tools Tab -->
<button onclick="switchMainTab('tools')" id="tab-tools" class="tab-btn active
px-3 py-1.5 rounded-lg bg-cyan-900/50 border border-cyan-500/50 text-xs font-medium
text-cyan-400 transition-all flex items-center gap-1">
<svg width="1em" height="1em" viewBox="0 0 24 24"
fill="currentColor"><path d="M22.7 19l-9.1-9.1c.9-2.3.4-5-1.5-6.9-2-2-5-2.4-7.4-1.3L9 6 6 9
1.6 4.7C.4 7.1.9 10.1 2.9 12.1c1.9 1.9 4.6 2.4 6.9 1.5l9.1 9.1c.4.4 1 .4 1.4
0l2.3-2.3c.5-.4.5-1.1.1-1.4z"/></svg>
<span class="hidden sm:inline">Clinical Tools</span>
<span class="sm:hidden">Tools</span>
</button>
<!-- OTC Medicines Tab -->
<button onclick="switchMainTab('otc')" id="tab-otc" class="tab-btn px-3 py-1.5
rounded-lg bg-slate-800 hover:bg-amber-900/50 border border-slate-700
hover:border-amber-500/50 text-xs font-medium text-slate-300 hover:text-amber-400
transition-all flex items-center gap-1">
<svg width="1em" height="1em" viewBox="0 0 24 24" fill="currentColor"
class="text-amber-400"><path d="M8 2a6 6 0 0 1 6 6v8a6 6 0 0 1-12 0V8a6 6 0 0 1 6-6zm8 0a6 6 0
0 1 0 12v-6a6 6 0 0 0-6-6h6z"/></svg>
<span class="hidden sm:inline">OTC Medicines</span>
<span class="sm:hidden">OTC</span>
</button>
</div>
</nav>
<!-- ============ TOOLS TAB CONTENT ============ -->
<div id="content-tools" class="tab-content">
<div class="grid lg:grid-cols-5 gap-6">
<!-- SIDEBAR: OTC Drug Reference -->
<aside class="lg:col-span-1 space-y-4">
<div class="bg-gradient-to-br from-slate-800 to-slate-900 rounded-2xl p-5
border border-slate-700 shadow-xl sticky top-24">
<h3 class="text-cyan-400 font-bold mb-4 flex items-center text-lg">
<svg width="1.2em" height="1.2em" viewBox="0 0 24 24"
fill="currentColor" class="mr-2"><path d="M19 6h-2V4a2 2 0 0 0-2-2h-6a2 2 0 0 0-2 2v2H5a2 2 0
0 0-2 2v12a2 2 0 0 0 2 2h14a2 2 0 0 0 2-2V8a2 2 0 0 0-2-2zm-7 12a3 3 0 1 1 0-6 3 3 0 0 1 0
6z"/></svg> OTC Reference
</h3>
<div id="otc-sidebar" class="space-y-3 h-[600px] overflow-y-auto pr-2">
<!-- Dynamic OTC cards will be rendered here -->
</div>
</div>
</aside>
<!-- MAIN CONTENT -->
<main class="lg:col-span-4 space-y-6">
<!-- VITAL SIGNS INPUT & ANALYSIS -->
<section id="vital-signs-section" class="bg-gradient-to-br from-slate-800
to-slate-900 rounded-2xl p-6 border border-slate-700 shadow-2xl scroll-mt-20">
<div class="flex justify-between items-center mb-6">
<h2 class="text-2xl font-bold text-white flex items-center">
<svg width="1.3em" height="1.3em" viewBox="0 0 24 24"
fill="currentColor" class="mr-3 text-red-500"><path d="M20.84 4.61a5.5 5.5 0 0 0-7.78 0L12
5.67l-1.06-1.06a5.5 5.5 0 0 0-7.78 7.78l1.06 1.06L12 21.23l7.78-7.78 1.06-1.06a5.5 5.5 0 0 0
0-7.78z"/></svg> Vital Signs Simulation
</h2>
<span id="status-badge" class="px-4 py-2 bg-slate-700 rounded-full
text-xs font-mono text-slate-400 font-bold">Enter Vitals</span>
</div>
<!-- Vital Signs Row -->
<div class="grid grid-cols-2 gap-2 mb-4 pb-4 border-b border-slate-700">
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Systolic (mmHg)</label>
<input type="number" id="sys" oninput="liveAnalyze()"
placeholder="120" min="0" max="300" class="w-full bg-slate-900 border border-slate-700 p-2
rounded-xl focus:border-blue-500 focus:ring-2 focus:ring-blue-500/30 outline-none text-base
font-bold text-cyan-400">
</div>
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Diastolic (mmHg)</label>
<input type="number" id="dia" oninput="liveAnalyze()"
placeholder="80" min="0" max="200" class="w-full bg-slate-900 border border-slate-700 p-2
rounded-xl focus:border-blue-500 focus:ring-2 focus:ring-blue-500/30 outline-none text-base
font-bold text-cyan-400">
</div>
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Temp (°C)</label>
<input type="number" id="temp" oninput="liveAnalyze()"
placeholder="37.0" min="35" max="42" step="0.1" class="w-full bg-slate-900 border
border-slate-700 p-2 rounded-xl focus:border-blue-500 focus:ring-2 focus:ring-blue-500/30
outline-none text-base font-bold text-cyan-400">
</div>
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Pulse (BPM)</label>
<input type="number" id="hr" oninput="liveAnalyze()"
placeholder="80" min="0" max="300" class="w-full bg-slate-900 border border-slate-700 p-2
rounded-xl focus:border-blue-500 focus:ring-2 focus:ring-blue-500/30 outline-none text-base
font-bold text-cyan-400">
</div>
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Resp (Rate)</label>
<input type="number" id="rr" oninput="liveAnalyze()"
placeholder="16" min="0" max="60" class="w-full bg-slate-900 border border-slate-700 p-2
rounded-xl focus:border-blue-500 focus:ring-2 focus:ring-blue-500/30 outline-none text-base
font-bold text-cyan-400">
</div>
</div>
<!-- Patient Demographics Row -->
<div class="grid grid-cols-2 gap-2 mb-4 pb-4 border-b border-slate-700">
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Age (years)</label>
<input type="number" id="age" oninput="liveAnalyze()"
placeholder="30" min="0" max="120" class="w-full bg-slate-900 border border-slate-700 p-2
rounded-xl focus:border-green-500 focus:ring-2 focus:ring-green-500/30 outline-none text-sm">
</div>
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Pregnancies</label>
<input type="number" id="pregnancies" oninput="liveAnalyze()"
placeholder="0" min="0" max="20" class="w-full bg-slate-900 border border-slate-700 p-2
rounded-xl focus:border-green-500 focus:ring-2 focus:ring-green-500/30 outline-none text-sm">
</div>
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Currently Pregnant</label>
<select id="pregnant" oninput="liveAnalyze()" class="w-full
bg-slate-900 border border-slate-700 p-2 rounded-xl focus:border-green-500 focus:ring-2
focus:ring-green-500/30 outline-none text-sm">
<option value="no">No</option>
<option value="yes">Yes</option>
</select>
</div>
<div class="space-y-1">
<label class="text-[9px] font-bold text-slate-500 uppercase
tracking-wider">Known Conditions</label>
<select id="conditions" oninput="liveAnalyze();
renderOTCSidebar()" class="w-full bg-slate-900 border border-slate-700 p-2 rounded-xl
focus:border-green-500 focus:ring-2 focus:ring-green-500/30 outline-none text-sm">
<option value="none">None</option>
<option value="hypertension">Hypertension</option>
<option value="diabetes">Diabetes</option>
<option value="asthma">Asthma</option>
<option value="copd">COPD</option>
<option value="ckd">Chronic Kidney Disease</option>
<option value="multiple">Multiple Conditions</option>
</select>
</div>
</div>
<!-- DIAGNOSIS BOX -->
<div id="dx-box" class="p-6 bg-slate-900/70 rounded-xl border
border-slate-700 min-h-[120px] flex items-center justify-center text-slate-500 italic
text-center">
<div class="flex flex-col items-center space-y-2">
<svg class="inline text-3xl text-slate-600 opacity-50"
width="1.3em" height="1.3em" viewBox="0 0 24 24" fill="currentColor"><path d="M3
3v18h18"/></svg>
<p class="text-sm">Enter all vital signs to generate assessment
and medication recommendations...</p>
</div>
</div>
</section>
<!-- TOOLS SECTION: IV CALCULATOR & BMI -->
<div class="grid md:grid-cols-2 gap-6">
<!-- IV FLOW RATE CALCULATOR -->
<div id="iv-calc-section" class="bg-gradient-to-br from-slate-800
to-slate-900 rounded-2xl p-6 border border-slate-700 shadow-2xl scroll-mt-20">
<h3 class="font-bold text-blue-400 mb-4 flex items-center text-lg">
<svg width="1.2em" height="1.2em" viewBox="0 0 24 24"
fill="currentColor" class="mr-2"><path d="M12 2.69l5.66 5.66a8 8 0 1 1-11.32 0z"/></svg> IV
Flow Rate Calculator
</h3>
<div class="space-y-4">
<div class="grid grid-cols-2 gap-3">
<div class="space-y-2">
<label class="text-[10px] font-bold text-slate-500
uppercase">Volume (mL)</label>
<input type="number" id="vol" placeholder="1000" min="0"
class="w-full bg-slate-900 border border-slate-700 p-3 rounded-xl focus:border-blue-500
outline-none text-sm">
</div>
<div class="space-y-2">
<label class="text-[10px] font-bold text-slate-500
uppercase">Time (Hours)</label>
<input type="number" id="hours" placeholder="8" min="0"
step="0.5" class="w-full bg-slate-900 border border-slate-700 p-3 rounded-xl
focus:border-blue-500 outline-none text-sm">
</div>
</div>
<div class="space-y-2">
<label class="text-[10px] font-bold text-slate-500
uppercase">Drop Factor (gtt/mL)</label>
<select id="factor" class="w-full bg-slate-900 border
border-slate-700 p-3 rounded-xl text-sm outline-none focus:border-blue-500">
<option value="10">Macro Drip (10 gtt/mL) -
Blood/Colloids</option>
<option value="15">Macro Drip (15 gtt/mL) -
Standard</option>
<option value="20">Macro Drip (20 gtt/mL) - Fast
Flow</option>
<option value="60">Micro Drip (60 gtt/mL) -
Pediatric/Medication</option>
</select>
</div>
<div id="iv-calcs" class="space-y-3">
<div class="bg-slate-700/30 p-3 rounded-lg border
border-blue-500/30">
<p class="text-[10px] text-slate-400 uppercase">Flow Rate
(mL/hr)</p>
<p id="mlhr" class="text-2xl font-mono font-bold
text-blue-400">--</p>
</div>
<div class="bg-slate-700/30 p-3 rounded-lg border
border-cyan-500/30">
<p class="text-[10px] text-slate-400 uppercase">Drop Rate
(gtt/min)</p>
<p id="iv-result" class="text-2xl font-mono font-bold
text-cyan-400">-- gtt/min</p>
</div>
<div class="bg-amber-900/20 p-2 rounded-lg border
border-amber-700/30">
<p class="text-[9px] text-amber-400 italic">📚 Ref:
Standard IV formula / Verify with CI</p>
</div>
</div>
<button onclick="calcIV()" class="w-full bg-gradient-to-r
from-blue-600 to-blue-500 hover:from-blue-500 hover:to-blue-400 py-3 rounded-xl font-bold
transition-all shadow-lg shadow-blue-900/30">
<svg class="inline mr-2" width="1em" height="1em" viewBox="0 0
24 24" fill="currentColor"><path d="M4 2h16a2 2 0 0 1 2 2v16a2 2 0 0 1-2 2H4a2 2 0 0 1-2-2V4a2
2 0 0 1 2-2zm2 4a1 1 0 0 0 0 2h1a1 1 0 0 0 0-2H6zm4 0a1 1 0 0 0 0 2h1a1 1 0 0 0 0-2h-1zm4 0a1
1 0 0 0 0 2h1a1 1 0 0 0 0-2h-1zm-8 4a1 1 0 0 0 0 2h7a1 1 0 0 0 0-2H6zm0 4a1 1 0 0 0 0 2h7a1 1
0 0 0 0-2H6z"/></svg> Calculate Drip Rate
</button>
</div>
</div>
<!-- BMI & BODY METRICS -->
<div id="bmi-calc-section" class="bg-gradient-to-br from-slate-800
to-slate-900 rounded-2xl p-6 border border-slate-700 shadow-2xl scroll-mt-20">
<h3 class="font-bold text-emerald-400 mb-4 flex items-center text-lg">
<svg width="1.2em" height="1.2em" viewBox="0 0 24 24"
fill="currentColor" class="mr-2"><path d="M13 6.3V5a2 2 0 1 0-4 0v1.3M4 14h16M5 9h14a2 2 0 0 1
2 2v9a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2v-9a2 2 0 0 1 2-2z"/></svg> BMI & Body Metrics
</h3>
<div class="space-y-4">
<div class="grid grid-cols-2 gap-3">
<div class="space-y-2">
<label class="text-[10px] font-bold text-slate-500
uppercase">Weight (kg)</label>
<input type="number" id="weight" placeholder="70" min="0"
class="w-full bg-slate-900 border border-slate-700 p-3 rounded-xl focus:border-emerald-500
outline-none text-sm">
</div>
<div class="space-y-2">
<label class="text-[10px] font-bold text-slate-500
uppercase">Height (cm)</label>
<input type="number" id="height" placeholder="170" min="0"
class="w-full bg-slate-900 border border-slate-700 p-3 rounded-xl focus:border-emerald-500
outline-none text-sm">
</div>
</div>
<div id="bmi-results" class="space-y-3">
<div class="bg-slate-700/30 p-3 rounded-lg border
border-emerald-500/30">
<p class="text-[10px] text-slate-400 uppercase">BMI
Score</p>
<p id="bmi-result" class="text-2xl font-mono font-bold
text-emerald-400">--</p>
<p id="bmi-status" class="text-xs text-slate-400
mt-1">Category: --</p>
</div>
<div class="bg-amber-900/20 p-2 rounded-lg border
border-amber-700/30">
<p class="text-[9px] text-amber-400 italic">📚 Ref: WHO
BMI Classification / Textbook Validation Required</p>
</div>
</div>
<button onclick="calcBMI()" class="w-full bg-gradient-to-r
from-emerald-600 to-emerald-500 hover:from-emerald-500 hover:to-emerald-400 py-3 rounded-xl
font-bold transition-all shadow-lg shadow-emerald-900/30">
<svg class="inline mr-2" width="1em" height="1em" viewBox="0 0
24 24" fill="currentColor"><path d="M4 2h16a2 2 0 0 1 2 2v16a2 2 0 0 1-2 2H4a2 2 0 0 1-2-2V4a2
2 0 0 1 2-2zm2 4a1 1 0 0 0 0 2h1a1 1 0 0 0 0-2H6zm4 0a1 1 0 0 0 0 2h1a1 1 0 0 0 0-2h-1zm4 0a1
1 0 0 0 0 2h1a1 1 0 0 0 0-2h-1zm-8 4a1 1 0 0 0 0 2h7a1 1 0 0 0 0-2H6zm0 4a1 1 0 0 0 0 2h7a1 1
0 0 0 0-2H6z"/></svg> Calculate BMI
</button>
<div class="bg-slate-700/20 p-3 rounded-lg border border-slate-600
text-[11px] text-slate-400">
<p class="font-bold text-slate-300 mb-1">BMI Categories:</p>
<p>Underweight: &lt;18.5 | Normal: 18.5-24.9 | Overweight:
25-29.9 | Obese: ≥30</p>
</div>
</div>
</div>
</div>
<!-- AOG & EDD CALCULATOR SECTION -->
<div id="aog-edd-section" class="mt-6 bg-gradient-to-br from-slate-800
to-slate-900 rounded-2xl p-6 border border-slate-700 shadow-2xl scroll-mt-20">
<h3 class="font-bold text-pink-400 mb-4 flex items-center text-lg">
<svg width="1.2em" height="1.2em" viewBox="0 0 24 24"
fill="currentColor" class="mr-2"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48
10-10S17.52 2 12 2zm-2 15l-5-5 1.41-1.41L10 14.17l7.59-7.59L19 8l-9 9z"/></svg> AOG & EDD
Calculator
</h3>
<div class="grid md:grid-cols-2 gap-6">
<!-- Input Section -->
<div class="space-y-4">
<div class="space-y-2">
<label class="text-[10px] font-bold text-slate-500
uppercase">Last Menstrual Period (LMP)</label>
<input type="date" id="lmp-date" class="w-full bg-slate-900
border border-slate-700 p-3 rounded-xl focus:border-pink-500 outline-none text-sm
text-slate-200" style="color-scheme: dark;">
</div>
<div class="space-y-2">
<label class="text-[10px] font-bold text-slate-500
uppercase">Calculation Date</label>
<input type="date" id="calc-date" class="w-full bg-slate-900
border border-slate-700 p-3 rounded-xl focus:border-pink-500 outline-none text-sm
text-slate-200" style="color-scheme: dark;">
</div>
<button onclick="calcAOGEDD()" class="w-full bg-gradient-to-r
from-pink-600 to-pink-500 hover:from-pink-500 hover:to-pink-400 py-3 rounded-xl font-bold
transition-all shadow-lg shadow-pink-900/30">
<svg class="inline mr-2" width="1em" height="1em" viewBox="0 0
24 24" fill="currentColor"><path d="M19 3h-1V1h-2v2H8V1H6v2H5c-1.1 0-2 .9-2 2v14c0 1.1.9 2 2
2h14c1.1 0 2-.9 2-2V5c0-1.1-.9-2-2-2zm0 16H5V8h14v11z"/></svg> Calculate AOG & EDD
</button>
<div class="bg-slate-700/20 p-3 rounded-lg border border-slate-600
text-[11px] text-slate-400">
<p class="font-bold text-slate-300 mb-1">📋 Naegele's
Rule:</p>
<p>EDD = LMP + 7 days − 3 months + 1 year</p>
<p class="mt-1 text-[10px]">Assumes 28-day cycle with
ovulation on day 14. Full term: 37-42 weeks.</p>
</div>
</div>
<!-- Results Section -->
<div class="space-y-3">
<div class="bg-slate-700/30 p-4 rounded-lg border
border-pink-500/30">
<p class="text-[10px] text-slate-400 uppercase">Age of
Gestation (AOG)</p>
<p id="aog-result" class="text-2xl font-mono font-bold
text-pink-400">-- weeks, -- days</p>
<p id="aog-days" class="text-xs text-slate-500 mt-1">Total: --
days</p>
</div>
<div class="bg-slate-700/30 p-4 rounded-lg border
border-purple-500/30">
<p class="text-[10px] text-slate-400 uppercase">Estimated Date
of Delivery (EDD)</p>
<p id="edd-result" class="text-2xl font-mono font-bold
text-purple-400">--</p>
<p id="edd-remaining" class="text-xs text-slate-500 mt-1">--
days remaining</p>
</div>
<div class="bg-slate-700/30 p-3 rounded-lg border
border-cyan-500/30">
<p class="text-[10px] text-slate-400 uppercase">Current
Trimester</p>
<p id="trimester-result" class="text-lg font-bold
text-cyan-400">--</p>
<p id="trimester-info" class="text-xs text-slate-500
mt-1">--</p>
</div>
<div id="pregnancy-milestones" class="bg-slate-900/50 p-3
rounded-lg border border-slate-700 hidden">
<p class="text-[10px] text-slate-400 uppercase mb-2">Key
Milestones</p>
<div id="milestones-list" class="text-xs text-slate-300
space-y-1"></div>
</div>
<div class="bg-amber-900/20 p-2 rounded-lg border
border-amber-700/30">
<p class="text-[9px] text-amber-400 italic">📚 Educational
reference only. Actual EDD should be confirmed by ultrasound & physician assessment.</p>
</div>
</div>
</div>
</div>
</main>
</div>
</div> <!-- End content-tools -->
</div>
<!-- ============ OTC MEDICINES TAB CONTENT ============ -->
<div id="content-otc" class="tab-content hidden max-w-7xl mx-auto px-3 sm:px-4
md:px-6">
<section id="otc-section" class="rounded-2xl p-4 sm:p-6 border border-slate-700
shadow-2xl scroll-mt-20" style="background: linear-gradient(135deg, #1e293b 0%, #0f172a
100%);">
<div class="flex flex-col sm:flex-row items-start sm:items-center justify-between
mb-4 gap-3">
<h2 class="text-lg sm:text-xl font-bold text-white flex items-center">
<svg width="1.2em" height="1.2em" viewBox="0 0 24 24" fill="currentColor"
class="mr-3 text-amber-400"><path d="M8 2a6 6 0 0 1 6 6v8a6 6 0 0 1-12 0V8a6 6 0 0 1 6-6zm8
0a6 6 0 0 1 0 12v-6a6 6 0 0 0-6-6h6z"/></svg> OTC Reference Directory
</h2>
<div class="w-full sm:w-1/2 md:w-1/3">
<input id="otc-search" type="search" placeholder="Search conditions or
medicine..." class="w-full border border-slate-700 p-3 rounded-xl text-sm outline-none"
style="background-color: #0f172a;" />
</div>
</div>
<div class="grid grid-cols-1 md:grid-cols-2 gap-4 sm:gap-6">
<div id="otc-list-container" class="order-2 md:order-1">
<div id="otc-list" class="space-y-3 max-h-[60vh] sm:max-h-[420px]
overflow-y-auto pr-2"></div>
</div>
<div id="otc-detail-container" class="order-1 md:order-2 hidden md:block">
<button id="otc-back-btn" onclick="hideOTCDetail()" class="md:hidden
w-full mb-3 py-2 px-4 rounded-xl font-semibold text-sm flex items-center justify-center gap-2"
style="background: linear-gradient(135deg, #475569, #334155); color: #cbd5e1; border: 1px
solid #475569;">
<span>←</span> Back to List
</button>
<div id="otc-detail" class="p-4 rounded-xl border border-slate-700
min-h-[200px] sm:min-h-[240px] text-slate-300 text-sm w-full" style="background-color:
#0f172a;">
<p class="text-slate-400 text-sm">Select an item to view full details.
Use the search to find a condition or brand name.</p>
</div>
</div>
</div>
</section>
</div> <!-- End content-otc -->
<footer class="mt-12 py-6 text-center text-slate-500 border-t border-slate-800">
<p class="text-xs">This tool is for educational purposes only. Always consult
qualified healthcare professionals. Data is not stored.</p>
</footer>
<script>
// ============= VITAL SIGNS REFERENCE DATABASE =============
const vitalSignsReference = {
ageGroups: {
infant: { name: "Infant (0-1y)", range: [0, 1], pulse: { min: 100, max: 160 },
rr: { min: 30, max: 60 }, bpSys: { min: 70, max: 90 }, bpDia: { min: 45, max: 55 } },
toddler: { name: "Toddler (1-3y)", range: [1, 3], pulse: { min: 90, max: 150
}, rr: { min: 24, max: 40 }, bpSys: { min: 80, max: 100 }, bpDia: { min: 55, max: 65 } },
preschool: { name: "Preschool (3-6y)", range: [3, 6], pulse: { min: 80, max:
120 }, rr: { min: 22, max: 34 }, bpSys: { min: 85, max: 110 }, bpDia: { min: 60, max: 70 } },
schoolAge: { name: "School Age (6-12y)", range: [6, 12], pulse: { min: 70,
max: 110 }, rr: { min: 18, max: 30 }, bpSys: { min: 90, max: 110 }, bpDia: { min: 60, max: 75
} },
adolescent: { name: "Adolescent (12-18y)", range: [12, 18], pulse: { min: 60,
max: 100 }, rr: { min: 12, max: 20 }, bpSys: { min: 100, max: 130 }, bpDia: { min: 65, max: 85
} },
adult: { name: "Adult (18+y)", range: [18, 120], pulse: { min: 60, max: 100 },
rr: { min: 12, max: 20 }, bpSys: { min: 110, max: 120 }, bpDia: { min: 70, max: 80 } },
elderly: { name: "Elderly (65+y)", range: [65, 120], pulse: { min: 55, max:
100 }, rr: { min: 12, max: 22 }, bpSys: { min: 130, max: 150 }, bpDia: { min: 70, max: 90 } }
},
pregnancy: {
notes: "Pregnant women typically have 15-20% increased cardiac output and
blood volume",
pulseIncrease: 10, // BPM increase during pregnancy
systolicIncrease: 0, // Usually stays same or slightly lower
diastolicDecrease: 5, // Often drops slightly
respiratoryIncrease: 1, // Slight increase
normalBP: { sys: [110, 135], dia: [70, 85] },
gestationalHypertension: { sys: 140, dia: 90 }, // ≥140/90
preeclampsia: { sys: 160, dia: 110 } // ≥160/110
},
comorbidities: {
hypertension: {
name: "Hypertension",
systolicTarget: 140,
diastolicTarget: 90,
severity: "ELEVATED",
notes: "Persistent elevation; aim for <130/80 if tolerated"
},
diabetes: {
name: "Diabetes",
systolicTarget: 140,
diastolicTarget: 90,
fever: "Monitor for DKA (fever + tachycardia + tachypnea)",
notes: "May have reduced fever response; check glucose"
},
asthma: {
name: "Asthma",
rrAlert: 25,
notes: "Increased RR may indicate asthma exacerbation; listen for wheeze"
},
copd: {
name: "COPD",
rrAlert: 25,
notes: "Chronic baseline elevation; major change concerning; watch for
exacerbation"
},
ckd: {
name: "Chronic Kidney Disease",
systolicTarget: 130,
diastolicTarget: 80,
notes: "Stricter BP control needed; avoid NSAIDs; monitor fluid balance"
}
}
};
// ============= DIAGNOSIS DATABASE (Simulation Reference) =============
const diagnosisDatabase = {
fever: { symptoms: "High temperature (>38°C)", meds: ["Ref: Acetaminophen
(500-1000mg)", "Ref: Ibuprofen (200-400mg with food)"], actions: "📚 In simulation, monitor
for dehydration signs, document fluid intake, consider cooling measures if >40°C. Verify
protocol with CI." },
hypothermia: { symptoms: "Low temperature (<35°C)", meds: ["Ref: Passive rewarming
measures"], actions: "📋 Simulation Note: Indicates critical hypothermia; follow institutional
thermal regulation protocols. Priority: Faculty notification required." },
hypertensiveCrisis: { symptoms: "BP ≥180/120", meds: ["No OTC intervention
indicated"], actions: "📋 Simulation Note: In a clinical setting, this represents a
hypertensive emergency. Priority: Instructor notification required for simulation guidance."
},
hypertension: { symptoms: "BP 140-179 systolic or 90-119 diastolic", meds: ["Ref:
Lifestyle modifications (sodium reduction, rest)"], actions: "📚 In simulation, recheck BP in
5-10 min. Document associated symptoms (headache, chest pain, SOB). Consult textbook for
staging." },
tachycardia: { symptoms: "Heart rate >100 BPM", meds: ["Ref: Non-pharmacological
interventions (positioning, environment)"], actions: "📚 In simulation, assess for
contributing factors (pain, anxiety, fever). Document rhythm characteristics." },
bradycardia: { symptoms: "Heart rate <60 BPM (abnormal)", meds: ["Ref: Monitor and
document"], actions: "📚 Academic Note: May be physiologic in athletes. In simulation,
document associated symptoms (dizziness, weakness)." },
tachypnea: { symptoms: "Respiratory rate >20/min", meds: ["Ref: Supplemental O2 if
SpO2 <94%", "Ref: Anxiety reduction techniques"], actions: "📚 In simulation, assess for
underlying causes (anxiety, pain, infection). Document oxygen saturation if available." },
hypoxia: { symptoms: "SpO2 <94% (if measured)", meds: ["Ref: Oxygen therapy per
protocol"], actions: "📚 In simulation, elevate HOB, ensure airway patency. Document SpO2
trend. Consult CI for intervention guidance." }
};
// Helper: Get age group from age
function getAgeGroup(age) {
if (age < 1) return vitalSignsReference.ageGroups.infant;
if (age < 3) return vitalSignsReference.ageGroups.toddler;
if (age < 6) return vitalSignsReference.ageGroups.preschool;
if (age < 12) return vitalSignsReference.ageGroups.schoolAge;
if (age < 18) return vitalSignsReference.ageGroups.adolescent;
if (age >= 65) return vitalSignsReference.ageGroups.elderly;
return vitalSignsReference.ageGroups.adult;
}
function generateDiagnosis(sys, dia, temp, hr, rr, age, pregnancies, pregnant,
conditions) {
let diagnosis = [];
let priority = "STABLE";
let color = "text-slate-400";
let recommendations = [];
let contextNotes = [];
// ===== PATIENT PROFILE SETUP =====
const isPregnant = pregnant === 'yes';
const ageGroup = getAgeGroup(age);
const hasComorbidity = conditions !== 'none';
const comorbidityData = hasComorbidity ?
vitalSignsReference.comorbidities[conditions] : null;
// Add patient context
contextNotes.push(`📋 Patient: ${ageGroup.name}${isPregnant ? ' | PREGNANT (' +
pregnancies + ' previous)' : ''}`);
if (hasComorbidity) contextNotes.push(`⚠️ Known condition:
${comorbidityData.name}`);
// Adjust vital sign targets based on pregnancy
let hrTarget = { min: ageGroup.pulse.min, max: ageGroup.pulse.max };
let rrTarget = { min: ageGroup.rr.min, max: ageGroup.rr.max };
let bpSysTarget = { min: ageGroup.bpSys.min, max: ageGroup.bpSys.max };
let bpDiaTarget = { min: ageGroup.bpDia.min, max: ageGroup.bpDia.max };
if (isPregnant) {
hrTarget.max += vitalSignsReference.pregnancy.pulseIncrease; // Allow +10 BPM
bpSysTarget.min = vitalSignsReference.pregnancy.normalBP.sys[0];
bpSysTarget.max = vitalSignsReference.pregnancy.normalBP.sys[1];
bpDiaTarget.min = vitalSignsReference.pregnancy.normalBP.dia[0];
bpDiaTarget.max = vitalSignsReference.pregnancy.normalBP.dia[1];
}
// ===== BP ASSESSMENT =====
// Check for critically low diastolic first
if (dia > 0 && dia < 40) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Low Diastolic (DBP <40)",
severity: "CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📚 Ref Note: Diastolic <40 mmHg suggests severe
hypoperfusion in simulation. Priority: Faculty/Instructor notification required for
guidance.");
} else if (dia > 0 && dia < 60) {
diagnosis.push({ name: "Low Diastolic Pressure (DBP <60)", severity:
"MONITOR", icon: "fa-arrow-down" });
if (priority === "STABLE") priority = "ELEVATED";
contextNotes.push(`📋 Simulation Finding: Diastolic ${dia} mmHg is below
reference range. In a clinical setting, this suggests monitoring for orthostatic symptoms.`);
}
// Systolic checks
if (sys > 0 && sys < 70) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Hypotension (SBP <70)", severity:
"CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📚 Ref Note: SBP <70 mmHg represents severe hypotension in
simulation. In a clinical setting, this indicates hemodynamic instability. Priority: Faculty
notification required.");
} else if (sys > 0 && sys < bpSysTarget.min) {
diagnosis.push({ name: `⚠️ SIM ALERT: Hypotension (Below ${ageGroup.name}
Range)`, severity: "CRITICAL", icon: "fa-arrow-down" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push(`📋 Simulation Finding: Systolic ${sys} is below reference
for ${ageGroup.name} (normal: ${bpSysTarget.min}-${bpSysTarget.max}). Consult textbook for
age-specific interventions.`);
} else if (sys >= 180 || (dia && dia >= 120)) {
diagnosis.push({ name: "⚠️ SIM ALERT: Hypertensive Crisis Pattern (SBP
≥180/DBP ≥120)", severity: "CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
recommendations.push(diagnosisDatabase.hypertensiveCrisis);
} else if (isPregnant && sys >= vitalSignsReference.pregnancy.preeclampsia.sys) {
diagnosis.push({ name: "⚠️ SIM ALERT: Preeclampsia Pattern (BP ≥160/110)",
severity: "CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📚 Ref Note: In simulation, severely elevated BP in
pregnancy suggests preeclampsia pattern. Assess for proteinuria, edema, headache. Priority:
Instructor notification required.");
} else if (isPregnant && sys >=
vitalSignsReference.pregnancy.gestationalHypertension.sys) {
diagnosis.push({ name: "Gestational Hypertension Pattern (SBP ≥140/DBP ≥90)",
severity: "ELEVATED", icon: "fa-arrow-up" });
priority = "ELEVATED";
color = "text-orange-500";
contextNotes.push("📋 Simulation Finding: In a clinical setting, this pattern
requires monitoring for progression to preeclampsia.");
} else if (sys >= 160 || (dia && dia >= 100)) {
diagnosis.push({ name: "Severe Hypertension Pattern (SBP 160-179 or DBP
100-109)", severity: "ELEVATED", icon: "fa-arrow-up" });
priority = priority === "CRITICAL" ? "CRITICAL" : "ELEVATED";
color = "text-orange-500";
if (!isPregnant) recommendations.push(diagnosisDatabase.hypertension);
} else if (sys >= 140 || (dia && dia >= 90)) {
diagnosis.push({ name: "Hypertension Pattern (SBP 140-159 or DBP 90-99)",
severity: "ELEVATED", icon: "fa-arrow-up" });
priority = priority === "CRITICAL" ? "CRITICAL" : "ELEVATED";
color = "text-orange-500";
if (!isPregnant) recommendations.push(diagnosisDatabase.hypertension);
} else if (sys >= bpSysTarget.max) {
diagnosis.push({ name: `Mildly Elevated BP (Above ${ageGroup.name}
Reference)`, severity: "MONITOR", icon: "fa-arrow-up-long" });
contextNotes.push(`📋 Simulation Finding: Systolic ${sys} is slightly above
reference for ${ageGroup.name} (normal: ${bpSysTarget.min}-${bpSysTarget.max}).`);
}
// ===== TEMPERATURE ASSESSMENT =====
if (temp > 0) {
if (temp <= 28) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Hypothermia (≤28°C)",
severity: "CRITICAL", icon: "fa-snowflake" });
priority = "CRITICAL";
color = "text-blue-500";
contextNotes.push("📋 Simulation Note: Temperature ≤28°C indicates
critical hypothermia pattern. In simulation, this requires immediate faculty-led intervention
per institutional thermal regulation protocols.");
} else if (temp <= 35.0) {
diagnosis.push({ name: "⚠️ SIM ALERT: Hypothermia (28-35°C)", severity:
"CRITICAL", icon: "fa-snowflake" });
priority = "CRITICAL";
color = "text-blue-400";
recommendations.push(diagnosisDatabase.hypothermia);
} else if (temp >= 40.5) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Hyperthermia (≥40.5°C)",
severity: "CRITICAL", icon: "fa-fire" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📋 Simulation Note: Temperature ≥40.5°C suggests heat
stroke pattern. In a clinical setting, this requires immediate cooling interventions.
Priority: Instructor notification required.");
} else if (temp >= 40.0) {
diagnosis.push({ name: "⚠️ SIM ALERT: Very High Fever (40.0-40.4°C)",
severity: "CRITICAL", icon: "fa-fire" });
priority = "CRITICAL";
color = "text-red-500";
recommendations.push(diagnosisDatabase.fever);
} else {
// Age-adjusted fever thresholds
let feverThreshold = 38.0;
if (age < 3) feverThreshold = 38.5;
if (age >= 65) feverThreshold = 37.5;
if (temp >= 39.5) {
diagnosis.push({ name: "High Fever Pattern (39.5-39.9°C)", severity:
"CRITICAL", icon: "fa-fire" });
color = "text-red-500";
recommendations.push(diagnosisDatabase.fever);
if (conditions === 'diabetes') contextNotes.push("📚 Academic Note:
Diabetic patient with fever pattern - in simulation, monitor for DKA signs and infection
indicators.");
} else if (temp >= 38.5) {
diagnosis.push({ name: "Moderate Fever Pattern (38.5-39.4°C)",
severity: "MONITOR", icon: "fa-fire" });
color = "text-orange-500";
recommendations.push(diagnosisDatabase.fever);
} else if (temp >= feverThreshold) {
diagnosis.push({ name: `Mild Fever Pattern
(${feverThreshold}-38.4°C)`, severity: "MONITOR", icon: "fa-thermometer" });
recommendations.push(diagnosisDatabase.fever);
}
}
}
// ===== HEART RATE ASSESSMENT (Age-Group Adjusted) =====
if (hr > 0 && hr < 30) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Bradycardia (HR <30)", severity:
"CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📚 Ref Note: HR <30 indicates severe bradycardia pattern.
In simulation, assess consciousness & pulse quality. Priority: Faculty notification
required.");
} else if (hr > 200) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Tachycardia (HR >200)", severity:
"CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📚 Ref Note: HR >200 indicates severe tachycardia pattern.
In a clinical setting, this suggests arrhythmia, sepsis, or shock. Priority: Instructor
notification required.");
} else if (hr > 0 && hr < hrTarget.min) {
diagnosis.push({ name: `Bradycardia Pattern (Below ${ageGroup.name} Reference:
HR ${hr})`, severity: "MONITOR", icon: "fa-heart" });
contextNotes.push(`📋 Simulation Finding: HR ${hr} is below reference for
${ageGroup.name} (normal: ${hrTarget.min}-${hrTarget.max}). Consult textbook for assessment
criteria.`);
recommendations.push(diagnosisDatabase.bradycardia);
} else if (hr > hrTarget.max && hr <= hrTarget.max + 20) {
let note = `Mild Tachycardia Pattern (HR ${hr})`;
if (isPregnant) note += " (within pregnancy range)";
if (temp >= 38.0) note += " (fever-related)";
diagnosis.push({ name: note, severity: "MONITOR", icon: "fa-heart" });
contextNotes.push(`📋 Simulation Finding: HR ${hr} is slightly above reference
for ${ageGroup.name} (normal: ${hrTarget.min}-${hrTarget.max}).`);
} else if (hr > hrTarget.max + 20 && hr <= hrTarget.max + 40) {
let note = `Tachycardia Pattern (HR ${hr})`;
if (temp >= 38.0) note += " (fever-related)";
diagnosis.push({ name: note, severity: "MONITOR", icon: "fa-heart" });
contextNotes.push(`📋 Simulation Finding: HR ${hr} exceeds reference for
${ageGroup.name} (normal: ${hrTarget.min}-${hrTarget.max}).`);
recommendations.push(diagnosisDatabase.tachycardia);
} else if (hr > hrTarget.max + 40) {
diagnosis.push({ name: `⚠️ SIM ALERT: Severe Tachycardia (HR ${hr})`,
severity: "CRITICAL", icon: "fa-exclamation-triangle" });
priority = priority === "STABLE" ? "CRITICAL" : priority;
color = "text-red-500";
contextNotes.push(`📚 Ref Note: HR ${hr} is significantly elevated. In a
clinical setting, this suggests shock, sepsis, or severe underlying condition.`);
}
// ===== RESPIRATORY RATE ASSESSMENT (Age-Group Adjusted) =====
if (rr > 0 && rr < 8) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Respiratory Depression (RR <8)",
severity: "CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📋 Simulation Note: RR <8 indicates severe respiratory
depression pattern. In simulation, this represents respiratory failure risk requiring
immediate faculty-led intervention.");
} else if (rr > 50) {
diagnosis.push({ name: "⚠️ SIM ALERT: Severe Tachypnea (RR >50)", severity:
"CRITICAL", icon: "fa-exclamation-triangle" });
priority = "CRITICAL";
color = "text-red-500";
contextNotes.push("📚 Ref Note: RR >50 indicates severe respiratory distress
pattern. Priority: Faculty/Instructor notification required for simulation guidance.");
} else if (rr > 0 && rr < rrTarget.min) {
diagnosis.push({ name: `Bradypnea Pattern (Below ${ageGroup.name} Reference:
RR ${rr})`, severity: "MONITOR", icon: "fa-wind" });
contextNotes.push(`📋 Simulation Finding: RR ${rr} is below reference for
${ageGroup.name} (normal: ${rrTarget.min}-${rrTarget.max}).`);
} else if (rr > rrTarget.max && rr <= rrTarget.max + 5) {
let note = `Mild Tachypnea Pattern (RR ${rr})`;
if (conditions === 'asthma' || conditions === 'copd') note += " (monitor for
exacerbation)";
diagnosis.push({ name: note, severity: "MONITOR", icon: "fa-wind" });
contextNotes.push(`📋 Simulation Finding: RR ${rr} is slightly above reference
for ${ageGroup.name} (normal: ${rrTarget.min}-${rrTarget.max}).`);
} else if (rr > rrTarget.max + 5 && rr <= rrTarget.max + 15) {
let note = `Tachypnea Pattern (RR ${rr})`;
if (conditions === 'asthma' || conditions === 'copd') note += " (exacerbation
indicator)";
diagnosis.push({ name: note, severity: "MONITOR", icon: "fa-wind" });
contextNotes.push(`📋 Simulation Finding: RR ${rr} exceeds reference for
${ageGroup.name} (normal: ${rrTarget.min}-${rrTarget.max}).`);
recommendations.push(diagnosisDatabase.tachypnea);
} else if (rr > rrTarget.max + 15) {
let note = `⚠️ SIM ALERT: Severe Tachypnea (RR ${rr})`;
if (conditions === 'asthma' || conditions === 'copd') note += " (EXACERBATION
PATTERN)";
diagnosis.push({ name: note, severity: "CRITICAL", icon:
"fa-exclamation-triangle" });
priority = priority === "STABLE" ? "CRITICAL" : priority;
color = "text-red-500";
contextNotes.push(`📚 Ref Note: RR ${rr} is significantly elevated. In a
clinical setting, this suggests respiratory distress or hypoxia.`);
}
// ===== COMORBIDITY-SPECIFIC CHECKS =====
if (hasComorbidity) {
if (conditions === 'ckd' && sys >
vitalSignsReference.comorbidities.ckd.systolicTarget) {
contextNotes.push("� Academic Note: CKD patient - in simulation, strict BP
control is emphasized. Current reading exceeds textbook target. Ref: Avoid NSAIDs in CKD.");
}
if (conditions === 'asthma' && rr > 25) {
contextNotes.push("📚 Academic Note: Asthma patient with elevated RR - in
simulation, auscultate for wheeze. This pattern may indicate exacerbation.");
}
if (conditions === 'copd' && rr > 25) {
contextNotes.push("📚 Academic Note: COPD patient - RR elevated. In
simulation, compare to patient's baseline. Consider COPD exacerbation pattern.");
}
}
return { diagnosis, priority, color, recommendations, contextNotes };
}
function liveAnalyze() {
const sys = parseInt(document.getElementById('sys').value);
const dia = parseInt(document.getElementById('dia').value);
const temp = parseFloat(document.getElementById('temp').value);
const hr = parseInt(document.getElementById('hr').value);
const rr = parseInt(document.getElementById('rr').value);
const age = parseInt(document.getElementById('age').value);
const pregnancies = parseInt(document.getElementById('pregnancies').value);
const pregnant = document.getElementById('pregnant').value;
const conditions = document.getElementById('conditions').value;
const box = document.getElementById('dx-box');
const badge = document.getElementById('status-badge');
if (!sys && !temp && !hr && !rr) {
box.innerHTML = `<div class="flex flex-col items-center space-y-2">
<svg class="inline text-3xl text-slate-600 opacity-50" width="1.3em"
height="1.3em" viewBox="0 0 24 24" fill="currentColor"><path d="M3 3v18h18"/></svg>
<p class="text-sm text-slate-500">Enter all vital signs to generate
assessment and medication recommendations...</p>
</div>`;
return;
}
const { diagnosis, priority, color, recommendations, contextNotes } =
generateDiagnosis(sys, dia, temp, hr, rr, age, pregnancies, pregnant, conditions);
if (diagnosis.length > 0) {
let html = `<div class="w-full space-y-4">`;
// Context Notes
if (contextNotes.length > 0) {
html += `<div class="bg-blue-900/30 border border-blue-700/50 p-3
rounded-lg space-y-1">`;
contextNotes.forEach(note => {
html += `<p class="text-xs text-blue-300">${note}</p>`;
});
html += `</div>`;
}
// Findings
html += `<div class="space-y-2">
<p class="font-bold text-slate-300 text-left text-sm">📋 Simulation
Findings:</p>
<ul class="text-left w-full pl-4 space-y-1">`;
diagnosis.forEach(d => {
const iconSvg = getIconSvg(d.icon);
html += `<li class="text-white text-sm">
${iconSvg} ${d.name}
</li>`;
});
html += `</ul></div>`;
// Citation Reference
html += `<div class="bg-amber-900/20 border border-amber-700/50 p-2 rounded-lg
mt-3">
<p class="text-[10px] text-amber-400 italic">📚 Ref: Standard Nursing
Protocol / Textbook Validation Required</p>
</div>`;
// Recommendations
if (recommendations.length > 0) {
html += `<div class="bg-slate-800/50 p-4 rounded-lg border
border-slate-700 space-y-3">`;
recommendations.forEach((rec, idx) => {
html += `<div class="space-y-2">
<p class="font-bold text-cyan-400 text-sm">� Reference ${idx +
1}:</p>
<p class="text-xs text-slate-300"><strong>Reference OTC:</strong>
${rec.meds.join(", ")}</p>
<p class="text-xs text-slate-400"><strong>Consideration:</strong>
${rec.actions}</p>
<p class="text-[10px] text-amber-400/70 italic">⚠️ Verify with CI
before any application</p>
</div>`;
});
html += `</div>`;
}
html += `</div>`;
box.innerHTML = html;
box.className = "p-6 bg-slate-700/20 rounded-xl border border-blue-500/50
min-h-[120px] flex items-center italic text-sm";
// Map internal priority to simulation-friendly display text
let displayPriority = priority;
let badgeColor = color;
if (priority === "CRITICAL") {
displayPriority = "⚠️ SIM ALERT";
badgeColor = "text-amber-400";
}
else if (priority === "ELEVATED") {
displayPriority = "📋 MONITOR REF";
badgeColor = "text-amber-400";
}
else if (priority === "STABLE") displayPriority = "✓ BASELINE";
badge.innerText = displayPriority;
badge.className = `px-4 py-2 rounded-full text-xs font-bold font-mono
${badgeColor} bg-slate-800 border border-current shadow-lg`;
} else {
box.innerHTML = `<div class="text-center text-slate-400">
<svg class="inline text-2xl text-green-500 mb-2" width="1.2em"
height="1.2em" viewBox="0 0 24 24" fill="currentColor"><path d="M12 2C6.48 2 2 6.48 2 12s4.48
10 10 10 10-4.48 10-10S17.52 2 12 2zm-2 15l-5-5 1.41-1.41L10 14.17l7.59-7.59L19 8l-9
9z"/></svg>
<p class="text-sm">Vitals appear within reference range</p>
<p class="text-[10px] text-amber-400 mt-2 italic">📚 Verify interpretation
with CI & textbooks</p>
</div>`;
badge.innerText = "✓ BASELINE";
badge.className = `px-4 py-2 rounded-full text-xs font-bold font-mono
text-green-400 bg-slate-800 border border-green-500 shadow-lg`;
}
}
function renderOTCSidebar() {
const conditions = document.getElementById('conditions').value;
const container = document.getElementById('otc-sidebar');
container.innerHTML = '';
const colors = ['yellow-500', 'orange-500', 'purple-500', 'red-500', 'green-500',
'blue-500', 'pink-500', 'indigo-500'];
otcDatabase.forEach((med, index) => {
const color = colors[index % colors.length];
const borderClass = `border-l-4 border-${color}`;
const hoverClass = `hover:border-${color.replace('500', '400')}`;
let safetyStatus = 'SAFE';
let safetyIcon = '🟢';
let warningText = '';
if (conditions && med.conditionSafety[conditions]) {
safetyStatus = med.conditionSafety[conditions];
if (safetyStatus === '⚠️ CONTRAINDICATED') {
safetyIcon = '🔴';
warningText = `⚠️ AVOID with ${conditions.toUpperCase()}`;
} else if (safetyStatus === 'CAUTION') {
safetyIcon = '🟡';
warningText = `⚠️ USE WITH CAUTION with ${conditions.toUpperCase()}`;
}
}
const brandNames = med.ph_brands ? med.ph_brands.join(' • ') : 'N/A';
const card = document.createElement('div');
card.className = `bg-slate-700/50 p-3 rounded-xl ${borderClass} ${hoverClass}
transition-all cursor-pointer hover:bg-slate-700/70`;
card.innerHTML = `
<p class="font-bold text-sm text-sky-300">${med.name}</p>
<p class="text-[10px] text-slate-500 font-semibold">PH Brands:
${brandNames}</p>
${warningText ? `<p class="text-[10px] mt-1 text-red-400
font-bold">${warningText}</p>` : ''}
<p class="text-[11px] mt-1 text-slate-300">${med.uses}</p>
<p class="text-[10px] text-slate-400 italic mt-1">When:
${med.whenToGive}</p>
`;
card.onclick = () => showOTCDetail(med);
container.appendChild(card);
});
}
function calcIV() {
const vol = parseFloat(document.getElementById('vol').value);
const hours = parseFloat(document.getElementById('hours').value);
const factor = parseFloat(document.getElementById('factor').value);
if(vol && hours) {
const mlPerHour = vol / hours;
const gttPerMin = Math.round((mlPerHour / 60) * factor);
document.getElementById('mlhr').innerText = mlPerHour.toFixed(1) + " mL/hr";
document.getElementById('iv-result').innerText = gttPerMin + " gtt/min";
} else {
document.getElementById('iv-result').innerText = "-- gtt/min";
document.getElementById('mlhr').innerText = "-- mL/hr";
}
}
function calcBMI() {
const w = parseFloat(document.getElementById('weight').value);
const h = parseFloat(document.getElementById('height').value) / 100;
if(w && h && h > 0) {
const bmi = (w / (h * h)).toFixed(1);
let category = "Normal Weight";
let categoryColor = "text-green-400";
if (bmi < 18.5) {
category = "Underweight";
categoryColor = "text-blue-400";
} else if (bmi < 25) {
category = "Normal Weight";
categoryColor = "text-green-400";
} else if (bmi < 30) {
category = "Overweight";
categoryColor = "text-yellow-400";
} else {
category = "Obese";
categoryColor = "text-red-400";
}
document.getElementById('bmi-result').innerText = bmi;
document.getElementById('bmi-status').innerHTML = `<span
class="${categoryColor} font-bold">Category: ${category}</span>`;
}
}
// ============= TAB SWITCHING FUNCTION =============
function switchMainTab(tab) {
// Hide all tab contents
document.getElementById('content-tools').classList.add('hidden');
document.getElementById('content-otc').classList.add('hidden');
// Remove active state from all tab buttons
document.getElementById('tab-tools').classList.remove('active', 'bg-cyan-900/50',
'border-cyan-500/50', 'text-cyan-400');
document.getElementById('tab-tools').classList.add('bg-slate-800',
'border-slate-700', 'text-slate-300');
document.getElementById('tab-otc').classList.remove('active', 'bg-amber-900/50',
'border-amber-500/50', 'text-amber-400');
document.getElementById('tab-otc').classList.add('bg-slate-800',
'border-slate-700', 'text-slate-300');
// Show selected tab content and activate button
if (tab === 'tools') {
document.getElementById('content-tools').classList.remove('hidden');
document.getElementById('tab-tools').classList.remove('bg-slate-800',
'border-slate-700', 'text-slate-300');
document.getElementById('tab-tools').classList.add('active', 'bg-cyan-900/50',
'border-cyan-500/50', 'text-cyan-400');
} else if (tab === 'otc') {
document.getElementById('content-otc').classList.remove('hidden');
document.getElementById('tab-otc').classList.remove('bg-slate-800',
'border-slate-700', 'text-slate-300');
document.getElementById('tab-otc').classList.add('active', 'bg-amber-900/50',
'border-amber-500/50', 'text-amber-400');
// Reset to initial preview count and re-render OTC list when switching to tab
otcVisibleCount = OTC_INCREMENT;
renderOTCList('');
}
// Scroll to top of content
window.scrollTo({ top: 0, behavior: 'smooth' });
}
// ============= AOG & EDD CALCULATOR =============
function calcAOGEDD() {
const lmpInput = document.getElementById('lmp-date').value;
const calcDateInput = document.getElementById('calc-date').value;
if (!lmpInput) {
document.getElementById('aog-result').innerText = 'Please enter LMP date';
document.getElementById('aog-result').className = 'text-lg font-mono font-bold
text-red-400';
return;
}
const lmp = new Date(lmpInput);
const calcDate = calcDateInput ? new Date(calcDateInput) : new Date();
// Validate dates
if (lmp > calcDate) {
document.getElementById('aog-result').innerText = 'LMP cannot be after
calculation date';
document.getElementById('aog-result').className = 'text-lg font-mono font-bold
text-red-400';
return;
}
// Calculate AOG (Age of Gestation)
const diffTime = calcDate - lmp;
const totalDays = Math.floor(diffTime / (1000 * 60 * 60 * 24));
const weeks = Math.floor(totalDays / 7);
const days = totalDays % 7;
// Calculate EDD using Naegele's Rule: LMP + 7 days - 3 months + 1 year (or LMP +
280 days)
const edd = new Date(lmp);
edd.setDate(edd.getDate() + 280); // 40 weeks = 280 days
// Days remaining until EDD
const daysRemaining = Math.floor((edd - calcDate) / (1000 * 60 * 60 * 24));
// Determine trimester
let trimester = '';
let trimesterInfo = '';
if (weeks < 13) {
trimester = '1st Trimester';
trimesterInfo = 'Weeks 1-12: Embryonic development, organ formation';
} else if (weeks < 27) {
trimester = '2nd Trimester';
trimesterInfo = 'Weeks 13-26: Fetal growth, movement felt, viability
threshold';
} else if (weeks <= 42) {
trimester = '3rd Trimester';
trimesterInfo = 'Weeks 27-40: Rapid growth, lung maturation, preparation for
birth';
} else {
trimester = 'Post-term';
trimesterInfo = 'Beyond 42 weeks: Requires immediate medical evaluation';
}
// Format EDD display
const eddOptions = { weekday: 'long', year: 'numeric', month: 'long', day:
'numeric' };
const eddFormatted = edd.toLocaleDateString('en-US', eddOptions);
// Update display
document.getElementById('aog-result').innerText = `${weeks} weeks, ${days} days`;
document.getElementById('aog-result').className = 'text-2xl font-mono font-bold
text-pink-400';
document.getElementById('aog-days').innerText = `Total: ${totalDays} days`;
document.getElementById('edd-result').innerText = eddFormatted;
if (daysRemaining > 0) {
document.getElementById('edd-remaining').innerText = `${daysRemaining} days
remaining`;
} else if (daysRemaining === 0) {
document.getElementById('edd-remaining').innerText = 'Due date is today!';
document.getElementById('edd-remaining').className = 'text-xs text-pink-400
mt-1 font-bold';
} else {
document.getElementById('edd-remaining').innerText =
`${Math.abs(daysRemaining)} days past due date`;
document.getElementById('edd-remaining').className = 'text-xs text-red-400
mt-1 font-bold';
}
document.getElementById('trimester-result').innerText = trimester;
document.getElementById('trimester-info').innerText = trimesterInfo;
// Show pregnancy milestones
showPregnancyMilestones(weeks, days, calcDate, lmp);
}
function showPregnancyMilestones(currentWeeks, currentDays, calcDate, lmp) {
const milestonesDiv = document.getElementById('pregnancy-milestones');
const milestonesList = document.getElementById('milestones-list');
const milestones = [
{ week: 6, name: 'Heartbeat detectable on ultrasound', icon: '💓' },
{ week: 8, name: 'All major organs forming', icon: '🫀' },
{ week: 10, name: 'End of embryonic period (now fetus)', icon: '👶' },
{ week: 12, name: 'First trimester screening (NT scan)', icon: '🔬' },
{ week: 13, name: 'Second trimester begins', icon: '📅' },
{ week: 16, name: 'Quickening (may feel movement)', icon: '✨' },
{ week: 18, name: 'Anomaly scan (18-22 weeks)', icon: '🩺' },
{ week: 24, name: 'Viability threshold', icon: '⭐' },
{ week: 27, name: 'Third trimester begins', icon: '📅' },
{ week: 28, name: 'GDM screening / Anti-D if Rh negative', icon: '💉' },
{ week: 32, name: 'Growth scan recommended', icon: '📊' },
{ week: 34, name: 'Group B Strep screening (35-37 wks)', icon: '🧫' },
{ week: 37, name: 'Early term (safe for delivery)', icon: '✅' },
{ week: 39, name: 'Full term', icon: '🎯' },
{ week: 40, name: 'Estimated due date', icon: '🗓️' },
{ week: 41, name: 'Late term - monitoring recommended', icon: '⚠️' },
{ week: 42, name: 'Post-term - induction usually recommended', icon: '🚨' }
];
let html = '';
milestones.forEach(m => {
const milestoneDate = new Date(lmp);
milestoneDate.setDate(milestoneDate.getDate() + (m.week * 7));
const dateStr = milestoneDate.toLocaleDateString('en-US', { month: 'short',
day: 'numeric' });
if (currentWeeks >= m.week) {
html += `<div class="flex items-center text-green-400"><span
class="mr-2">✓</span><span class="flex-1">${m.icon} ${m.name}</span><span
class="text-slate-500 text-[10px]">${dateStr}</span></div>`;
} else if (currentWeeks >= m.week - 4) {
html += `<div class="flex items-center text-yellow-400"><span
class="mr-2">○</span><span class="flex-1">${m.icon} ${m.name}</span><span
class="text-slate-500 text-[10px]">${dateStr}</span></div>`;
}
});
if (html) {
milestonesList.innerHTML = html;
milestonesDiv.classList.remove('hidden');
} else {
milestonesDiv.classList.add('hidden');
}
}
// Initialize calc date to today
document.addEventListener('DOMContentLoaded', function() {
const today = new Date().toISOString().split('T')[0];
document.getElementById('calc-date').value = today;
});
// Live IV and BMI calculations
document.getElementById('vol').addEventListener('input', calcIV);
document.getElementById('hours').addEventListener('input', calcIV);
document.getElementById('factor').addEventListener('change', calcIV);
document.getElementById('weight').addEventListener('input', calcBMI);
document.getElementById('height').addEventListener('input', calcBMI);
// Live AOG/EDD calculation
document.getElementById('lmp-date').addEventListener('change', calcAOGEDD);
document.getElementById('calc-date').addEventListener('change', calcAOGEDD);
// ------------------ OTC Medicines Data + Search ------------------
const otcDatabase = [
{
id: 'acetaminophen',
name: 'Acetaminophen',
ph_brands: ['Biogesic', 'Tempra', 'Calpol', 'Tylenol', 'Panadol'],
uses: 'Fever, mild to moderate pain relief (headache, myalgia)',
origin: 'Synthetic analgesic discovered in the late 19th century',
whenToGive: 'For fever >38°C or pain as needed; follow dosing limits (max
4g/day)',
contraindications: 'Severe hepatic impairment, chronic alcohol use; check
liver function if repeated dosing',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['fever','pain','analgesic'],
// Additional Information (only shown in OTC Reference Directory when tab is
clicked)
additionalInfo: {
genericNames: ['Paracetamol', 'APAP', 'N-acetyl-p-aminophenol'],
drugClass: 'Analgesic, Antipyretic (Non-opioid)',
usesExpanded: 'Fever reduction (antipyretic), mild to moderate pain relief
including headache, toothache, muscle aches, backache, menstrual cramps, arthritis pain,
post-vaccination fever, and post-operative pain management',
mechanismOfAction: 'Inhibits cyclooxygenase (COX) enzymes primarily in the
central nervous system, reducing prostaglandin synthesis. Unlike NSAIDs, it has minimal
peripheral anti-inflammatory activity. Also activates descending serotonergic pathways and may
interact with the endocannabinoid system for pain modulation.',
originExpanded: 'First synthesized in 1877 by Harmon Northrop Morse.
Clinically used since 1893. Became widely available after 1950s when it was found to be safer
than phenacetin. Named "paracetamol" from para-acetylaminophenol.',
pharmacokinetics: 'Absorption: Rapid oral absorption (30-60 min to peak).
Bioavailability: 63-89%. Distribution: Widely distributed, crosses blood-brain barrier.
Metabolism: Hepatic via glucuronidation (60%), sulfation (35%), and CYP2E1 oxidation (5% -
produces toxic NAPQI metabolite). Half-life: 1.5-3 hours. Excretion: Renal (90% as
metabolites).',
dosing: 'Adults: 500-1000mg every 4-6 hours (max 4g/day, or 3g/day for
chronic use or elderly). Pediatric: 10-15mg/kg/dose every 4-6 hours (max 75mg/kg/day, not
exceeding 4g). Reduce dose in hepatic impairment.',
whenToGiveExpanded: 'Administer for fever >38°C (100.4°F) or pain as
needed. Can be given with or without food. For consistent fever control, give at regular
intervals rather than PRN. Preferred analgesic in patients where NSAIDs are contraindicated
(renal disease, GI bleeding risk, aspirin-sensitive asthma).',
sideEffects: 'Common: Generally well-tolerated at therapeutic doses. Rare:
Skin rash, hypersensitivity reactions. Serious (overdose): Hepatotoxicity (nausea, vomiting,
RUQ pain within 24 hours, followed by liver failure at 72-96 hours), acute kidney injury.
Chronic use: Potential nephrotoxicity.',
contraindicationsExpanded: 'Absolute: Severe hepatic impairment, active
liver disease, known hypersensitivity. Relative: Chronic alcohol use (>3 drinks/day),
malnutrition, glutathione depletion, G6PD deficiency, concurrent use of hepatotoxic drugs or
CYP2E1 inducers.',
drugInteractions: 'Warfarin: May increase INR with chronic use. Alcohol:
Increased hepatotoxicity risk. Isoniazid, rifampin, phenytoin, carbamazepine: CYP450 inducers
increase toxic metabolite formation. Metoclopramide: Increases absorption rate.
Cholestyramine: Decreases absorption.',
nursingConsiderations: '1) Assess pain level before and 30-60 min after
administration using appropriate pain scale. 2) Monitor liver function tests if prolonged use.
3) Check for acetaminophen in combination products to avoid inadvertent overdose. 4) Teach
patient about maximum daily dose and hidden sources in OTC products. 5) For overdose:
N-acetylcysteine (NAC) is the antidote - most effective within 8-10 hours.',
patientEducation: 'Do not exceed 4g/day from ALL sources combined. Read
labels of cold/flu medications as many contain acetaminophen. Avoid alcohol while taking this
medication. Seek immediate medical attention if you experience nausea, vomiting, loss of
appetite, or yellowing of skin/eyes. Safe for pregnancy (Category B) when used as directed.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy: 'SAFE (preferred analgesic)', liver_disease: '⚠️
CONTRAINDICATED' }
}
},
{
id: 'ibuprofen',
name: 'Ibuprofen',
ph_brands: ['Advil', 'Motrin', 'Medicol Advance', 'Midol', 'Brufen'],
uses: 'Pain, inflammation, fever',
origin: 'A widely used NSAID introduced in the 1960s',
whenToGive: 'For inflammatory pain or fever; give with food to reduce GI
upset',
contraindications: 'Active peptic ulcer disease, severe renal impairment,
hypersensitivity to NSAIDs',
conditionSafety: { hypertension: 'CAUTION', diabetes: 'SAFE', asthma:
'CAUTION', copd: 'SAFE', ckd: '⚠️ CONTRAINDICATED' },
tags: ['pain','fever','inflammation','nsaid'],
additionalInfo: {
genericNames: ['Ibuprofen', '2-(4-isobutylphenyl)propionic acid'],
drugClass: 'Nonsteroidal Anti-inflammatory Drug (NSAID), Propionic Acid
Derivative',
usesExpanded: 'Mild to moderate pain (headache, dental pain, menstrual
cramps, muscle aches), inflammatory conditions (arthritis, tendinitis, bursitis), fever
reduction, primary dysmenorrhea, patent ductus arteriosus closure in neonates (IV form)',
mechanismOfAction: 'Non-selective inhibition of cyclooxygenase (COX-1 and
COX-2) enzymes, blocking prostaglandin synthesis. This reduces inflammation, pain, and fever.
COX-1 inhibition causes GI and platelet side effects; COX-2 inhibition provides
anti-inflammatory effects.',
originExpanded: 'Developed by Stewart Adams and John Nicholson at Boots UK
in 1961. First used for rheumatoid arthritis in 1969. Became available OTC in the US in 1984.
Named from iso-butyl-propanoic-phenolic acid.',
pharmacokinetics: 'Absorption: Rapid and complete (80-100%
bioavailability). Peak: 1-2 hours. Distribution: 99% protein-bound. Metabolism: Hepatic via
CYP2C9 to inactive metabolites. Half-life: 2-4 hours. Excretion: Renal (90% as metabolites).
Food delays absorption but does not reduce extent.',
dosing: 'Adults: 200-400mg every 4-6 hours (max 1200mg/day OTC, 3200mg/day
prescription). Pediatric (6mo+): 5-10mg/kg every 6-8 hours (max 40mg/kg/day). Take with food
or milk. Reduce dose in renal impairment.',
whenToGiveExpanded: 'For inflammatory pain, fever, or conditions requiring
anti-inflammatory effect. Always give with food, milk, or antacid to minimize GI irritation.
Best for inflammatory conditions vs acetaminophen. Use lowest effective dose for shortest
duration.',
sideEffects: 'Common: GI upset, nausea, dyspepsia, abdominal pain,
diarrhea, constipation, headache, dizziness. Serious: GI bleeding/ulceration, cardiovascular
events (MI, stroke), renal impairment, hypersensitivity reactions, Stevens-Johnson syndrome,
aseptic meningitis.',
contraindicationsExpanded: 'Absolute: Active GI bleeding, history of
NSAID-induced asthma/urticaria/angioedema, third trimester pregnancy, severe heart failure,
post-CABG surgery. Relative: History of peptic ulcer, renal impairment, hypertension, heart
failure, concurrent anticoagulants, elderly patients.',
drugInteractions: 'Anticoagulants (warfarin): Increased bleeding risk.
Aspirin: Reduced cardioprotective effect, increased GI risk. ACE inhibitors/ARBs: Reduced
antihypertensive effect, increased renal risk. Lithium: Increased lithium levels.
Methotrexate: Increased toxicity. Diuretics: Reduced efficacy.',
nursingConsiderations: '1) Assess pain level and location before and 1
hour after administration. 2) Monitor for GI bleeding (dark stools, hematemesis). 3) Check
renal function and BP in long-term use. 4) Assess for signs of cardiovascular events. 5)
Educate about taking with food. 6) Monitor for allergic reactions especially in
aspirin-sensitive patients.',
patientEducation: 'Take with food or milk to prevent stomach upset. Do not
lie down for 30 minutes after taking. Avoid alcohol. Report black/tarry stools, persistent
stomach pain, or unusual bleeding. Do not exceed recommended dose. Inform healthcare provider
before surgery. Avoid if pregnant (especially third trimester).',
conditionSafetyExpanded: { hypertension: 'CAUTION - can elevate BP',
diabetes: 'SAFE', asthma: 'CAUTION - risk of bronchospasm in aspirin-sensitive', copd: 'SAFE',
ckd: '⚠️ CONTRAINDICATED', pregnancy: '⚠️ CONTRAINDICATED in 3rd trimester', gi_disease:
'CAUTION' }
}
},
{
id: 'diphenhydramine',
name: 'Diphenhydramine',
ph_brands: ['Benadryl', 'Allergia', 'Unisom SleepGels', 'ZzzQuil',
'Sleepwell'],
uses: 'Allergic reactions, urticaria, short-term insomnia',
origin: 'First-generation antihistamine introduced in the 1940s',
whenToGive: 'For mild allergic symptoms; caution with sedation',
contraindications: 'Elderly (falls), glaucoma, urinary retention, MAOI use',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['allergy','antihistamine','sleep','sedating'],
additionalInfo: {
genericNames: ['Diphenhydramine HCl', 'Diphenhydramine Citrate'],
drugClass: 'First-Generation Antihistamine (H1-receptor antagonist),
Sedating Antihistamine, Anticholinergic',
usesExpanded: 'Allergic rhinitis, allergic conjunctivitis, urticaria
(hives), pruritus, anaphylaxis (adjunct), motion sickness, short-term insomnia, common cold
symptoms, antitussive, drug-induced extrapyramidal symptoms, mild Parkinsonism',
mechanismOfAction: 'Competitively blocks H1-histamine receptors,
preventing histamine-mediated allergic responses. Crosses blood-brain barrier causing CNS
depression (sedation). Also has anticholinergic (muscarinic) blocking activity and local
anesthetic properties.',
originExpanded: 'Discovered by George Rieveschl at the University of
Cincinnati in 1943. First antihistamine approved by the FDA in 1946. Marketed as Benadryl.
Became one of the most widely used OTC medications worldwide.',
pharmacokinetics: 'Absorption: Well absorbed orally (40-60%
bioavailability due to first-pass metabolism). Onset: 15-30 minutes. Peak: 1-4 hours.
Distribution: Widely distributed, crosses BBB and placenta. Metabolism: Hepatic via CYP2D6.
Half-life: 2.4-9.3 hours (longer in elderly). Excretion: Renal.',
dosing: 'Adults: 25-50mg every 4-6 hours (max 300mg/day). For sleep:
25-50mg at bedtime. Pediatric (6-12y): 12.5-25mg every 4-6 hours (max 150mg/day). Children
2-6y: 6.25mg every 4-6 hours. Not recommended <2 years.',
whenToGiveExpanded: 'For acute allergic reactions, hives, or itching. For
sleep: take 30 minutes before bedtime. For motion sickness: take 30 minutes before travel.
Avoid in activities requiring alertness. Consider non-sedating antihistamines (cetirizine,
loratadine) for daytime allergies.',
sideEffects: 'Common: Drowsiness, sedation, dry mouth, urinary retention,
constipation, blurred vision, thickened bronchial secretions, dizziness. Serious: Paradoxical
excitation (especially in children), seizures (overdose), anticholinergic toxicity,
hypersensitivity reactions.',
contraindicationsExpanded: 'Absolute: Neonates/premature infants,
breastfeeding (can cause irritability/sedation in infants), MAOI use within 14 days, acute
asthma attack. Relative: Elderly (fall risk, confusion), narrow-angle glaucoma, prostatic
hypertrophy, GI/GU obstruction, hyperthyroidism, cardiovascular disease.',
drugInteractions: 'CNS depressants (alcohol, benzodiazepines, opioids):
Additive sedation. MAOIs: Prolonged and intensified anticholinergic effects. Anticholinergics:
Additive effects. CYP2D6 inhibitors: Increased diphenhydramine levels. May mask ototoxicity of
aminoglycosides.',
nursingConsiderations: '1) Assess allergy symptoms before and after
administration. 2) Monitor for excessive sedation, especially in elderly. 3) Assess fall risk
and implement safety measures. 4) Monitor for anticholinergic effects (dry mouth, urinary
retention, constipation). 5) Caution patient about driving/operating machinery. 6) Not
recommended for chronic insomnia.',
patientEducation: 'Causes drowsiness - avoid driving or operating
machinery. Avoid alcohol and other sedatives. May cause dry mouth - sip water or suck hard
candy. Report difficulty urinating or severe constipation. Not for long-term sleep use - can
cause tolerance. Keep away from children due to overdose risk.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'CAUTION - may thicken secretions', copd: 'CAUTION - anticholinergic effects', ckd: 'SAFE',
pregnancy: 'Category B - consult provider', elderly: '⚠️ AVOID - Beers Criteria' }
}
},
{
id: 'omeprazole',
name: 'Omeprazole',
ph_brands: ['Losec', 'Prilosec', 'Omepron', 'Gastroloc', 'Zegerid'],
uses: 'Gastroesophageal reflux disease, peptic ulcer disease',
origin: 'Proton pump inhibitor introduced in the late 1980s',
whenToGive: 'For symptomatic heartburn or diagnosed reflux; usually once daily
before meals',
contraindications: 'Known hypersensitivity; caution long-term (B12, Mg, C.diff
risk)',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['reflux','heartburn','acid','ppi'],
additionalInfo: {
genericNames: ['Omeprazole', 'Omeprazole Magnesium'],
drugClass: 'Proton Pump Inhibitor (PPI), Gastric Acid Secretion
Inhibitor',
usesExpanded: 'GERD (erosive and non-erosive), peptic ulcer disease
(gastric and duodenal), H. pylori eradication (with antibiotics), Zollinger-Ellison syndrome,
stress ulcer prophylaxis, NSAID-induced ulcer prevention, dyspepsia',
mechanismOfAction: 'Irreversibly inhibits the hydrogen-potassium ATPase
(proton pump) in gastric parietal cells. This is the final step of acid secretion, resulting
in profound and prolonged suppression of gastric acid production (up to 90% reduction).
Requires activation in acidic environment.',
originExpanded: 'Developed by AstraZeneca (then Hässle) in Sweden. First
PPI approved by FDA in 1989. Revolutionary treatment for acid-related disorders. Named from
OME (oxygen-methyl-ethyl) and PRAZOLE (common PPI suffix).',
pharmacokinetics: 'Absorption: Rapid but variable (30-40% bioavailability,
increased to 60% with repeated doses). Peak: 0.5-3.5 hours. Distribution: 95% protein-bound.
Metabolism: Extensive hepatic via CYP2C19 and CYP3A4. Half-life: 0.5-1 hour (but effect lasts
24 hours due to irreversible binding). Excretion: 80% renal, 20% fecal.',
dosing: 'GERD: 20mg once daily for 4-8 weeks. Peptic ulcer: 20-40mg once
daily for 4-8 weeks. H. pylori: 20mg twice daily with antibiotics for 10-14 days. Maintenance:
10-20mg daily. Take 30-60 minutes before breakfast on empty stomach.',
whenToGiveExpanded: 'Administer 30-60 minutes before the first meal of the
day for maximum efficacy. Swallow capsules whole - do not crush or chew. For patients with
difficulty swallowing, can open capsule and mix granules with applesauce. OTC use limited to
14 days; see physician if symptoms persist.',
sideEffects: 'Common: Headache, diarrhea, abdominal pain, nausea,
flatulence, dizziness. Long-term: Vitamin B12 deficiency, hypomagnesemia, increased fracture
risk (hip, wrist, spine), C. difficile infection, community-acquired pneumonia, fundic gland
polyps.',
contraindicationsExpanded: 'Absolute: Hypersensitivity to PPIs or
benzimidazoles, concurrent rilpivirine use. Relative: Osteoporosis (long-term use), hepatic
impairment (dose adjustment), pregnancy (use only if clearly needed), patients at risk for B12
or magnesium deficiency.',
drugInteractions: 'Clopidogrel: Reduced antiplatelet effect (CYP2C19
interaction) - avoid combination. Methotrexate: Increased levels. Digoxin: Increased
absorption. Warfarin: May increase INR. Ketoconazole, itraconazole, iron: Reduced absorption
due to decreased gastric acid. CYP2C19 substrates: Potential interactions.',
nursingConsiderations: '1) Assess GI symptoms before and during therapy.
2) Monitor for signs of C. difficile (watery diarrhea, abdominal pain). 3) Monitor magnesium
levels in long-term use. 4) Educate about proper timing (before meals). 5) Monitor for bone
fractures in long-term elderly patients. 6) Check B12 levels periodically in chronic use.',
patientEducation: 'Take 30-60 minutes before breakfast. Swallow whole - do
not crush or chew. Complete full course even if feeling better. Report persistent diarrhea,
bone pain, or muscle cramps/spasms. Not for immediate heartburn relief - use antacids for
quick relief. Limit OTC use to 14 days; consult physician for ongoing symptoms.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy: 'Category C - use if benefit outweighs risk',
osteoporosis: 'CAUTION - long-term use increases fracture risk' }
}
},
{
id: 'dextromethorphan',
name: 'Dextromethorphan',
ph_brands: ['Robitussin DM', 'Delsym', 'Tuseran', 'Benadryl DM', 'NyQuil'],
uses: 'Non-productive cough suppression',
origin: 'Synthetic cough suppressant used since mid-20th century',
whenToGive: 'For dry cough disrupting rest; avoid in productive cough',
contraindications: 'MAOI use, some serotonergic meds (risk of serotonin
syndrome)',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['cough','antitussive','dry cough'],
additionalInfo: {
genericNames: ['Dextromethorphan HBr', 'Dextromethorphan Polistirex',
'DXM', 'DM'],
drugClass: 'Antitussive (Cough Suppressant), Non-opioid, NMDA Receptor
Antagonist',
usesExpanded: 'Temporary relief of non-productive (dry) cough due to
common cold, flu, or inhaled irritants. Also being studied for pseudobulbar affect
(combination with quinidine), neuropathic pain, and as an adjunct in opioid withdrawal.',
mechanismOfAction: 'Acts centrally on the cough center in the medulla
oblongata by elevating cough threshold. Unlike codeine, it has minimal opioid activity. Also
acts as an NMDA receptor antagonist and sigma-1 receptor agonist, contributing to its
dissociative effects at high doses.',
originExpanded: 'Developed in the 1950s by the US Navy and CIA as a
non-addictive alternative to codeine for cough suppression. FDA approved in 1958. Became the
most widely used cough suppressant globally. "Dextro" indicates it is the right-handed isomer
of levomethorphan.',
pharmacokinetics: 'Absorption: Rapidly absorbed orally. Onset: 15-30
minutes. Peak: 2-3 hours (immediate-release), 6 hours (extended-release). Metabolism:
Extensive hepatic via CYP2D6 to active metabolite dextrorphan. Half-life: 3-6 hours (up to 24
hours in CYP2D6 poor metabolizers). Excretion: Renal.',
dosing: 'Adults & children >12y: 10-20mg every 4 hours or 30mg every 6-8
hours (max 120mg/day). Extended-release: 60mg every 12 hours. Children 6-12y: 5-10mg every 4
hours or 15mg every 6-8 hours. Not recommended <4 years.',
whenToGiveExpanded: 'For dry, hacking cough that disrupts sleep or daily
activities. NOT for productive cough (with mucus) as suppressing the cough reflex can lead to
mucus accumulation. Best used at bedtime if cough is disrupting sleep. Increase fluid intake
to help loosen secretions.',
sideEffects: 'Common: Dizziness, drowsiness, nausea, stomach upset. High
doses: Confusion, excitability, nervousness, restlessness, slurred speech, hallucinations,
dissociative effects. Serious: Serotonin syndrome (with serotonergic drugs), respiratory
depression (massive overdose).',
contraindicationsExpanded: 'Absolute: MAOI use within 14 days (can cause
fatal serotonin syndrome), hypersensitivity. Relative: Chronic cough (smokers, asthma,
emphysema - needs evaluation), productive cough, concurrent serotonergic medications (SSRIs,
SNRIs), CYP2D6 poor metabolizers, history of substance abuse.',
drugInteractions: 'MAOIs: LIFE-THREATENING - can cause serotonin syndrome,
hyperpyrexia, death. SSRIs/SNRIs: Increased risk of serotonin syndrome. CYP2D6 inhibitors
(quinidine, fluoxetine, paroxetine): Increased DXM levels. Alcohol/CNS depressants: Additive
effects. Haloperidol: Increased sedation.',
nursingConsiderations: '1) Assess cough characteristics - only for
non-productive cough. 2) Monitor respiratory status. 3) Check medication list for MAOIs and
serotonergic drugs. 4) Educate about abuse potential, especially in adolescents. 5) Monitor
for signs of serotonin syndrome (agitation, hyperthermia, tachycardia). 6) Assess
effectiveness - if cough persists >7 days, refer to physician.',
patientEducation: 'Do not use for productive cough (with phlegm). Do not
exceed recommended dose - high doses can cause serious side effects. Avoid alcohol. Do not
take with MAOIs or antidepressants without consulting provider. If cough persists more than 7
days, worsens, or is accompanied by fever, see a doctor. Keep out of reach of teenagers (abuse
potential).',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'CAUTION -
check sugar content in syrups', asthma: 'CAUTION - evaluate underlying cause', copd: 'CAUTION
- evaluate underlying cause', ckd: 'SAFE', pregnancy: 'Category C - use only if clearly
needed' }
}
},
{
id: 'psyllium',
name: 'Psyllium Husk',
ph_brands: ['Metamucil', 'Fiberall', 'Konsyl', 'Fiberlax', 'Reguloid'],
uses: 'Bulk-forming laxative for constipation',
origin: 'Plant-derived fiber used as a laxative',
whenToGive: 'For mild constipation; ensure adequate fluid intake',
contraindications: 'Obstruction of GI tract, difficulty swallowing',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['constipation','laxative','fiber'],
additionalInfo: {
genericNames: ['Psyllium Husk', 'Psyllium Hydrophilic Mucilloid',
'Ispaghula Husk', 'Plantago ovata'],
drugClass: 'Bulk-Forming Laxative, Dietary Fiber Supplement, Antidiarrheal
(paradoxically)',
usesExpanded: 'Chronic constipation, irritable bowel syndrome (IBS),
adjunct in diabetes (reduces postprandial glucose), hypercholesterolemia (LDL reduction),
hemorrhoids, anal fissures, post-surgical bowel regulation, diverticular disease maintenance',
mechanismOfAction: 'Absorbs water in the intestine to form a viscous gel
that increases stool bulk and moisture content. The increased bulk stimulates peristalsis and
facilitates easier bowel movements. Also binds bile acids, promoting cholesterol excretion and
LDL reduction.',
originExpanded: 'Derived from the seed husks of Plantago ovata, a plant
native to India and Pakistan (known as Isabgol). Used in traditional Ayurvedic medicine for
centuries. Introduced to Western medicine in the early 20th century. India remains the largest
producer.',
pharmacokinetics: 'Absorption: Not systemically absorbed - works locally
in GI tract. Onset: 12-72 hours for laxative effect. The fiber passes through the GI tract
intact, adding bulk to stool. No hepatic metabolism or renal excretion - eliminated in
feces.',
dosing: 'Adults: 1 rounded teaspoon (approximately 3.4g) in 8 oz of
liquid, 1-3 times daily. Start low and increase gradually. For cholesterol: 10.2g/day in
divided doses with meals. Pediatric (6-12y): Half adult dose. Must be taken with adequate
fluid (at least 8 oz per dose).',
whenToGiveExpanded: 'For constipation relief or prevention. Take with a
full glass of water or other liquid IMMEDIATELY - do not let it sit as it will gel. Best taken
with meals when used for cholesterol lowering. May take 1-3 days for full effect. Can be used
daily for long-term bowel regulation.',
sideEffects: 'Common: Bloating, flatulence, abdominal cramping (usually
temporary as body adjusts). If taken without adequate fluid: Esophageal/bowel obstruction
(serious), choking. Rare: Allergic reactions (especially in healthcare workers with
occupational exposure).',
contraindicationsExpanded: 'Absolute: GI obstruction, fecal impaction,
difficulty swallowing (dysphagia), esophageal stricture. Relative: Intestinal adhesions, acute
abdominal pain, nausea/vomiting of unknown cause. Patients should be able to drink adequate
fluids.',
drugInteractions: 'May decrease absorption of: Lithium, warfarin,
carbamazepine, digoxin, nitrofurantoin, salicylates - take medications 1 hour before or 2-4
hours after psyllium. May alter insulin requirements in diabetics (improves glycemic
control).',
nursingConsiderations: '1) Ensure patient can swallow normally and drink
adequate fluids. 2) Mix dose immediately before administration - do not let it thicken. 3)
Monitor for choking, especially in elderly. 4) Assess bowel pattern and stool consistency. 5)
Encourage adequate daily fluid intake (6-8 glasses). 6) May take 1-3 days for effect - educate
patient.',
patientEducation: 'Always mix with at least 8 oz of liquid and drink
immediately. Follow with another glass of water. Do not take dry powder - choking hazard.
Start with low dose and increase gradually to reduce bloating. May take 1-3 days to work. Take
other medications 1 hour before or 2-4 hours after. Increase overall fluid and fiber intake
for best results.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'BENEFICIAL -
may improve glycemic control', asthma: 'SAFE', copd: 'SAFE', ckd: 'SAFE', hyperlipidemia:
'BENEFICIAL - lowers LDL', ibs: 'BENEFICIAL' }
}
},
{
id: 'loperamide',
name: 'Loperamide',
ph_brands: ['Imodium', 'Diatabs', 'Loperam', 'Entestop', 'Kaopectate'],
uses: 'Symptomatic relief of diarrhea',
origin: 'Synthetic opioid receptor agonist acting on gut motility',
whenToGive: 'For acute non-bloody diarrhea without fever; follow age/dose
guidance',
contraindications: 'Bloody diarrhea, high fever, suspected C. difficile,
pediatric limits',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['diarrhea','antidiarrheal'],
additionalInfo: {
genericNames: ['Loperamide HCl', 'Loperamide Hydrochloride'],
drugClass: 'Antidiarrheal, Peripheral Opioid Receptor Agonist
(μ-receptor)',
usesExpanded: 'Acute nonspecific diarrhea, travelers diarrhea, chronic
diarrhea from inflammatory bowel disease, diarrhea associated with ileostomy, reduction of
fecal volume from ileostomies',
mechanismOfAction: 'Acts on μ-opioid receptors in the intestinal wall to
slow intestinal motility, increase transit time, and enhance water and electrolyte absorption.
Does not cross blood-brain barrier significantly at therapeutic doses, so no CNS opioid
effects (no analgesia, euphoria, or respiratory depression).',
originExpanded: 'Developed by Janssen Pharmaceutica in 1969. FDA approved
in 1976 as prescription, switched to OTC in 1988. Designed to have potent peripheral opioid
effects without CNS penetration. One of the most widely used antidiarrheals worldwide.',
pharmacokinetics: 'Absorption: ~40% absorbed orally. Peak: 2.5-5 hours.
Distribution: Highly bound to intestinal wall (local effect). Does not significantly cross
BBB. Metabolism: Extensive hepatic via CYP3A4 and CYP2C8 with significant first-pass effect.
Half-life: 9-14 hours. Excretion: Mainly fecal.',
dosing: 'Acute diarrhea - Adults: 4mg initially, then 2mg after each loose
stool (max 16mg/day OTC, 8 mg/day self-treatment limit). Children 6-12y: 2mg initially, then
1mg after loose stool (max 6mg/day). Not recommended <6 years (OTC). Limit self-treatment to 2
days.',
whenToGiveExpanded: 'For acute diarrhea without blood, high fever, or
signs of bacterial infection. NOT for diarrhea associated with antibiotics (possible C.
difficile), dysentery, or invasive bacteria. Use with ORS for dehydration prevention.
Discontinue if no improvement in 48 hours or if abdominal distension occurs.',
sideEffects: 'Common: Constipation, abdominal cramps, nausea, dizziness,
drowsiness, dry mouth. Serious (overdose/abuse): Cardiac arrhythmias (QT prolongation,
torsades de pointes), cardiac arrest, paralytic ileus, toxic megacolon, CNS depression.',
contraindicationsExpanded: 'Absolute: Bloody diarrhea (dysentery), high
fever (>38.5°C/101.3°F), suspected C. difficile or bacterial enterocolitis, acute ulcerative
colitis, children <6 years (OTC). Relative: Hepatic impairment (reduced metabolism), acute
inflammatory bowel disease.',
drugInteractions: 'P-glycoprotein inhibitors (quinidine, ritonavir): Can
increase CNS penetration causing opioid effects. CYP3A4 inhibitors: Increased loperamide
levels. QT-prolonging drugs: Additive cardiac risk. Opioids: Additive constipation.',
nursingConsiderations: '1) Assess stool characteristics - contraindicated
if bloody or with fever. 2) Monitor for dehydration and electrolyte imbalance. 3) Encourage
oral rehydration alongside medication. 4) Monitor for abdominal distension or decreased bowel
sounds (ileus). 5) Educate about 48-hour self-treatment limit. 6) Watch for signs of cardiac
issues with high doses.',
patientEducation: 'Do NOT use if diarrhea is bloody, has mucus, or you
have high fever - see a doctor instead. Stop use and seek medical help if diarrhea lasts more
than 2 days. Drink plenty of clear fluids to prevent dehydration. Take only as directed - do
not exceed recommended dose. Stop taking if constipation, bloating, or abdominal distension
occurs.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy: 'Category C - use only if needed', ibd: 'CAUTION
- may trigger toxic megacolon in acute flares' }
}
},
{
id: 'ginger',
name: 'Ginger / Peppermint',
ph_brands: ['Ginger Capsules', 'Peppermint Oil Caps', 'Gin Gin', 'Altoids',
'Gravol Ginger'],
uses: 'Nausea relief, mild digestive upset',
origin: 'Herbal remedies used historically across cultures',
whenToGive: 'For mild nausea and indigestion; non-pharmacologic first-line',
contraindications: 'None common; caution with anticoagulants in high doses',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['nausea','digestive','herbal','natural'],
additionalInfo: {
genericNames: ['Zingiber officinale (Ginger)', 'Mentha piperita
(Peppermint)', 'Ginger Root Extract', 'Peppermint Oil'],
drugClass: 'Herbal Antiemetic, Carminative, Digestive Aid',
usesExpanded: 'GINGER: Nausea and vomiting (pregnancy morning sickness,
chemotherapy-induced, postoperative), motion sickness, dyspepsia, anti-inflammatory
(arthritis). PEPPERMINT: IBS symptoms, dyspepsia, tension headache (topical), nasal
congestion, nausea.',
mechanismOfAction: 'GINGER: Contains gingerols and shogaols that block
serotonin receptors (5-HT3) in the GI tract and may affect the vestibular system.
Anti-inflammatory via inhibition of prostaglandin synthesis. PEPPERMINT: Menthol relaxes GI
smooth muscle (calcium channel blocking), activates cold receptors (TRPM8) providing cooling
sensation.',
originExpanded: 'GINGER: Native to Southeast Asia, used in Traditional
Chinese Medicine and Ayurveda for over 3,000 years. PEPPERMINT: Hybrid of watermint and
spearmint, native to Europe. Used since ancient Egyptian, Greek, and Roman times for digestive
complaints.',
pharmacokinetics: 'GINGER: Gingerols absorbed in GI tract, metabolized
hepatically. Half-life: 1-3 hours. PEPPERMINT: Menthol rapidly absorbed, metabolized by
glucuronidation. Enteric-coated capsules bypass stomach to release in intestines (for IBS).',
dosing: 'GINGER: 250mg 4 times daily or 500-1000mg daily for nausea. For
pregnancy: 250mg 4 times daily. PEPPERMINT: Oil capsules 0.2-0.4mL (enteric-coated) 3 times
daily for IBS. Tea: 1 teaspoon dried leaves in hot water. Topical: diluted oil for headache.',
whenToGiveExpanded: 'For mild nausea without serious underlying cause.
GINGER: Start 1 day before travel for motion sickness. Safe first-line for pregnancy nausea.
PEPPERMINT: Take IBS capsules 30-60 minutes before meals. Not for GERD (relaxes LES). Can suck
peppermint candy for mild nausea.',
sideEffects: 'GINGER: Generally well tolerated. May cause heartburn, mouth
irritation, or diarrhea in high doses. Theoretical bleeding risk at very high doses.
PEPPERMINT: Heartburn (relaxes LES), perianal burning (enteric coating dissolves early),
allergic reactions. Topical: skin irritation.',
contraindicationsExpanded: 'GINGER: Caution with anticoagulants
(theoretical bleeding risk), gallstones (may increase bile flow). PEPPERMINT: GERD (worsens
reflux), hiatal hernia, severe liver disease, gallbladder disease, infants/young children
(menthol can cause breathing problems).',
drugInteractions: 'GINGER: Anticoagulants/antiplatelets (warfarin,
aspirin): theoretical increased bleeding risk. Antidiabetics: may lower blood sugar.
PEPPERMINT: Drugs metabolized by CYP3A4: may increase levels. Antacids/PPIs: may dissolve
enteric coating prematurely.',
nursingConsiderations: '1) Assess severity of nausea - rule out serious
causes. 2) For pregnancy nausea, ginger is first-line non-pharmacologic option. 3) Monitor for
heartburn with peppermint use. 4) Ensure enteric-coated peppermint capsules are swallowed
whole. 5) Assess for contraindications (GERD, gallbladder disease). 6) Educate about realistic
expectations - mild to moderate relief.',
patientEducation: 'GINGER: Can be taken as tea, capsules, candies, or
fresh. Start before travel for motion sickness. Generally safe in pregnancy at recommended
doses. PEPPERMINT: Do not chew enteric-coated capsules. Avoid if you have heartburn or reflux.
Keep peppermint oil away from face of infants. These are for mild symptoms - see doctor if
persistent.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'GINGER -
monitor blood sugar', asthma: 'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy: 'GINGER - SAFE for
morning sickness', gerd: 'PEPPERMINT - AVOID' }
}
},
{
id: 'cetirizine',
name: 'Cetirizine',
ph_brands: ['Zyrtec', 'Virlix', 'Allerkid', 'Reactine', 'Alerid'],
uses: 'Allergic rhinitis, urticaria, seasonal allergies, itching',
origin: 'Second-generation antihistamine developed in the 1980s with less
sedation',
whenToGive: 'For allergic symptoms; once daily dosing; may cause mild
drowsiness',
contraindications: 'Severe renal impairment (dose adjustment needed),
hypersensitivity to hydroxyzine',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['allergy','antihistamine','rhinitis','urticaria'],
additionalInfo: {
genericNames: ['Cetirizine HCl', 'Cetirizine Dihydrochloride',
'Levocetirizine (active enantiomer)'],
drugClass: 'Second-Generation Antihistamine (H1-receptor antagonist),
Low-Sedating Antihistamine',
usesExpanded: 'Seasonal allergic rhinitis (hay fever), perennial allergic
rhinitis, chronic idiopathic urticaria (hives), allergic conjunctivitis, pruritus (itching)
from various causes, atopic dermatitis (adjunct)',
mechanismOfAction: 'Selective peripheral H1-receptor antagonist.
Stabilizes mast cells and inhibits histamine release. Unlike first-generation antihistamines,
it has poor CNS penetration due to P-glycoprotein efflux, resulting in less sedation. Has
anti-inflammatory effects beyond antihistamine activity.',
originExpanded: 'Developed by UCB Pharma in Belgium. Active metabolite of
hydroxyzine. FDA approved in 1995. Became OTC in 2007. Represents advancement over
first-generation antihistamines with better safety profile and once-daily dosing.',
pharmacokinetics: 'Absorption: Rapid and extensive (>70% bioavailability).
Onset: 1 hour. Peak: 1-2 hours. Duration: 24 hours. Distribution: 93% protein-bound, minimal
CNS penetration. Metabolism: Minimal hepatic (limited CYP involvement). Half-life: 8-9 hours
(prolonged in renal impairment). Excretion: 70% renal unchanged.',
dosing: 'Adults & children >6y: 5-10mg once daily. Children 2-6y: 2.5mg
once or twice daily (max 5mg/day). Children 6mo-2y: 2.5mg once daily. Renal impairment: Reduce
dose by 50%. Hemodialysis: 5mg after dialysis.',
whenToGiveExpanded: 'Can be taken with or without food. Once daily dosing
(morning or evening). For seasonal allergies, may start before pollen season. Works best when
taken regularly rather than PRN. May cause mild drowsiness - if affected, take at bedtime.',
sideEffects: 'Common: Drowsiness (more than loratadine but less than
first-gen), headache, dry mouth, fatigue, pharyngitis. Rare: GI upset, dizziness. Very rare:
Hypersensitivity reactions, elevated liver enzymes, urinary retention, tremor, confusion
(elderly).',
contraindicationsExpanded: 'Absolute: Hypersensitivity to cetirizine,
hydroxyzine, or levocetirizine. Relative: Severe renal impairment (CrCl <10 mL/min), end-stage
renal disease on dialysis (dose adjustment required), caution in elderly, hepatic
impairment.',
drugInteractions: 'CNS depressants (alcohol, benzodiazepines): Additive
sedation. Theophylline: May slightly decrease cetirizine clearance. Generally fewer drug
interactions than first-generation antihistamines due to minimal CYP450 metabolism.',
nursingConsiderations: '1) Assess allergy symptoms before and after
treatment. 2) Check renal function - dose adjustment needed in impairment. 3) Monitor for
drowsiness, especially initially. 4) Assess effectiveness - switch to different antihistamine
if inadequate response. 5) Educate about once-daily dosing for compliance. 6) Review for CNS
depressant interactions.',
patientEducation: 'Take once daily at the same time. May cause drowsiness
- avoid driving until you know how it affects you. Avoid alcohol. Can be taken with or without
food. For best results during allergy season, take daily rather than as needed. Do not double
dose if missed - take next dose at regular time. Safe for long-term use.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE - may help allergic asthma', copd: 'SAFE', ckd: 'DOSE ADJUSTMENT REQUIRED', pregnancy:
'Category B - relatively safe', elderly: 'CAUTION - increased sensitivity' }
}
},
{
id: 'loratadine',
name: 'Loratadine',
ph_brands: ['Claritin', 'Allerta', 'Clarityne', 'Alavert', 'Loratadine
Generics'],
uses: 'Allergic rhinitis, chronic urticaria, hay fever',
origin: 'Non-sedating second-generation antihistamine introduced in 1988',
whenToGive: 'For allergic symptoms; once daily; minimal sedation compared to
first-gen',
contraindications: 'Severe hepatic impairment; caution with CYP3A4
inhibitors',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['allergy','antihistamine','rhinitis','non-sedating'],
additionalInfo: {
genericNames: ['Loratadine', 'Desloratadine (active metabolite)'],
drugClass: 'Second-Generation Antihistamine (H1-receptor antagonist),
Non-Sedating Antihistamine',
usesExpanded: 'Seasonal allergic rhinitis (hay fever), perennial allergic
rhinitis, chronic idiopathic urticaria (hives), allergic conjunctivitis, allergic skin
reactions. Desloratadine (Clarinex) is the active metabolite with similar uses.',
mechanismOfAction: 'Selective peripheral H1-receptor antagonist with
minimal CNS penetration (does not cross blood-brain barrier readily). Prevents histamine from
binding to receptors, blocking allergic response. Does not significantly affect serotonin,
dopamine, or muscarinic receptors.',
originExpanded: 'Developed by Schering-Plough. FDA approved in 1993 as
prescription, became OTC in 2002. One of the first truly non-sedating antihistamines. Generic
versions widely available since 2002.',
pharmacokinetics: 'Absorption: Rapidly absorbed, food delays absorption
but does not affect extent. Onset: 1-3 hours. Peak: 1.5 hours (loratadine), 3-4 hours
(desloratadine metabolite). Distribution: 97-99% protein-bound. Metabolism: Extensive hepatic
via CYP3A4 and CYP2D6 to active metabolite desloratadine. Half-life: 8-14 hours (loratadine),
17-24 hours (desloratadine). Excretion: Renal and fecal.',
dosing: 'Adults & children >6y: 10mg once daily. Children 2-6y: 5mg once
daily (syrup). Can be taken with or without food. No dose adjustment needed for renal
impairment. Reduce frequency in severe hepatic impairment.',
whenToGiveExpanded: 'Once daily at any time. For seasonal allergies, can
start before allergy season begins. Food does not affect absorption. Truly non-sedating in
most patients - preferred for daytime use when alertness is required.',
sideEffects: 'Common (generally well tolerated): Headache, dry mouth,
fatigue, somnolence (rare). Children: Nervousness, hyperkinesia, abdominal pain. Rare:
Tachycardia, palpitations. Very rare: Liver function abnormalities, hypersensitivity.',
contraindicationsExpanded: 'Absolute: Hypersensitivity to loratadine or
desloratadine. Relative: Severe hepatic impairment (reduce dose/frequency), caution with drugs
that inhibit CYP3A4 (ketoconazole, erythromycin).',
drugInteractions: 'CYP3A4 inhibitors (ketoconazole, erythromycin,
cimetidine): Increased loratadine levels (usually not clinically significant). Alcohol: No
significant interaction (unlike first-gen antihistamines). Generally very few clinically
significant interactions.',
nursingConsiderations: '1) Assess allergy symptoms before and during
therapy. 2) Check liver function if hepatic impairment suspected. 3) Preferred antihistamine
for patients requiring alertness. 4) Can be used during pregnancy if antihistamine needed
(Category B). 5) Monitor for adequate symptom relief. 6) Educate about consistent daily dosing
for best effect.',
patientEducation: 'Take once daily - works for 24 hours. Does not usually
cause drowsiness, but avoid alcohol. Safe to drive and operate machinery for most people. Can
be taken with or without food. For best results, take daily during allergy season rather than
as needed. If symptoms not controlled, consult healthcare provider about alternatives.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy: 'Category B - preferred antihistamine if
needed', hepatic_impairment: 'CAUTION - reduce dose' }
}
},
{
id: 'mefenamic-acid',
name: 'Mefenamic Acid',
ph_brands: ['Ponstan', 'Dolfenal', 'Ponstel', 'Mefran', 'Mefenamic'],
uses: 'Dysmenorrhea, mild to moderate pain, dental pain, headache',
origin: 'NSAID introduced in the 1960s, particularly effective for menstrual
pain',
whenToGive: 'For pain relief especially dysmenorrhea; take with food;
short-term use only',
contraindications: 'Active peptic ulcer, renal impairment, aspirin-sensitive
asthma, third trimester pregnancy',
conditionSafety: { hypertension: 'CAUTION', diabetes: 'SAFE', asthma:
'CAUTION', copd: 'SAFE', ckd: '⚠️ CONTRAINDICATED' },
tags: ['pain','dysmenorrhea','nsaid','menstrual'],
additionalInfo: {
genericNames: ['Mefenamic Acid', 'Mefenamic'],
drugClass: 'Nonsteroidal Anti-inflammatory Drug (NSAID), Fenamate Class,
Anthranilic Acid Derivative',
usesExpanded: 'Primary dysmenorrhea (menstrual cramps - particularly
effective), mild to moderate pain, rheumatoid arthritis, osteoarthritis, dental pain,
headache, postoperative pain, menorrhagia (heavy menstrual bleeding)',
mechanismOfAction: 'Inhibits cyclooxygenase (COX-1 and COX-2), reducing
prostaglandin synthesis. Particularly effective for menstrual pain because prostaglandins play
a major role in uterine contractions. Also has central analgesic effects and may antagonize
prostaglandin receptors directly.',
originExpanded: 'Developed by Parke-Davis and introduced in 1967. One of
the fenamate class NSAIDs. Became popular for dysmenorrhea due to superior efficacy compared
to other NSAIDs for menstrual pain.',
pharmacokinetics: 'Absorption: Rapidly absorbed. Peak: 2-4 hours.
Distribution: Highly protein-bound (>90%). Metabolism: Hepatic via glucuronidation and
oxidation (CYP2C9) to 3-hydroxymethyl and 3-carboxyl metabolites. Half-life: 2-4 hours.
Excretion: 52% renal, 20% fecal.',
dosing: 'Adults: 500mg initially, then 250mg every 6 hours as needed.
Maximum: 1000mg/day (short-term) or 1500mg/day for menstrual pain for up to 3 days. Take with
food. Not recommended for children <14 years. Limit use to 7 days maximum.',
whenToGiveExpanded: 'For dysmenorrhea, start at onset of menstruation or
pain - most effective when started early. Always take with food to reduce GI irritation. For
short-term use only (maximum 7 days). Not for chronic pain management.',
sideEffects: 'Common: GI upset (diarrhea more common than with other
NSAIDs), nausea, abdominal pain, dyspepsia, dizziness, headache. Serious: GI
bleeding/ulceration, hemolytic anemia (rare, with prolonged use), renal impairment,
hepatotoxicity, severe skin reactions.',
contraindicationsExpanded: 'Absolute: Active peptic ulcer or GI bleeding,
severe renal impairment, history of NSAID-induced asthma/urticaria, third trimester pregnancy,
inflammatory bowel disease. Relative: History of GI disease, hypertension, heart failure,
concurrent anticoagulants, first/second trimester pregnancy.',
drugInteractions: 'Anticoagulants (warfarin): Increased bleeding risk.
Aspirin: Reduced efficacy, increased GI risk. Lithium: Increased levels. Methotrexate:
Increased toxicity. Antihypertensives (ACE inhibitors, diuretics): Reduced efficacy. Other
NSAIDs: Avoid combination.',
nursingConsiderations: '1) Assess pain level and menstrual history. 2)
Ensure taken with food. 3) Monitor for GI bleeding (dark stools). 4) Limit use to 7 days
maximum. 5) Monitor renal function in prolonged use. 6) Educate about early dosing for
dysmenorrhea. 7) Watch for diarrhea (more common with mefenamic acid).',
patientEducation: 'Take with food or milk. Start taking at the first sign
of menstrual pain for best effect. Do not use for more than 7 days. Stop and seek medical
attention if you experience severe stomach pain, black stools, or vomiting blood. Avoid during
third trimester of pregnancy. Report any rash immediately.',
conditionSafetyExpanded: { hypertension: 'CAUTION - may elevate BP',
diabetes: 'SAFE', asthma: 'CAUTION - risk of bronchospasm if aspirin-sensitive', copd: 'SAFE',
ckd: '⚠️ CONTRAINDICATED', pregnancy: '⚠️ CONTRAINDICATED in 3rd trimester', gi_disease:
'CAUTION' }
}
},
{
id: 'antacid',
name: 'Aluminum/Magnesium Hydroxide',
ph_brands: ['Kremil-S', 'Maalox', 'Mylanta', 'Gaviscon', 'Gelusil'],
uses: 'Heartburn, acid indigestion, upset stomach, GERD symptoms',
origin: 'Classic antacid combination neutralizing gastric acid',
whenToGive: 'For acute heartburn or indigestion; take 1-3 hours after meals
and at bedtime',
contraindications: 'Severe renal impairment (magnesium toxicity risk),
hypophosphatemia',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['heartburn','antacid','indigestion','reflux'],
additionalInfo: {
genericNames: ['Aluminum Hydroxide/Magnesium Hydroxide',
'Al(OH)3/Mg(OH)2', 'Magaldrate', 'Hydrotalcite'],
drugClass: 'Antacid, Acid Neutralizer',
usesExpanded: 'Symptomatic relief of heartburn, acid indigestion, sour
stomach, GERD symptoms, peptic ulcer disease (symptom relief), stress ulcer prophylaxis,
phosphate binding in chronic kidney disease (aluminum hydroxide alone)',
mechanismOfAction: 'Directly neutralizes gastric acid (HCl) through
chemical reaction, raising gastric pH. Aluminum hydroxide produces AlCl3 + water. Magnesium
hydroxide produces MgCl2 + water. The combination balances constipating effect of aluminum
with laxative effect of magnesium. Also may stimulate prostaglandin production and enhance
mucosal defense.',
originExpanded: 'Aluminum and magnesium compounds have been used as
antacids since the early 20th century. The combination product was developed to minimize
individual side effects (aluminum causes constipation, magnesium causes diarrhea).',
pharmacokinetics: 'Absorption: Minimal systemic absorption (10-30% of
magnesium, minimal aluminum). Onset: Immediate (5-15 minutes). Duration: 20-60 minutes (empty
stomach), up to 3 hours (after meals). Metabolism: Not significantly metabolized. Excretion:
Primarily fecal; absorbed magnesium excreted renally.',
dosing: 'Adults: 10-20 mL (liquid) or 1-2 tablets chewed thoroughly, 1-3
hours after meals and at bedtime. May repeat every 4-6 hours as needed. Maximum varies by
product (check label). Pediatric: Consult physician for appropriate dosing.',
whenToGiveExpanded: 'For immediate relief of heartburn or indigestion.
Most effective when taken 1-3 hours after meals (when acid secretion peaks) and at bedtime.
Chew tablets thoroughly before swallowing. Shake liquid well. Not for prevention - use PPIs or
H2 blockers for that.',
sideEffects: 'Aluminum: Constipation, hypophosphatemia (chronic use),
aluminum accumulation (renal failure). Magnesium: Diarrhea, hypermagnesemia (renal failure).
Combination: Usually balanced bowel effects. Others: Chalky taste, belching, nausea.',
contraindicationsExpanded: 'Absolute: Severe renal impairment (magnesium
accumulation risk). Relative: Hypophosphatemia, dehydration, bowel obstruction, appendicitis
symptoms. Chronic use in CKD patients requires monitoring.',
drugInteractions: 'Decreases absorption of many drugs (take 2 hours
apart): Tetracyclines, fluoroquinolones, ketoconazole, itraconazole, iron supplements,
digoxin, H2 blockers, bisphosphonates. Aluminum binds phosphate (useful in hyperphosphatemia
of CKD).',
nursingConsiderations: '1) Assess heartburn symptoms - rule out cardiac
causes if atypical. 2) Shake liquid preparations well. 3) Instruct to chew tablets thoroughly.
4) Monitor for rebound acid hypersecretion with overuse. 5) Check for drug interactions -
separate dosing by 2 hours. 6) Monitor phosphate levels in chronic use. 7) Assess renal
function before recommending magnesium-containing products.',
patientEducation: 'Chew tablets completely before swallowing. Works fast
but effect is short-lived. Take 1-3 hours after meals for best effect. Separate from other
medications by 2 hours. If needed daily for more than 2 weeks, see a doctor. May cause
constipation (aluminum) or diarrhea (magnesium) - combination products balance this.',
conditionSafetyExpanded: { hypertension: 'CAUTION - check sodium content',
diabetes: 'SAFE', asthma: 'SAFE', copd: 'SAFE', ckd: 'CAUTION/AVOID - hypermagnesemia risk',
hypophosphatemia: 'AVOID aluminum-containing' }
}
},
{
id: 'ranitidine',
name: 'Famotidine',
ph_brands: ['Pepcid', 'Famocid', 'Quamatel', 'Famotidine Generics', 'Pepcid
AC'],
uses: 'Peptic ulcer, GERD, heartburn, acid reflux',
origin: 'H2-receptor antagonist; famotidine replaced ranitidine after NDMA
concerns',
whenToGive: 'For heartburn prevention; take 15-60 minutes before meals that
cause symptoms',
contraindications: 'Severe renal impairment (dose adjustment);
hypersensitivity to H2 blockers',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['heartburn','h2blocker','reflux','ulcer'],
additionalInfo: {
genericNames: ['Famotidine'],
drugClass: 'Histamine H2-Receptor Antagonist (H2 Blocker), Antisecretory
Agent',
usesExpanded: 'GERD (heartburn, acid reflux), peptic ulcer disease
(gastric and duodenal), erosive esophagitis, Zollinger-Ellison syndrome, stress ulcer
prophylaxis, prevention of aspiration pneumonia (preoperative), heartburn prevention before
eating trigger foods',
mechanismOfAction: 'Competitively blocks histamine H2 receptors on gastric
parietal cells, inhibiting histamine-stimulated gastric acid secretion. Reduces both basal and
stimulated acid secretion by 60-70%. Less potent than PPIs but faster onset for acute
relief.',
originExpanded: 'Developed by Yamanouchi (now Astellas) and Merck. FDA
approved in 1986. Became preferred H2 blocker after ranitidine was withdrawn in 2020 due to
NDMA (probable carcinogen) contamination concerns. Most potent H2 blocker by weight.',
pharmacokinetics: 'Absorption: Rapidly absorbed (40-45% bioavailability).
Onset: 1 hour. Peak: 1-3 hours. Duration: 10-12 hours. Distribution: 15-20% protein-bound.
Metabolism: Minimal hepatic metabolism (no significant CYP450 involvement). Half-life: 2.5-3.5
hours (prolonged in renal impairment). Excretion: 65-70% renal unchanged.',
dosing: 'Heartburn prevention: 10-20mg 15-60 minutes before eating. GERD:
20mg twice daily for up to 6 weeks. Peptic ulcer: 20-40mg at bedtime or 20mg twice daily.
Renal impairment (CrCl <50): Reduce dose by 50% or extend interval. Pediatric:
0.5mg/kg/dose.',
whenToGiveExpanded: 'For heartburn prevention, take 15-60 minutes before
eating foods that trigger symptoms. For active ulcer or GERD, take regularly as prescribed.
Can be taken with or without food. For nighttime heartburn, take at bedtime.',
sideEffects: 'Common (generally well-tolerated): Headache, dizziness,
constipation, diarrhea. Uncommon: Dry mouth, fatigue, rash. Rare: Thrombocytopenia, confusion
(elderly), elevated liver enzymes, QT prolongation (IV high doses).',
contraindicationsExpanded: 'Absolute: Hypersensitivity to famotidine or
other H2 blockers. Relative: Severe renal impairment (dose adjustment needed), hepatic
impairment, phenylketonuria (some formulations contain aspartame), elderly (increased risk of
confusion).',
drugInteractions: 'Minimal drug interactions (advantage over cimetidine).
May reduce absorption of drugs requiring acid environment: Ketoconazole, itraconazole,
atazanavir, iron, vitamin B12. Does not significantly affect CYP450 enzymes.',
nursingConsiderations: '1) Assess heartburn/ulcer symptoms. 2) Check renal
function - dose adjustment needed. 3) Monitor for symptom improvement. 4) Preferred H2 blocker
in pregnancy if needed. 5) Educate about timing relative to meals. 6) If symptoms persist
beyond 2 weeks of OTC use, refer to physician.',
patientEducation: 'Take 15-60 minutes before eating foods that cause
heartburn. Can be taken at bedtime for nighttime symptoms. Works longer than antacids but
takes longer to start working. If using OTC for more than 2 weeks, consult a doctor. Safer
alternative to ranitidine (which was recalled).',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'DOSE ADJUSTMENT REQUIRED', pregnancy: 'Category B - safe',
elderly: 'CAUTION - monitor for confusion' }
}
},
{
id: 'guaifenesin',
name: 'Guaifenesin',
ph_brands: ['Robitussin', 'Mucinex', 'Guaifenesin Expectorant', 'Solmux',
'Benadryl Expectorant'],
uses: 'Productive cough with thick mucus, chest congestion, expectorant',
origin: 'Expectorant derived from guaiac tree, used since 16th century',
whenToGive: 'For productive cough to thin mucus; increase fluid intake for
best effect',
contraindications: 'Persistent cough with excessive mucus; avoid in children
<4 years',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['cough','expectorant','congestion','mucus'],
additionalInfo: {
genericNames: ['Guaifenesin', 'Glyceryl Guaiacolate', 'Guaiphenesin'],
drugClass: 'Expectorant, Mucolytic',
usesExpanded: 'Relief of chest congestion and productive cough associated
with common cold, bronchitis, flu, and other respiratory infections. Helps loosen and thin
mucus/phlegm in airways, making coughs more productive.',
mechanismOfAction: 'Increases respiratory tract fluid secretions by
reducing mucus viscosity and surface tension. Stimulates secretion from bronchial glands and
increases mucociliary clearance. Makes mucus thinner and less sticky, facilitating
expectoration.',
originExpanded: 'Derived from guaiacum tree bark, used by indigenous
peoples of the Caribbean. Synthesized form developed in the early 20th century. FDA approved
in 1952. Only FDA-approved expectorant for OTC use.',
pharmacokinetics: 'Absorption: Rapidly and well absorbed from GI tract.
Onset: 15-30 minutes. Peak: 1-2 hours. Duration: 4-6 hours (immediate-release), 12 hours
(extended-release). Metabolism: Hepatic via oxidation and glucuronidation. Half-life: ~1 hour.
Excretion: Primarily renal as metabolites.',
dosing: 'Adults & children ≥12y: 200-400mg every 4 hours (max 2.4g/day) or
extended-release 600-1200mg every 12 hours. Children 6-12y: 100-200mg every 4 hours (max
1.2g/day). Children 4-6y: 50-100mg every 4 hours. Not for <4 years. Take with full glass of
water.',
whenToGiveExpanded: 'For coughs with thick, sticky mucus that is difficult
to cough up. Always take with plenty of water (at least 8 oz) to help thin secretions.
Continue adequate fluid intake throughout the day. Most effective when used regularly while
congested.',
sideEffects: 'Common: Nausea, vomiting, stomach upset, dizziness,
headache, drowsiness. Rare: Skin rash, urticaria. Very rare: Kidney stones (at very high doses
with inadequate hydration). Generally well tolerated.',
contraindicationsExpanded: 'Absolute: Hypersensitivity to guaifenesin.
Relative: Persistent cough from smoking, asthma, chronic bronchitis, or emphysema (needs
evaluation). Not for dry, non-productive cough. Children under 4 years (safety not
established).',
drugInteractions: 'Generally few significant interactions. May interfere
with certain laboratory tests: Can cause false-positive for 5-HIAA (serotonin metabolite) and
VMA (catecholamine metabolite). Notify lab if taking guaifenesin before these tests.',
nursingConsiderations: '1) Assess cough character - confirm productive
cough with thick secretions. 2) Encourage adequate fluid intake (8+ glasses daily). 3) Monitor
effectiveness - should make cough more productive. 4) If cough persists >7 days or returns,
refer to physician. 5) Assess for underlying conditions in chronic cough.',
patientEducation: 'Drink plenty of fluids (water, juice) while taking this
medication - at least 8 glasses per day. This helps the medication work better. Take with a
full glass of water. Do not take for more than 7 days without consulting a doctor. If cough is
accompanied by fever, rash, or persistent headache, see a healthcare provider.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'CAUTION -
check sugar content in syrups', asthma: 'SAFE - but evaluate underlying cause', copd: 'SAFE -
but evaluate underlying cause', ckd: 'SAFE', pregnancy: 'Category C - appears safe but use
only if needed' }
}
},
{
id: 'phenylephrine',
name: 'Phenylephrine',
ph_brands: ['Neozep', 'Bioflu', 'Decolgen', 'Sinutab', 'Sudafed PE'],
uses: 'Nasal congestion, sinus pressure, common cold symptoms',
origin: 'Sympathomimetic decongestant replacing pseudoephedrine in many
formulations',
whenToGive: 'For nasal congestion relief; short-term use only (3-5 days max)',
contraindications: 'Severe hypertension, MAOIs, narrow-angle glaucoma, severe
coronary artery disease',
conditionSafety: { hypertension: '⚠️ CONTRAINDICATED', diabetes: 'CAUTION',
asthma: 'SAFE', copd: 'SAFE', ckd: 'SAFE' },
tags: ['decongestant','cold','sinus','congestion'],
additionalInfo: {
genericNames: ['Phenylephrine HCl', 'Phenylephrine Hydrochloride',
'Neo-Synephrine (nasal)'],
drugClass: 'Sympathomimetic Amine, Alpha-1 Adrenergic Agonist, Nasal
Decongestant',
usesExpanded: 'Nasal and sinus congestion from common cold, hay fever,
upper respiratory allergies, sinusitis. Also used as ophthalmic mydriatic (eye drops) and as
vasopressor (IV form) for hypotension.',
mechanismOfAction: 'Selective alpha-1 adrenergic receptor agonist. Causes
vasoconstriction of blood vessels in nasal mucosa, reducing swelling/edema and congestion.
Unlike pseudoephedrine, has minimal beta-adrenergic activity so less stimulant effect.',
originExpanded: 'Synthesized in 1910. Became common replacement for
pseudoephedrine (PSE) in OTC products after 2006 Combat Methamphetamine Epidemic Act
restricted PSE sales. FDA review in 2023 questioned oral efficacy at standard doses.',
pharmacokinetics: 'Absorption: Poorly absorbed orally (~38%), extensive
first-pass metabolism. Bioavailability: Only ~3% reaches systemic circulation. Onset: 15-30
minutes. Duration: 4-6 hours. Metabolism: Extensive hepatic and intestinal by MAO. Half-life:
2-3 hours. Excretion: Renal.',
dosing: 'Adults & children ≥12y: 10mg every 4 hours (max 60mg/day).
Children 6-12y: 5mg every 4 hours (max 30mg/day). Nasal spray: 2-3 sprays each nostril every 4
hours. Do not use nasal spray >3 days (rebound congestion). Not recommended <6 years.',
whenToGiveExpanded: 'For temporary relief of nasal congestion. Use for
shortest time possible (3-5 days oral, 3 days nasal). Take with food if stomach upset occurs.
Note: Recent FDA review questions whether oral phenylephrine is effective at current OTC
doses.',
sideEffects: 'Common: Restlessness, insomnia, headache, dizziness,
increased blood pressure, tachycardia. Nasal spray: Burning, stinging, sneezing, rebound
congestion (rhinitis medicamentosa). Rare: Palpitations, arrhythmias.',
contraindicationsExpanded: 'Absolute: Severe hypertension, severe coronary
artery disease, MAOI use within 14 days, narrow-angle glaucoma. Relative: Hypertension,
hyperthyroidism, diabetes mellitus, prostatic hypertrophy, cardiovascular disease, elderly.',
drugInteractions: 'MAOIs: Severe hypertensive crisis (CONTRAINDICATED).
Beta-blockers: Exaggerated hypertension. Other sympathomimetics: Additive effects. TCAs:
Enhanced vasopressor effects. Antihypertensives: Reduced efficacy.',
nursingConsiderations: '1) Check blood pressure before and during therapy.
2) Assess for contraindications (HTN, cardiac disease, glaucoma). 3) Educate about short-term
use only. 4) Monitor for signs of hypertension/stimulation. 5) Warn about rebound congestion
with nasal spray. 6) Consider pseudoephedrine if phenylephrine ineffective (with pharmacy
consultation).',
patientEducation: 'Do not use for more than 3-5 days - prolonged use
causes rebound congestion. Check blood pressure if you have hypertension. Do not take if you
take MAOIs. May cause restlessness, difficulty sleeping - avoid taking close to bedtime. Stop
and consult doctor if symptoms worsen or persist beyond 7 days.',
conditionSafetyExpanded: { hypertension: '⚠️ AVOID/CONTRAINDICATED',
diabetes: 'CAUTION - may increase blood sugar', asthma: 'SAFE', copd: 'SAFE', ckd: 'SAFE',
hyperthyroidism: 'CAUTION', cardiac_disease: '⚠️ AVOID', glaucoma: '⚠️ CONTRAINDICATED' }
}
},
{
id: 'salbutamol',
name: 'Salbutamol (Albuterol)',
ph_brands: ['Ventolin', 'Airomir', 'Respirol', 'Salbulin', 'ProAir'],
uses: 'Acute bronchospasm, asthma relief, COPD exacerbation',
origin: 'Short-acting beta-2 agonist developed in 1968',
whenToGive: 'For acute bronchospasm relief; use as rescue inhaler; seek
medical attention if frequent use needed',
contraindications: 'Tachyarrhythmias, hypersensitivity; caution with
hypertension, hyperthyroidism',
conditionSafety: { hypertension: 'CAUTION', diabetes: 'CAUTION', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE' },
tags: ['asthma','bronchodilator','copd','breathing','rescue'],
additionalInfo: {
genericNames: ['Salbutamol', 'Albuterol', 'Salbutamol Sulfate', 'Albuterol
Sulfate'],
drugClass: 'Short-Acting Beta-2 Agonist (SABA), Bronchodilator,
Sympathomimetic',
usesExpanded: 'Acute bronchospasm relief in asthma, exercise-induced
bronchospasm (prevention), COPD exacerbations, hyperkalemia (off-label - drives K+ into
cells), preterm labor (off-label). Used as "rescue inhaler" for quick relief.',
mechanismOfAction: 'Selective beta-2 adrenergic receptor agonist. Relaxes
bronchial smooth muscle by increasing cAMP, causing bronchodilation. Also inhibits release of
mediators from mast cells, increases mucociliary clearance, and decreases vascular
permeability.',
originExpanded: 'Developed by Allen & Hanburys (now GSK) in 1968. First
selective beta-2 agonist (previous bronchodilators had cardiac effects). Revolutionary
treatment for asthma. "Salbutamol" used in UK/PH, "Albuterol" used in US.',
pharmacokinetics: 'Inhaled - Absorption: Small fraction absorbed from
lungs and swallowed portion. Onset: 5-15 minutes. Peak: 30-60 minutes. Duration: 4-6 hours.
Metabolism: Hepatic to inactive sulfate conjugate. Half-life: 2.5-5 hours. Excretion: Renal
(primarily as metabolites).',
dosing: 'Acute bronchospasm - MDI: 1-2 puffs (90-180 mcg) every 4-6 hours
as needed. Nebulizer: 2.5-5mg every 4-6 hours. Severe exacerbation: 4-8 puffs every 20 minutes
for 3 doses. Pediatric: Similar dosing. If using >2 times/week for symptoms, asthma control is
inadequate.',
whenToGiveExpanded: 'Use as "rescue" medication for sudden breathing
difficulty. Shake inhaler before use. Use spacer for better delivery. Wait 1 minute between
puffs if taking multiple. If no relief or needing increasingly frequent doses, seek immediate
medical attention.',
sideEffects: 'Common: Tremor (fine trembling of hands), palpitations,
tachycardia, headache, muscle cramps, nervousness. Rare: Hypokalemia (high doses), paradoxical
bronchospasm (rare), hyperglycemia. Serious: Cardiac arrhythmias (overdose).',
contraindicationsExpanded: 'Absolute: Hypersensitivity to salbutamol or
any component. Relative: Cardiac arrhythmias, tachycardia, hypertension, hyperthyroidism,
diabetes mellitus, hypokalemia, seizure disorders, pregnancy (use only if benefit > risk).',
drugInteractions: 'Beta-blockers: Antagonize bronchodilator effect (avoid
non-selective beta-blockers in asthma). MAOIs/TCAs: Enhanced cardiovascular effects.
Diuretics: Additive hypokalemia. Other sympathomimetics: Additive effects. Digoxin: May
increase risk of arrhythmias.',
nursingConsiderations: '1) Assess respiratory status (breath sounds,
respiratory rate, O2 sat) before and after. 2) Teach proper inhaler technique with spacer. 3)
Monitor heart rate and for tremors. 4) Track frequency of use - frequent need indicates poor
control. 5) Ensure patient has rescue inhaler accessible at all times. 6) Rinse mouth after
use (especially with steroid inhalers).',
patientEducation: 'Keep rescue inhaler with you at all times. Shake well
before each use. Use a spacer for better delivery. If not getting relief or using more than
twice weekly, your asthma may not be well controlled - see doctor. Common to feel shaky or
have fast heartbeat after use. Track how often you use it and report to doctor.',
conditionSafetyExpanded: { hypertension: 'CAUTION - may transiently
increase BP', diabetes: 'CAUTION - may increase blood glucose', asthma: 'FIRST-LINE RESCUE',
copd: 'FIRST-LINE RESCUE', ckd: 'SAFE', pregnancy: 'Category C - use if clearly needed',
cardiac_disease: 'CAUTION' }
}
},
{
id: 'hydrocortisone-cream',
name: 'Hydrocortisone Cream (1%)',
ph_brands: ['Cortaid', 'Cortizone-10', 'Hydrocortisone Cream', 'Dermacort',
'Aveeno Hydrocortisone'],
uses: 'Minor skin irritation, itching, rashes, eczema, insect bites, contact
dermatitis',
origin: 'Topical corticosteroid for anti-inflammatory and anti-itch effects',
whenToGive: 'For minor skin inflammation; apply thin layer 2-4x daily; limit
to 7 days without physician consult',
contraindications: 'Bacterial/fungal/viral skin infections, open wounds,
face/groin use without physician guidance',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['skin','rash','itching','steroid','topical'],
additionalInfo: {
genericNames: ['Hydrocortisone', 'Cortisol', 'Hydrocortisone Acetate'],
drugClass: 'Topical Corticosteroid (Low Potency, Class VII),
Anti-inflammatory, Antipruritic',
usesExpanded: 'Minor skin irritation, itching, rashes, eczema (mild),
psoriasis (mild), seborrheic dermatitis, contact dermatitis (poison ivy/oak), insect bites,
minor allergic skin reactions, anal/perianal itching, external feminine itching',
mechanismOfAction: 'Binds to intracellular glucocorticoid receptors,
modifying gene transcription. Reduces inflammation by inhibiting phospholipase A2 (decreasing
prostaglandins and leukotrienes), reducing capillary permeability, suppressing immune
response, and decreasing histamine release from mast cells.',
originExpanded: 'Hydrocortisone (cortisol) is the naturally occurring
glucocorticoid hormone produced by the adrenal cortex. First isolated in 1950s. Topical
formulation developed for skin conditions. 1% concentration is the highest available OTC.',
pharmacokinetics: 'Absorption: Variable depending on site (1% scalp, 7%
forehead, 30% scrotum), occlusion increases absorption. Systemic absorption minimal with 1%
cream used appropriately. Metabolism: Primarily in skin, systemic portion metabolized
hepatically. Excretion: Renal as metabolites.',
dosing: 'Apply thin film to affected area 2-4 times daily. Gently rub in.
For OTC use, limit to 7 days unless directed by physician. Do not apply to large surface
areas, broken skin, or use under occlusive dressings without medical supervision.',
whenToGiveExpanded: 'For temporary relief of minor skin irritation and
itching. Apply after cleaning and drying skin. Use the least amount needed. Not for face,
groin, or underarms unless directed by physician (increased absorption). Stop use if
irritation worsens.',
sideEffects: 'Local: Burning, itching, irritation, dryness at application
site. Prolonged use: Skin atrophy, striae, telangiectasia, purpura, acneiform eruptions,
hypopigmentation, delayed wound healing. Systemic (rare with OTC use): HPA axis suppression
with extensive use.',
contraindicationsExpanded: 'Absolute: Bacterial skin infections
(impetigo), fungal infections (ringworm, athletes foot), viral skin infections (herpes,
chickenpox), rosacea, perioral dermatitis. Relative: Face/groin/axillae (use lower potency
shorter duration), children (increased absorption), wounds/ulcers.',
drugInteractions: 'Minimal systemic interactions with topical 1% use.
Theoretically, other corticosteroids may have additive effects. May mask signs of skin
infection if used inappropriately.',
nursingConsiderations: '1) Assess the skin condition - ensure not infected
(bacterial, fungal, viral). 2) Teach proper application (thin layer, gently rub in). 3)
Educate about limited duration (7 days OTC). 4) Monitor for signs of skin atrophy with
prolonged use. 5) Advise avoiding face, groin, broken skin. 6) If no improvement in 7 days,
refer to physician.',
patientEducation: 'Apply a thin layer and rub in gently. Do not use on
face, groin, or armpits unless told by doctor. Do not cover with bandages unless directed.
Stop use after 7 days unless doctor says otherwise. Do not use on cuts, wounds, or infected
skin. If condition worsens or does not improve, see a doctor. This is NOT for treating
infections.',
conditionSafetyExpanded: { hypertension: 'SAFE - topical', diabetes: 'SAFE
- minimal systemic absorption', asthma: 'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy:
'Category C - use sparingly if needed', children: 'CAUTION - increased absorption' }
}
},
{
id: 'clotrimazole',
name: 'Clotrimazole',
ph_brands: ['Canesten', 'Lotrimin', 'Mycelex', 'Fungisol', 'Clotrimazole
Cream'],
uses: 'Fungal skin infections, athletes foot, ringworm, yeast infections, jock
itch',
origin: 'Imidazole antifungal developed in the 1960s',
whenToGive: 'For superficial fungal infections; apply 2-3x daily for 2-4
weeks',
contraindications: 'Hypersensitivity to imidazoles; avoid contact with eyes',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['fungal','antifungal','skin','ringworm','athletes foot'],
additionalInfo: {
genericNames: ['Clotrimazole',
'1-(o-Chloro-alpha,alpha-diphenylbenzyl)imidazole'],
drugClass: 'Imidazole Antifungal, Azole Antifungal',
usesExpanded: 'Tinea pedis (athletes foot), tinea cruris (jock itch),
tinea corporis (ringworm), cutaneous candidiasis, vulvovaginal candidiasis (yeast infection),
oral thrush (troche form), tinea versicolor, otomycosis (ear fungus)',
mechanismOfAction: 'Inhibits ergosterol synthesis by blocking lanosterol
14-alpha demethylase (CYP51), a fungal cytochrome P450 enzyme. Ergosterol is essential for
fungal cell membrane integrity. Disruption causes increased permeability, leakage of cellular
contents, and cell death. Fungistatic at low concentrations, fungicidal at higher
concentrations.',
originExpanded: 'Developed by Bayer AG in Germany in 1969. One of the
first imidazole antifungals. FDA approved in 1975. Available in multiple formulations (cream,
solution, vaginal tablets, troches). Became OTC in 1990.',
pharmacokinetics: 'Topical - Absorption: Minimal systemic absorption
(<0.5% through intact skin). Acts locally at site of application. Vaginal: <10% systemic
absorption. Oral troche: Small amount swallowed absorbed. Metabolism: Hepatic. Half-life: Not
clinically relevant for topical. Duration: Fungistatic effect lasts several hours.',
dosing: 'Topical cream/solution: Apply thin layer to affected area 2 times
daily (morning and evening) for 2-4 weeks depending on infection. Athletes foot: 4 weeks. Jock
itch/ringworm: 2 weeks. Continue for 2 weeks after symptoms resolve. Vaginal: 100-500mg
intravaginally for 1-7 days depending on formulation.',
whenToGiveExpanded: 'Clean and dry affected area before application. Apply
thin layer and rub in gently. Continue treatment for full duration even if symptoms improve to
prevent recurrence. For athletes foot, continue 2 weeks after symptoms clear.',
sideEffects: 'Topical: Local burning, stinging, redness, itching, peeling,
irritation, edema at application site. Vaginal: Mild burning/irritation, abdominal cramps,
urinary frequency. Oral: Nausea, vomiting, altered liver function (rare with topical).',
contraindicationsExpanded: 'Absolute: Hypersensitivity to clotrimazole or
other imidazoles/azoles. Relative: First trimester pregnancy (vaginal use - consult provider),
contact lens use (some formulations contain ingredients irritating to eyes).',
drugInteractions: 'Topical: Minimal interactions. Vaginal: May damage
latex condoms/diaphragms (oil-based formulations). Oral troches: May increase
tacrolimus/sirolimus levels. Generally, systemic drug interactions not relevant for
topical/vaginal use.',
nursingConsiderations: '1) Assess the infection - confirm it appears
fungal (not bacterial). 2) Teach proper application and duration. 3) Emphasize completing full
course. 4) Advise on hygiene (keep area dry, change socks frequently for athletes foot). 5) If
no improvement in 4 weeks (2 weeks for jock itch), refer to physician. 6) For vaginal use,
advise avoiding tampons during treatment.',
patientEducation: 'Clean and dry the affected area before applying. Use
for the full treatment time even if symptoms improve early. For athletes foot, keep feet dry,
change socks daily, wear breathable shoes. Wash hands before and after application. Do not
cover with airtight bandages unless directed. If no improvement in 2-4 weeks, see a doctor.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE - but
monitor, prone to fungal infections', asthma: 'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy:
'Topical SAFE; Vaginal - consult provider in 1st trimester' }
}
},
{
id: 'oral-rehydration-salts',
name: 'Oral Rehydration Salts (ORS)',
ph_brands: ['Hydrite', 'Pedialyte', 'Oresol', 'Glucolyte', 'Electrolit'],
uses: 'Dehydration from diarrhea, vomiting, heat exposure, fluid replacement',
origin: 'WHO-formulated solution for oral rehydration therapy developed in
1960s',
whenToGive: 'For mild to moderate dehydration; small frequent sips; continue
during diarrhea',
contraindications: 'Severe dehydration (needs IV), intestinal obstruction,
persistent vomiting',
conditionSafety: { hypertension: 'CAUTION', diabetes: 'CAUTION', asthma:
'SAFE', copd: 'SAFE', ckd: 'CAUTION' },
tags: ['dehydration','diarrhea','vomiting','electrolytes','rehydration'],
additionalInfo: {
genericNames: ['Oral Rehydration Salts', 'ORS', 'Oral Rehydration
Solution', 'Electrolyte Solution'],
drugClass: 'Oral Rehydration Therapy (ORT), Electrolyte Replacement',
usesExpanded: 'Mild to moderate dehydration from acute diarrhea
(gastroenteritis), vomiting, excessive sweating/heat exposure, exercise-induced dehydration,
hangover recovery, maintenance of hydration during illness',
mechanismOfAction: 'Based on sodium-glucose cotransport mechanism: Glucose
enhances sodium absorption in the small intestine through SGLT-1 transporter. Water follows
sodium osmotically. The balanced electrolyte composition replaces losses and maintains osmotic
balance. WHO formula optimized for maximum water and electrolyte absorption.',
originExpanded: 'Developed in the 1960s-70s during cholera epidemics in
Bangladesh. WHO and UNICEF standardized the formula in 1975. Called "potentially the most
important medical advance this century" by The Lancet (1978). Reduced childhood diarrhea
mortality by 90% in developing countries. Low-osmolarity formula adopted in 2002.',
pharmacokinetics: 'Absorption: Rapid intestinal absorption due to
glucose-sodium cotransport. Onset: Rehydration begins within 30 minutes. Components
distributed according to body fluid compartments. Sodium and glucose absorbed in small
intestine. Excess excreted renally.',
dosing: 'Mild dehydration: 50-100 mL/kg over 4 hours. Moderate
dehydration: 100 mL/kg over 4 hours. Maintenance: 10 mL/kg for each watery stool. Infants:
Teaspoon amounts frequently. Children: Small sips every few minutes. Adults: Cup amounts as
tolerated. Continue until diarrhea stops + adequate urine output.',
whenToGiveExpanded: 'Begin at first sign of diarrhea or vomiting. Give in
small, frequent amounts (teaspoons for infants, small sips for children/adults). If vomiting,
wait 10 minutes and try again with smaller amounts. Continue regular feeding/breastfeeding
alongside ORS. More effective than water, juice, or soda for rehydration.',
sideEffects: 'Common: Nausea if drunk too fast. Hypernatremia if mixed
incorrectly (too concentrated). Hyperglycemia in diabetics. Fluid overload if
over-administered in renal/cardiac disease. Generally very safe when used correctly.',
contraindicationsExpanded: 'Absolute: Severe dehydration (>10% body weight
- needs IV), shock, unconsciousness, ileus, intestinal obstruction, intractable vomiting.
Relative: Renal failure (electrolyte concerns), severe malnutrition (refeeding issues),
hypernatremia.',
drugInteractions: 'Minimal drug interactions. Absorption of some
medications may be affected during acute diarrhea. Glucose content should be considered in
diabetic management. Does not interact directly with medications.',
nursingConsiderations: '1) Assess hydration status (skin turgor, mucous
membranes, urine output, capillary refill). 2) Weigh patient if possible. 3) Ensure correct
mixing if using powder (1 packet to 1 liter water). 4) Monitor intake and output. 5) Assess
for signs of severe dehydration needing IV. 6) Educate on giving small frequent amounts if
vomiting. 7) Continue breastfeeding/regular diet alongside.',
patientEducation: 'Mix exactly as directed on packet - not more or less
water. Give small frequent sips, not large amounts at once. If vomiting, wait 10 minutes and
try smaller amounts. Continue breastfeeding or regular diet. ORS does not stop diarrhea - it
prevents dehydration. Seek medical help if: blood in stool, severe vomiting, no urine for 6+
hours, very drowsy, or condition worsens.',
conditionSafetyExpanded: { hypertension: 'CAUTION - check sodium content',
diabetes: 'CAUTION - contains glucose, monitor blood sugar', asthma: 'SAFE', copd: 'SAFE',
ckd: 'CAUTION - electrolyte concerns', heart_failure: 'CAUTION - fluid overload risk' }
}
},
{
id: 'simethicone',
name: 'Simethicone',
ph_brands: ['Gas-X', 'Mylicon', 'Phazyme', 'Degas', 'Flatulex'],
uses: 'Gas, bloating, flatulence, abdominal discomfort from gas',
origin: 'Anti-foaming agent that reduces surface tension of gas bubbles',
whenToGive: 'For gas-related discomfort; take after meals and at bedtime',
contraindications: 'None significant; considered very safe',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['gas','bloating','flatulence','digestive'],
additionalInfo: {
genericNames: ['Simethicone', 'Dimethicone activated',
'Polydimethylsiloxane'],
drugClass: 'Antiflatulent, Antifoaming Agent, GI Defoamer',
usesExpanded: 'Relief of painful symptoms from excess gas in the GI tract
(bloating, pressure, fullness, cramping), postoperative gas pain, infant colic (drops),
adjunct to gastric imaging (reduces gas artifacts), adjunct before endoscopy',
mechanismOfAction: 'Acts as a surfactant/defoaming agent. Reduces surface
tension of gas bubbles in the GI tract, causing them to coalesce (merge) into larger bubbles
that can be more easily expelled by belching or passing flatus. Does not reduce gas production
- only changes physical properties. Inert and not absorbed.',
originExpanded: 'Silicone-based compound developed mid-20th century. First
used in industrial applications as anti-foaming agent. Pharmaceutical use recognized for GI
gas relief. FDA approved for OTC use. One of the safest medications available.',
pharmacokinetics: 'Absorption: NOT absorbed from GI tract - acts purely
locally (physical effect). Passes through GI tract unchanged. Onset: Within minutes. Duration:
As long as in contact with gas. Excretion: Eliminated unchanged in feces. No systemic
effects.',
dosing: 'Adults & children ≥12y: 40-125mg after meals and at bedtime (max
500mg/day). Children 2-12y: 40mg up to 4 times daily. Infants: 20mg (0.3mL drops) up to 4
times daily, with or after feeds. Chewable tablets should be chewed thoroughly.',
whenToGiveExpanded: 'Take after meals and at bedtime for best effect. For
infant colic, give during or after feeding. Chew tablets thoroughly before swallowing for
faster action. Can be used regularly or as needed. Safe for long-term use.',
sideEffects: 'Essentially no side effects due to lack of absorption.
Rarely: Mild GI upset. No systemic effects. Considered one of the safest OTC medications. Safe
for infants, pregnant/nursing women.',
contraindicationsExpanded: 'Essentially none. Hypersensitivity to
simethicone (extremely rare). No known contraindications due to lack of systemic absorption.',
drugInteractions: 'None known. Because it is not absorbed, it does not
interact with other medications systemically. May theoretically affect absorption of
fat-soluble drugs, but not clinically significant.',
nursingConsiderations: '1) Assess source of GI discomfort - rule out
serious causes (obstruction, perforation). 2) Reassure patient about excellent safety profile.
3) Advise chewing tablets thoroughly. 4) For infants, use calibrated dropper. 5) If symptoms
persist or worsen, further evaluation needed. 6) Educate about dietary causes of gas.',
patientEducation: 'Chew tablets completely before swallowing. Very safe -
even for babies and pregnant women. Works by making gas bubbles smaller and easier to pass.
Does not reduce gas production - just helps expel it. If symptoms persist, see a doctor.
Dietary changes may help reduce gas: avoid beans, carbonated drinks, eat slowly, reduce
lactose if intolerant.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy: 'SAFE - not absorbed', infants: 'SAFE - commonly
used for colic' }
}
},
{
id: 'bisacodyl',
name: 'Bisacodyl',
ph_brands: ['Dulcolax', 'Fleet Laxative', 'Correctol', 'Bisalax', 'Magic
Bullet'],
uses: 'Constipation, bowel preparation before procedures',
origin: 'Stimulant laxative that increases intestinal motility',
whenToGive: 'For occasional constipation; take at bedtime for morning effect;
not for daily use',
contraindications: 'Intestinal obstruction, acute abdominal conditions, severe
dehydration',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['constipation','laxative','bowel'],
additionalInfo: {
genericNames: ['Bisacodyl', 'Bis(4-acetoxyphenyl)-2-pyridylmethane'],
drugClass: 'Stimulant Laxative, Diphenylmethane Derivative',
usesExpanded: 'Occasional constipation, bowel preparation before
colonoscopy/surgery/radiological procedures, constipation due to opioids or immobility,
neurogenic bowel (spinal cord injury), relief of fecal impaction (suppository)',
mechanismOfAction: 'Stimulates enteric neurons in the colonic wall,
causing peristaltic contractions. Also inhibits water and electrolyte absorption in the
intestine and stimulates secretion, resulting in fluid accumulation that further promotes
evacuation. Acts primarily on the large intestine.',
originExpanded: 'Developed by Boehringer Ingelheim in 1953. First marketed
in Germany. FDA approved. One of the most commonly used stimulant laxatives worldwide.
Available in both oral and rectal (suppository) forms.',
pharmacokinetics: 'Absorption: Oral tablets are enteric-coated; minimal
absorption (<5%). Converted to active metabolite (bis-(p-hydroxyphenyl)-pyridyl-2-methane) by
intestinal bacteria and enzymes. Onset: Oral 6-12 hours, Suppository 15-60 minutes. Duration:
Single bowel movement. Excretion: Minimal systemic; mostly fecal.',
dosing: 'Oral tablets (adults): 5-15mg once daily at bedtime. Take on
empty stomach. Children 6-12y: 5mg. Suppository (adults): 10mg once daily. Children 6-12y:
5-10mg. Children 2-6y: 5mg. For bowel prep: Higher doses per protocol. Not for daily use
beyond 1 week.',
whenToGiveExpanded: 'Take oral tablets at bedtime for morning bowel
movement. Do NOT crush, chew, or take with milk/antacids (damages enteric coating causing
stomach irritation). Suppositories work faster (15-60 min) for more urgent relief. Not for
daily long-term use - can cause dependency.',
sideEffects: 'Common: Abdominal cramping, diarrhea, nausea. Suppository:
Rectal irritation/burning. Prolonged use: Electrolyte imbalance (hypokalemia), dehydration,
"lazy bowel" syndrome (laxative dependency), melanosis coli (harmless discoloration).',
contraindicationsExpanded: 'Absolute: Intestinal obstruction, ileus, acute
abdominal conditions (appendicitis, inflammatory bowel disease flare), severe dehydration,
undiagnosed abdominal pain/vomiting. Relative: Recent abdominal surgery, elderly (electrolyte
concerns), children <2 years.',
drugInteractions: 'Antacids, milk, PPIs, H2 blockers: Can dissolve enteric
coating prematurely (take 1 hour apart). Diuretics: Additive hypokalemia risk. Digoxin:
Hypokalemia may enhance toxicity. Corticosteroids: Additive electrolyte loss.',
nursingConsiderations: '1) Assess bowel pattern and rule out obstruction.
2) Ensure patient does not crush/chew tablets or take with milk/antacids. 3) Monitor for
cramping and adequate hydration. 4) Educate about expected timing (oral: morning, suppository:
15-60 min). 5) Warn against long-term daily use. 6) Monitor electrolytes if repeated use.',
patientEducation: 'Swallow tablets whole - do not crush or chew. Do not
take with milk or antacids (wait 1 hour). Expect bowel movement 6-12 hours after oral dose.
For suppository, retain as long as comfortable for best effect. May cause cramping. Increase
fiber, fluids, and exercise for long-term bowel health. Not for daily use - only occasional
constipation.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'CAUTION - monitor electrolytes', pregnancy: 'Category C -
occasional use likely safe', ibd: 'AVOID during flare' }
}
},
{
id: 'zinc-supplements',
name: 'Zinc Supplements',
ph_brands: ['Zinc Sulfate', 'Soluzinc', 'Immunpro', 'Bewell-C Zinc',
'Cold-EEZE'],
uses: 'Zinc deficiency, immune support, diarrhea in children (adjunct), wound
healing',
origin: 'Essential mineral supplement; WHO recommends for pediatric diarrhea',
whenToGive: 'For zinc deficiency or as adjunct therapy in acute diarrhea
(children); take with food to reduce GI upset',
contraindications: 'Copper deficiency with prolonged high-dose use; avoid with
certain antibiotics (reduces absorption)',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['supplement','immune','diarrhea','zinc','vitamin'],
additionalInfo: {
genericNames: ['Zinc Sulfate', 'Zinc Gluconate', 'Zinc Acetate', 'Zinc
Picolinate', 'Elemental Zinc'],
drugClass: 'Essential Mineral Supplement, Trace Element',
usesExpanded: 'Zinc deficiency (acrodermatitis enteropathica,
malabsorption, alcoholism), adjunct treatment of pediatric diarrhea (WHO-recommended), Wilson
disease (high dose), immune support, wound healing, common cold (possibly reduces duration),
age-related macular degeneration prevention, acne (adjunct)',
mechanismOfAction: 'Zinc is a cofactor for >300 enzymes involved in
protein synthesis, DNA synthesis, cell division, wound healing, and immune function. In
diarrhea, zinc restores intestinal mucosal integrity and enhances immune response. May also
inhibit rhinovirus replication (cold lozenges).',
originExpanded: 'Zinc\'s essential role in human nutrition recognized in
1960s. WHO added zinc to ORS recommendation in 2004 after studies showed reduced diarrhea
duration and severity in children. Named from German "Zink" (meaning pointed, referring to
crystal shape).',
pharmacokinetics: 'Absorption: 20-40% absorbed from GI tract (reduced by
phytates, fiber, calcium). Absorption better with picolinate/gluconate forms. Distribution:
Found in all tissues; highest in muscle, bone, liver. Metabolism: Not metabolized. Excretion:
Primarily fecal; small amount renal.',
dosing: 'RDA: Adults 8-11mg/day. Zinc deficiency: 25-50mg elemental zinc
daily. Pediatric diarrhea (WHO): 10mg/day (<6 months), 20mg/day (≥6 months) for 10-14 days.
Common cold: 75mg+ daily as lozenges. Upper limit: 40mg/day for adults (prolonged use).',
whenToGiveExpanded: 'Take with food to reduce GI upset. For diarrhea in
children, start within 3 days of onset and continue for 10-14 days. For cold, zinc lozenges
may be most effective within 24 hours of symptom onset. Space from antibiotics (quinolones,
tetracyclines) by 2 hours.',
sideEffects: 'Common: Nausea, vomiting, metallic taste, diarrhea, stomach
cramps (especially on empty stomach). Lozenges: Mouth irritation, altered taste. Chronic high
doses: Copper deficiency (anemia, neutropenia), HDL reduction. Intranasal zinc: Loss of smell
(anosmia - avoid!).',
contraindicationsExpanded: 'Relative: Copper deficiency (zinc inhibits
copper absorption), chronic kidney disease (accumulation risk). Avoid intranasal zinc products
(permanent anosmia risk). Caution with prolonged high doses >40mg/day.',
drugInteractions: 'Fluoroquinolones, tetracyclines: Reduced antibiotic
absorption (take 2 hours apart). Penicillamine: Reduced effect. Thiazide diuretics: Increased
zinc excretion. Calcium, iron: May reduce zinc absorption if taken together.',
nursingConsiderations: '1) Assess for zinc deficiency symptoms (poor wound
healing, taste changes, skin lesions, frequent infections). 2) For pediatric diarrhea, combine
with ORS. 3) Monitor copper levels with prolonged supplementation. 4) Educate about food
timing to reduce GI upset. 5) Space from certain antibiotics. 6) Check for drug
interactions.',
patientEducation: 'Take with food to prevent stomach upset. Do NOT use
zinc nasal sprays (can cause permanent loss of smell). For colds, start at first sign of
symptoms. If taking antibiotics, take zinc at least 2 hours apart. High doses over long
periods can cause copper deficiency. For children with diarrhea, continue for 10-14 days as
recommended.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'CAUTION - accumulation risk', pregnancy: 'SAFE at recommended
doses', pediatric_diarrhea: 'WHO-RECOMMENDED' }
}
},
{
id: 'ascorbic-acid',
name: 'Ascorbic Acid (Vitamin C)',
ph_brands: ['Cecon', 'Celin', 'Fern-C', 'Bewell-C', 'Poten-Cee', 'Cee Plus'],
uses: 'Vitamin C deficiency, immune support, antioxidant, wound healing',
origin: 'Essential vitamin; deficiency causes scurvy; popularized for cold
prevention',
whenToGive: 'For deficiency or supplementation; daily dosing; high doses may
cause GI upset',
contraindications: 'History of kidney stones (high doses), hemochromatosis,
G6PD deficiency (very high doses)',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['vitamin','supplement','immune','antioxidant'],
additionalInfo: {
genericNames: ['Ascorbic Acid', 'Vitamin C', 'L-ascorbic acid', 'Sodium
Ascorbate', 'Calcium Ascorbate'],
drugClass: 'Water-Soluble Vitamin, Antioxidant, Dietary Supplement',
usesExpanded: 'Scurvy prevention and treatment, dietary supplementation,
wound healing, iron absorption enhancement, immune support, common cold (may reduce
duration/severity slightly), antioxidant protection, collagen synthesis, adjunct in
methemoglobinemia',
mechanismOfAction: 'Essential cofactor for collagen synthesis
(hydroxylation of proline/lysine), carnitine biosynthesis, and neurotransmitter synthesis.
Potent antioxidant that scavenges free radicals. Enhances iron absorption by reducing ferric
to ferrous iron. Supports immune cell function.',
originExpanded: 'Identified in 1932 by Albert Szent-Györgyi (Nobel Prize
1937). Deficiency causes scurvy (known since ancient times in sailors). Linus Pauling
popularized megadose therapy in 1970s (controversial). "Ascorbic" means "without scurvy."',
pharmacokinetics: 'Absorption: Active transport in small intestine
(saturable at ~200mg). Higher doses have decreased bioavailability. Distribution: Widely
distributed; highest in leukocytes, adrenal glands, pituitary. Not stored significantly.
Half-life: 10-20 days at normal intake. Excretion: Renal (as oxalate and unchanged).',
dosing: 'RDA: Adults 75-90mg/day (smokers add 35mg). Deficiency treatment:
100-200mg 3 times daily. Immune support: 200-1000mg daily. Upper limit: 2000mg/day (higher
doses cause GI upset, oxalate stones). Pediatric: 15-45mg/day depending on age.',
whenToGiveExpanded: 'Can be taken anytime; food may reduce GI upset at
high doses. Divide high doses throughout the day (better absorption). For iron deficiency,
take with iron supplements to enhance absorption. Excess is excreted in urine (expensive
urine!).',
sideEffects: 'Low doses: Generally well tolerated. High doses (>2g/day):
Diarrhea, nausea, abdominal cramps, kidney stones (oxalate), headache. Rebound scurvy (if
suddenly stopped after prolonged high doses). False-negative stool occult blood and glucose
tests.',
contraindicationsExpanded: 'Relative: History of kidney stones (oxalate
stones - limit to <1g/day), hemochromatosis and other iron overload conditions (enhances iron
absorption), G6PD deficiency (very high IV doses can cause hemolysis), renal impairment.',
drugInteractions: 'Iron: Enhanced absorption (beneficial in deficiency).
Warfarin: High doses may reduce anticoagulant effect. Aluminum antacids: Increases aluminum
absorption. Aspirin: High doses increase aspirin levels. Estrogens: Increased estrogen levels.
May interfere with some lab tests.',
nursingConsiderations: '1) Assess for scurvy symptoms (bleeding gums,
petechiae, poor wound healing, fatigue). 2) Identify patients at risk (elderly, alcoholics,
restricted diets). 3) Educate about realistic expectations (modest cold benefit). 4) Monitor
for GI upset with high doses. 5) Warn about kidney stone risk with megadoses. 6) Advise
gradual dose reduction if stopping high doses.',
patientEducation: 'Best obtained from fruits and vegetables (citrus,
berries, peppers, broccoli). Supplements not necessary for most people with balanced diet.
High doses (>2g) can cause stomach upset and kidney stones. If taking iron supplements,
vitamin C helps absorption. Evidence for cold prevention is modest - may slightly reduce
duration but not prevent colds.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'CAUTION - limit dose, oxalate concerns', kidney_stones: 'CAUTION -
limit to <1g/day', hemochromatosis: 'AVOID - increases iron absorption' }
}
},
{
id: 'lagundi',
name: 'Lagundi (Vitex negundo)',
ph_brands: ['Ascof', 'Lagundi Tablet', 'Plemex', 'Lagundex', 'Ascof Lagundi'],
uses: 'Cough (productive and non-productive), mild asthma symptoms,
pharyngitis',
origin: 'DOH-approved Philippine herbal medicine with bronchodilator
properties',
whenToGive: 'For cough relief; may be used as first-line for mild respiratory
symptoms',
contraindications: 'Pregnancy (traditional caution), hypersensitivity to
plant',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['cough','herbal','philippine','respiratory','doh-approved'],
additionalInfo: {
genericNames: ['Vitex negundo', 'Five-Leaved Chaste Tree', 'Lagundi Leaf
Extract', 'Dangla'],
drugClass: 'Herbal Antitussive, Bronchodilator, Expectorant (DOH-Approved
Herbal Medicine)',
usesExpanded: 'Cough (both productive and non-productive), mild asthma,
pharyngitis, bronchitis, URTI symptoms, fever, rheumatism and body pain (traditional use),
headache, boils and skin disorders (poultice)',
mechanismOfAction: 'Contains chrysoplenol D and other flavonoids that
relax bronchial smooth muscle (bronchodilator effect). Also has expectorant,
anti-inflammatory, and antimicrobial properties. May inhibit leukotriene and histamine
release, contributing to anti-asthmatic effects.',
originExpanded: 'Native shrub widespread in the Philippines. Used in
traditional Philippine medicine for generations. Became one of the 10 DOH-approved herbal
medicines in 1997 under the Traditional Medicine Program. Scientifically validated for cough
and asthma.',
pharmacokinetics: 'Limited pharmacokinetic data for herbal preparations.
Active compounds (flavonoids, terpenes) absorbed from GI tract. Onset: 30-60 minutes for cough
relief. Duration: 4-6 hours. Metabolism and excretion not fully characterized.',
dosing: 'Leaf decoction: 1-2 tablespoons of chopped fresh leaves in 2
glasses of water, boil to 1 glass, drink 1/3 cup 3 times daily. Syrup (Ascof): Adults: 10mL 3
times daily. Children: 5mL 3 times daily. Tablets/capsules: Follow product labeling (usually
300-600mg 3 times daily).',
whenToGiveExpanded: 'Can be used as first-line treatment for mild cough
and respiratory symptoms. Take with or without food. Can be used for both dry and productive
cough. For acute symptoms, may use for 7-14 days. If no improvement, seek medical
evaluation.',
sideEffects: 'Generally well tolerated. Rare: Mild GI upset, skin rash
(allergic reaction). No serious side effects reported in clinical studies at recommended
doses.',
contraindicationsExpanded: 'Pregnancy and lactation (insufficient safety
data - traditional caution). Hypersensitivity to Vitex negundo or related plants (Verbenaceae
family). Use with caution in children under 2 years.',
drugInteractions: 'No significant drug interactions documented. As an
herbal product, potential for interaction with other medications exists but is not well
studied. Use caution if taking multiple medications.',
nursingConsiderations: '1) Assess cough character and duration. 2) Verify
patient is not pregnant or breastfeeding. 3) Educate about proper preparation if using fresh
leaves. 4) Monitor for allergic reactions. 5) Refer to physician if cough persists >2 weeks or
is associated with fever, hemoptysis, or weight loss. 6) One of 10 DOH-approved herbal
medicines.',
patientEducation: 'DOH-approved herbal medicine for cough. Can use for
both dry and wet cough. If using fresh leaves, follow proper decoction instructions. Available
as convenient syrup and tablet forms. Generally safe but avoid during pregnancy. See a doctor
if cough persists more than 2 weeks or if you develop fever or cough up blood.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE - may help mild symptoms', copd: 'SAFE - may help symptoms', ckd: 'SAFE', pregnancy:
'AVOID - insufficient safety data', children: 'SAFE >2 years at appropriate dose' }
}
},
{
id: 'sambong',
name: 'Sambong (Blumea balsamifera)',
ph_brands: ['Sambong Tablet', 'Releaf Forte', 'Sambong Plus', 'Natatanging
Gamot'],
uses: 'Mild urinary tract infections, kidney stone dissolution (adjunct),
diuretic',
origin: 'DOH-approved Philippine herbal medicine with diuretic and
anti-urolithiatic properties',
whenToGive: 'For UTI symptoms or kidney stone prevention; increase fluid
intake',
contraindications: 'Severe renal impairment, pregnancy',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['uti','herbal','philippine','diuretic','kidney','doh-approved'],
additionalInfo: {
genericNames: ['Blumea balsamifera', 'Ngai Camphor', 'Sambong Leaf
Extract', 'Subsob'],
drugClass: 'Herbal Diuretic, Anti-urolithiatic, Anti-edema Agent
(DOH-Approved Herbal Medicine)',
usesExpanded: 'Mild urinary tract infections, dissolution and prevention
of kidney stones (calcium oxalate type), edema, hypertension (adjunct due to diuretic effect),
rheumatism (traditional use), postpartum care, wound healing (poultice)',
mechanismOfAction: 'Contains flavonoids and sesquiterpenes with diuretic
properties that increase urine output. Anti-urolithiatic effect through promotion of stone
dissolution and prevention of calcium oxite crystal formation. Also has antimicrobial and
anti-inflammatory properties.',
originExpanded: 'Native plant found throughout the Philippines, known
locally as "sambong" or "subsob." Used in traditional Filipino medicine for centuries. One of
the 10 DOH-approved herbal medicines since 1997. Scientifically studied for urological
conditions.',
pharmacokinetics: 'Limited formal pharmacokinetic studies. Active
components absorbed from GI tract. Diuretic effect noted within 1-2 hours. Duration of action:
4-6 hours. Excreted primarily through kidneys.',
dosing: 'Decoction: 1 cup of chopped fresh leaves (50g) boiled in 2
glasses of water, reduced to 1 glass. Drink 1/3 glass 3 times daily after meals. Tablets:
Usually 500mg 3 times daily after meals. Continue for 2-4 weeks for kidney stones. Increase
fluid intake.',
whenToGiveExpanded: 'Take after meals to reduce GI upset. Always encourage
high fluid intake (8+ glasses daily) when using for UTI or kidney stones. Can be used as
first-line for mild UTI symptoms. For kidney stones, usually used as adjunct to medical
management.',
sideEffects: 'Generally well tolerated. May cause increased urination
(expected diuretic effect). Rare: Mild GI upset, allergic reactions. No serious adverse
effects reported at recommended doses.',
contraindicationsExpanded: 'Pregnancy (may have uterotonic effects),
breastfeeding (insufficient safety data), severe renal impairment, dehydration, electrolyte
imbalances. Use with caution in patients on diuretics or with heart failure.',
drugInteractions: 'Diuretics: Additive diuretic effect (monitor for
dehydration, electrolyte imbalance). Lithium: May affect lithium levels due to diuretic
effect. Other nephrotoxic drugs: Use with caution.',
nursingConsiderations: '1) Assess urinary symptoms and hydration status.
2) Encourage high fluid intake. 3) Monitor urine output. 4) Verify patient is not pregnant. 5)
If symptoms persist beyond 2 weeks or worsen (fever, flank pain, hematuria), refer to
physician. 6) One of 10 DOH-approved herbal medicines.',
patientEducation: 'DOH-approved herbal medicine for urinary conditions.
Drink plenty of water (8+ glasses daily) while taking sambong. Take after meals. May notice
increased urination - this is expected. See a doctor if you have fever, severe pain, blood in
urine, or symptoms worsen. Not recommended during pregnancy. Continue treatment for
recommended duration.',
conditionSafetyExpanded: { hypertension: 'SAFE - may help via diuretic
effect', diabetes: 'SAFE', asthma: 'SAFE', copd: 'SAFE', ckd: 'CAUTION - monitor renal
function', pregnancy: 'AVOID', dehydration: 'AVOID - increase fluids first' }
}
},
{
id: 'naproxen',
name: 'Naproxen',
ph_brands: ['Aleve', 'Flanax', 'Naprosyn', 'Anaprox', 'Synflex'],
uses: 'Pain, inflammation, arthritis, menstrual cramps, headache, fever',
origin: 'NSAID introduced in 1976; longer duration of action than ibuprofen',
whenToGive: 'For pain and inflammation; take with food; suitable for twice
daily dosing',
contraindications: 'Active peptic ulcer, severe renal/hepatic impairment,
aspirin-sensitive asthma, cardiovascular disease',
conditionSafety: { hypertension: 'CAUTION', diabetes: 'SAFE', asthma:
'CAUTION', copd: 'SAFE', ckd: '⚠️ CONTRAINDICATED' },
tags: ['pain','nsaid','inflammation','arthritis','fever'],
additionalInfo: {
genericNames: ['Naproxen', 'Naproxen Sodium',
'(S)-(+)-6-methoxy-α-methyl-2-naphthaleneacetic acid'],
drugClass: 'Nonsteroidal Anti-inflammatory Drug (NSAID), Propionic Acid
Derivative',
usesExpanded: 'Mild to moderate pain, inflammatory conditions (rheumatoid
arthritis, osteoarthritis, ankylosing spondylitis, gout), primary dysmenorrhea, tendinitis,
bursitis, fever, migraine (acute), dental pain',
mechanismOfAction: 'Non-selective COX-1 and COX-2 inhibitor, blocking
prostaglandin synthesis. Results in anti-inflammatory, analgesic, and antipyretic effects. Has
longer half-life than ibuprofen, allowing twice-daily dosing.',
originExpanded: 'Developed by Syntex Corporation. FDA approved in 1976 as
prescription, OTC naproxen sodium (Aleve) approved in 1994. Naproxen sodium has faster onset
than naproxen base. Considered to have slightly lower cardiovascular risk compared to some
other NSAIDs.',
pharmacokinetics: 'Absorption: Rapid and complete (95% bioavailability).
Peak: 1-2 hours (naproxen sodium), 2-4 hours (naproxen). Distribution: 99% protein-bound.
Metabolism: Hepatic via CYP2C9 to 6-O-desmethyl naproxen (inactive). Half-life: 12-17 hours
(allows twice-daily dosing). Excretion: 95% renal.',
dosing: 'Pain/dysmenorrhea: 500mg initially, then 250mg every 6-8 hours
(max 1250mg first day, then 1000mg/day). OTC (Aleve): 220mg every 8-12 hours (max 660mg/day).
Arthritis: 250-500mg twice daily. Take with food. Elderly: Use lowest effective dose.',
whenToGiveExpanded: 'Take with food, milk, or antacid to reduce GI
irritation. Long half-life allows twice-daily dosing - advantage for chronic conditions like
arthritis. Use lowest effective dose for shortest duration. For menstrual cramps, start at
onset of bleeding.',
sideEffects: 'Common: GI upset, heartburn, nausea, headache, dizziness,
drowsiness. Serious: GI bleeding/ulceration, cardiovascular events (MI, stroke - though lower
than some NSAIDs), renal impairment, hepatotoxicity, severe skin reactions, fluid retention.',
contraindicationsExpanded: 'Absolute: Active GI bleeding or peptic ulcer,
hypersensitivity to NSAIDs, aspirin-triad (asthma, rhinitis, nasal polyps), severe heart
failure, post-CABG surgery, third trimester pregnancy. Relative: History of GI disease,
renal/hepatic impairment, hypertension, cardiovascular disease.',
drugInteractions: 'Anticoagulants (warfarin): Increased bleeding risk.
Aspirin: Reduced cardioprotection, increased GI risk. ACE inhibitors/ARBs: Reduced efficacy,
increased renal risk. Lithium: Increased levels. Methotrexate: Increased toxicity. Diuretics:
Reduced efficacy. Other NSAIDs: Avoid combination.',
nursingConsiderations: '1) Assess pain level before and after
administration. 2) Monitor for GI bleeding (dark stools, epigastric pain). 3) Check renal
function and BP, especially with prolonged use. 4) Ensure taken with food. 5) Educate about
cardiovascular warning signs. 6) Lower CV risk than some NSAIDs, but caution still needed.',
patientEducation: 'Take with food or milk. Do not lie down for 30 minutes
after taking. Avoid alcohol. Can take every 12 hours (longer-lasting than ibuprofen). Report
black stools, persistent stomach pain, or unusual bleeding. Avoid if pregnant, especially in
third trimester. Inform doctor before surgery.',
conditionSafetyExpanded: { hypertension: 'CAUTION - may elevate BP',
diabetes: 'SAFE', asthma: 'CAUTION - if aspirin-sensitive', copd: 'SAFE', ckd: '⚠️
CONTRAINDICATED', pregnancy: '⚠️ CONTRAINDICATED in 3rd trimester', cardiovascular: 'CAUTION -
lower risk than some NSAIDs' }
}
},
{
id: 'chlorpheniramine',
name: 'Chlorpheniramine',
ph_brands: ['Chlor-Trimeton', 'Neozep', 'Decolgen', 'Tuseran', 'Allergy
Relief'],
uses: 'Allergic rhinitis, common cold symptoms, urticaria, hay fever',
origin: 'First-generation antihistamine introduced in 1949; common in
combination cold medicines',
whenToGive: 'For allergy/cold symptoms; causes drowsiness; avoid driving',
contraindications: 'Narrow-angle glaucoma, urinary retention, MAOIs, elderly
(increased sensitivity)',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'CAUTION',
copd: 'CAUTION', ckd: 'SAFE' },
tags: ['allergy','antihistamine','cold','sedating'],
additionalInfo: {
genericNames: ['Chlorpheniramine Maleate', 'Chlorphenamine', 'CPM'],
drugClass: 'First-Generation Antihistamine (H1-receptor antagonist),
Alkylamine Derivative, Sedating Antihistamine',
usesExpanded: 'Allergic rhinitis (seasonal and perennial), common cold
symptoms (runny nose, sneezing), urticaria (hives), allergic conjunctivitis, hay fever,
pruritus, adjunct in anaphylaxis, sedation (off-label)',
mechanismOfAction: 'Competitively blocks H1-histamine receptors,
preventing histamine-mediated allergic responses. Readily crosses blood-brain barrier causing
significant sedation. Also has anticholinergic (drying) effects that help reduce nasal
secretions.',
originExpanded: 'Developed by Schering Corporation (now Merck). FDA
approved in 1949. One of the first commercially available antihistamines. Very inexpensive and
widely available. Common component in combination cold/flu medications.',
pharmacokinetics: 'Absorption: Well absorbed orally. Onset: 30-60 minutes.
Peak: 2-6 hours. Duration: 4-6 hours. Distribution: Widely distributed, crosses BBB (causes
sedation). Metabolism: Hepatic via CYP enzymes. Half-life: 12-24 hours. Excretion: Renal.',
dosing: 'Adults: 4mg every 4-6 hours (max 24mg/day). Extended-release:
8-12mg every 8-12 hours. Children 6-12y: 2mg every 4-6 hours (max 12mg/day). Children 2-6y:
1mg every 4-6 hours (max 6mg/day). Not recommended <2 years.',
whenToGiveExpanded: 'For allergy and cold symptoms. Take at bedtime if
daytime drowsiness is problematic. Effective for drying nasal secretions. Sedating properties
can be beneficial for nighttime dosing or when sleep is disrupted by symptoms.',
sideEffects: 'Common: Drowsiness (significant), dry mouth, urinary
retention, constipation, blurred vision, dizziness, thickened bronchial secretions. Rare:
Paradoxical excitation (children), hypersensitivity, blood dyscrasias.',
contraindicationsExpanded: 'Absolute: Narrow-angle glaucoma, MAOI use
within 14 days, premature/newborn infants. Relative: Elderly (increased anticholinergic
sensitivity), prostatic hypertrophy, urinary retention, GI obstruction, severe cardiovascular
disease, asthma/COPD (may thicken secretions).',
drugInteractions: 'CNS depressants (alcohol, opioids, benzodiazepines):
Enhanced sedation. MAOIs: Prolonged anticholinergic effects. Anticholinergic drugs: Additive
effects. CYP inhibitors: May increase levels.',
nursingConsiderations: '1) Assess allergy symptoms before and after
administration. 2) Warn about significant sedation - advise against driving. 3) Monitor for
anticholinergic effects (dry mouth, urinary retention). 4) Use caution in elderly (Beers
criteria). 5) Consider non-sedating alternatives for daytime use. 6) Monitor in children for
paradoxical excitation.',
patientEducation: 'Causes significant drowsiness - do not drive or operate
machinery. Avoid alcohol and other sedatives. May cause dry mouth - sip water or suck hard
candy. Report difficulty urinating. Consider taking at bedtime. For daytime use, non-sedating
antihistamines (loratadine, cetirizine) may be better options.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'CAUTION - may thicken secretions', copd: 'CAUTION - anticholinergic effects', ckd: 'SAFE',
pregnancy: 'Category B - may be used if needed', elderly: '⚠️ AVOID - Beers Criteria' }
}
},
{
id: 'dimenhydrinate',
name: 'Dimenhydrinate',
ph_brands: ['Dramamine', 'Bonamine', 'Travel-Ease', 'Gravol', 'Vertirex'],
uses: 'Motion sickness, nausea, vomiting, vertigo',
origin: 'Antihistamine/anticholinergic combination; diphenhydramine
derivative',
whenToGive: 'For motion sickness prevention; take 30 min before travel; causes
drowsiness',
contraindications: 'Narrow-angle glaucoma, urinary retention,
newborns/premature infants',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'CAUTION', ckd: 'SAFE' },
tags: ['motion sickness','nausea','antiemetic','travel'],
additionalInfo: {
genericNames: ['Dimenhydrinate', 'Diphenhydramine theoclate',
'Dramamine'],
drugClass: 'Antihistamine-Anticholinergic, Antiemetic, Motion Sickness
Agent',
usesExpanded: 'Prevention and treatment of motion sickness (car, sea,
air), nausea and vomiting, vertigo and dizziness from vestibular disorders, Ménière disease
symptoms',
mechanismOfAction: 'Dimenhydrinate is a salt of diphenhydramine and
8-chlorotheophylline. Blocks H1 histamine receptors and muscarinic cholinergic receptors in
the vomiting center and vestibular system. The theophylline component was thought to
counteract drowsiness but has minimal effect. Acts primarily on the vomiting center in the
medulla.',
originExpanded: 'Developed by G.D. Searle & Company in 1949. Combines
diphenhydramine with 8-chlorotheophylline. First effective OTC treatment for motion sickness.
Trade name "Dramamine" comes from "drama" (originally tested on theater workers) and
"amine."',
pharmacokinetics: 'Absorption: Well absorbed orally. Onset: 30-60 minutes
(oral), 20-30 minutes (chewable). Peak: 1-2 hours. Duration: 4-6 hours. Distribution: Crosses
BBB (causes sedation). Metabolism: Hepatic. Half-life: ~2.5 hours. Excretion: Renal.',
dosing: 'Prevention of motion sickness - Adults: 50-100mg 30 minutes
before travel, then 50-100mg every 4-6 hours (max 400mg/day). Children 6-12y: 25-50mg every
6-8 hours (max 150mg/day). Children 2-6y: 12.5-25mg every 6-8 hours (max 75mg/day).',
whenToGiveExpanded: 'For motion sickness prevention, take 30 minutes to 1
hour before travel. Once motion sickness has started, may be less effective. Can redose during
long trips. Take with food if GI upset occurs. Chewable forms act faster.',
sideEffects: 'Common: Drowsiness (significant), dry mouth, blurred vision,
constipation, urinary retention. Rare: Paradoxical excitement (especially children),
hypersensitivity, confusion (elderly), tinnitus.',
contraindicationsExpanded: 'Absolute: Neonates and premature infants
(increased sensitivity), hypersensitivity. Relative: Narrow-angle glaucoma, prostatic
hypertrophy, urinary obstruction, GI obstruction, asthma, COPD, elderly (increased CNS
effects).',
drugInteractions: 'CNS depressants (alcohol, opioids, sedatives): Enhanced
sedation. Anticholinergics: Additive effects. MAOIs: Enhanced anticholinergic effects.
Aminoglycosides: May mask ototoxicity symptoms. Ototoxic drugs: May mask symptoms.',
nursingConsiderations: '1) Administer 30-60 minutes before travel. 2) Warn
about significant drowsiness. 3) Assess for anticholinergic side effects. 4) Monitor for
paradoxical excitement in children. 5) Ensure adequate hydration during travel. 6) May mask
symptoms of ototoxicity - use caution if on ototoxic drugs.',
patientEducation: 'Take 30 minutes to 1 hour before travel for best
effect. Causes drowsiness - do not drive. Avoid alcohol. May cause dry mouth. For long trips,
may redose every 4-6 hours. Works best for prevention - less effective once motion sickness
starts. Chewable forms may work faster.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'CAUTION', copd: 'CAUTION - anticholinergic effects', ckd: 'SAFE', pregnancy: 'Category B -
commonly used for hyperemesis', elderly: 'CAUTION - increased sensitivity', glaucoma: '⚠️
AVOID' }
}
},
{
id: 'povidone-iodine',
name: 'Povidone-Iodine',
ph_brands: ['Betadine', 'Isodine', 'Wokadine', 'Povidone Solution',
'Defensil', 'Videne'],
uses: 'Wound antisepsis, skin disinfection, minor cuts and burns, surgical
scrub',
origin: 'Iodophor antiseptic developed in 1955; broad-spectrum antimicrobial',
whenToGive: 'For wound cleaning and infection prevention; not for deep
puncture wounds',
contraindications: 'Iodine hypersensitivity, thyroid disorders (prolonged
use), newborns, deep wounds',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['antiseptic','wound','topical','disinfectant'],
additionalInfo: {
genericNames: ['Povidone-Iodine', 'PVP-I', 'Polyvinylpyrrolidone-Iodine',
'Iodopovidone'],
drugClass: 'Topical Antiseptic, Iodophor, Broad-Spectrum Antimicrobial',
usesExpanded: 'Wound disinfection (minor cuts, abrasions, burns),
preoperative skin preparation, antiseptic hand scrub, vaginal infections (douches), oral
antiseptic (gargle for pharyngitis), umbilical cord care, catheter care',
mechanismOfAction: 'Iodine complexed with polyvinylpyrrolidone (PVP) which
slowly releases free iodine. Free iodine penetrates microbial cell walls and disrupts protein
and nucleic acid structure. Broad-spectrum activity against bacteria (gram+ and gram-), fungi,
viruses, protozoa, and spores.',
originExpanded: 'Developed by H.A. Shelanski and M.V. Shelanski in 1955.
The iodophor complex provides sustained iodine release with less tissue irritation and
staining than tincture of iodine. Became the gold standard for surgical skin preparation.',
pharmacokinetics: 'Minimal systemic absorption from intact skin.
Absorption increases with damaged skin, mucous membranes, or prolonged/large-area use.
Absorbed iodine is concentrated in thyroid, excreted renally. Local antimicrobial effect
begins within 1 minute.',
dosing: 'Solution (10%): Apply to affected area 1-3 times daily.
Preoperative: Apply and allow to dry (2-3 minutes). Gargle: Dilute to 1% (5ml in 50ml water),
gargle for 30 seconds. Scrub: Use for 3-5 minutes. Avoid prolonged use over large areas.',
whenToGiveExpanded: 'Apply to clean wound after gentle washing. Allow to
dry before covering with bandage. For preoperative skin prep, apply in concentric circles from
incision site outward. Brown color indicates active iodine - if faded, reapply.',
sideEffects: 'Common: Skin staining (temporary), mild burning on
application, skin irritation. Rare: Contact dermatitis, allergic reactions, systemic iodine
absorption (thyroid effects with prolonged/extensive use), delayed wound healing (high
concentrations).',
contraindicationsExpanded: 'Absolute: Iodine or povidone hypersensitivity,
use on premature neonates. Relative: Thyroid disorders (Graves disease, Hashimoto), pregnancy
(avoid large areas or prolonged use), breastfeeding, deep puncture wounds, severe burns (risk
of absorption), renal impairment (chronic use).',
drugInteractions: 'Lithium: May enhance hypothyroid effect. Mercury
compounds: Potential corrosive reaction. Hydrogen peroxide: Inactivates povidone-iodine.
Silver-containing products: May reduce efficacy. Avoid mixing with other antiseptics.',
nursingConsiderations: '1) Assess for iodine allergy before use. 2) Clean
wound with saline before applying. 3) Allow to dry completely before covering. 4) Monitor for
signs of irritation or allergy. 5) Do not use on deep wounds or burns over large areas. 6)
Avoid prolonged use in patients with thyroid disorders.',
patientEducation: 'Clean wound gently before applying. Allow to dry (brown
color indicates active ingredient). Temporary skin staining is normal and will fade. Do not
use on deep puncture wounds or animal bites - seek medical attention. Stop use and consult
doctor if irritation or rash develops. Not for long-term use over large areas.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE -
important for wound care', asthma: 'SAFE', copd: 'SAFE', ckd: 'CAUTION with prolonged use',
pregnancy: 'CAUTION - avoid large areas', thyroid: 'CAUTION - monitor function', neonates: '⚠️
AVOID in premature infants' }
}
},
{
id: 'bacitracin-neomycin',
name: 'Bacitracin/Neomycin/Polymyxin B',
ph_brands: ['Neosporin', 'Triple Antibiotic Ointment', 'Polysporin',
'Bacitracin Plus', 'First Aid Antibiotic'],
uses: 'Minor cuts, scrapes, burns; prevention of wound infection',
origin: 'Triple antibiotic combination for broad-spectrum topical coverage',
whenToGive: 'For minor wound care; apply 1-3 times daily; cover with bandage
if needed',
contraindications: 'Deep wounds, puncture wounds, animal bites, serious burns;
neomycin allergy common',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['antibiotic','wound','topical','cuts','burns'],
additionalInfo: {
genericNames: ['Bacitracin Zinc', 'Neomycin Sulfate', 'Polymyxin B
Sulfate', 'Triple Antibiotic'],
drugClass: 'Topical Antibiotic Combination (Polypeptide + Aminoglycoside +
Cationic Detergent)',
usesExpanded: 'Prevention of infection in minor cuts, scrapes, and burns.
First-degree burns, abrasions, minor surgical wounds, skin grafts. NOT for treatment of
established infections (requires systemic antibiotics).',
mechanismOfAction: 'Three antibiotics provide synergistic broad-spectrum
coverage: Bacitracin inhibits bacterial cell wall synthesis (gram-positive coverage). Neomycin
inhibits protein synthesis at 30S ribosomal subunit (gram-negative coverage). Polymyxin B
disrupts bacterial cell membranes (gram-negative coverage, especially Pseudomonas).',
originExpanded: 'Bacitracin discovered in 1943 (named after patient
Margaret Tracy). Neomycin discovered by Selman Waksman in 1949. Polymyxin discovered in 1947.
The combination (Neosporin) was developed to provide broad-spectrum topical coverage.',
pharmacokinetics: 'Topical application - minimal systemic absorption from
intact skin. Neomycin may be absorbed from damaged skin or large wounds (risk of
ototoxicity/nephrotoxicity). Local antibiotic effect is primary mechanism.',
dosing: 'Clean wound gently first. Apply thin layer to affected area 1-3
times daily. May cover with sterile bandage. Continue until wound is healed or for up to 1
week. If no improvement or worsening after 1 week, seek medical attention.',
whenToGiveExpanded: 'For minor wounds only - cuts, scrapes, abrasions,
minor burns. Apply after cleaning wound with soap and water or saline. Not a substitute for
proper wound cleaning. Not for deep wounds, puncture wounds, animal bites, or infected
wounds.',
sideEffects: 'Common: Local irritation, redness at application site.
Neomycin allergy is common (affects ~3-6% of population) - presents as contact dermatitis
(rash, itching, worsening redness). Rare: Systemic absorption with large wounds (neomycin
ototoxicity/nephrotoxicity).',
contraindicationsExpanded: 'Absolute: Known allergy to any component
(especially neomycin - common allergen). Relative: Deep puncture wounds, animal/human bites,
serious burns (systemic absorption risk), infected wounds requiring systemic antibiotics.',
drugInteractions: 'Generally not significant with topical use. If
extensive absorption occurs: Aminoglycosides (additive toxicity), loop diuretics (increased
ototoxicity risk), neuromuscular blockers (enhanced effect).',
nursingConsiderations: '1) Clean wound thoroughly before application. 2)
Ask about previous allergic reactions to antibiotic ointments (neomycin allergy common). 3)
Apply thin layer only. 4) Monitor for signs of contact dermatitis. 5) Educate that this is for
PREVENTION, not treatment of infection. 6) Refer if wound appears infected.',
patientEducation: 'Clean wound with soap and water first. Apply thin layer
1-3 times daily. Cover with bandage if desired. Stop use if rash, increased redness, or
itching develops (may indicate allergy - neomycin allergy is common). Not for deep cuts,
puncture wounds, animal bites, or obviously infected wounds. See doctor if wound worsens or
doesn\'t improve in 1 week.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE - wound
care important', asthma: 'SAFE', copd: 'SAFE', ckd: 'CAUTION with large wounds',
neomycin_allergy: '⚠️ AVOID - use bacitracin only' }
}
},
{
id: 'docusate',
name: 'Docusate Sodium',
ph_brands: ['Colace', 'Dulcoease', 'Surfak', 'Stool Softener', 'Laxadin'],
uses: 'Constipation prevention, stool softener, post-surgical bowel care',
origin: 'Surfactant stool softener that increases water penetration into
stool',
whenToGive: 'For constipation prevention or hard stools; takes 1-3 days for
effect; not for acute relief',
contraindications: 'Intestinal obstruction, fecal impaction, nausea/vomiting,
abdominal pain',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['constipation','stool softener','laxative'],
additionalInfo: {
genericNames: ['Docusate Sodium', 'Dioctyl Sodium Sulfosuccinate', 'DSS',
'Docusate Calcium'],
drugClass: 'Stool Softener (Emollient Laxative), Surfactant, Anionic
Surfactant',
usesExpanded: 'Prevention of constipation in at-risk patients, softening
hard stools, post-operative bowel care, post-myocardial infarction (avoid straining),
hemorrhoids, anal fissures, opioid-induced constipation (adjunct), patients on bed rest',
mechanismOfAction: 'Acts as a surfactant/detergent that reduces surface
tension, allowing water and fats to penetrate the stool. Softens stool by increasing water and
fat content. Does NOT stimulate peristalsis - purely a stool softener, not a stimulant
laxative.',
originExpanded: 'Docusate was developed in the 1950s as the first
commercial stool softener. The name comes from "dioctyl" (chemical structure). Available as
sodium salt (Colace) or calcium salt (Surfak). One of the mildest laxatives available.',
pharmacokinetics: 'Onset: 1-3 days (not for acute constipation). Minimal
systemic absorption. Works locally in the intestine. May enhance absorption of other drugs in
the GI tract.',
dosing: 'Adults: 50-300mg daily in 1-4 divided doses. Usual: 100mg 1-2
times daily. Children 6-12y: 40-150mg daily. Children 3-6y: 20-60mg daily. Take with full
glass of water. Effect takes 1-3 days.',
whenToGiveExpanded: 'For PREVENTION of constipation, not treatment of
acute constipation. Ideal for patients who should avoid straining: post-surgical, post-MI,
hemorrhoids, anal fissures. Take with plenty of water. Often used with opioids to prevent
opioid-induced constipation.',
sideEffects: 'Generally very well tolerated. Mild cramping, diarrhea (if
excessive dose), throat irritation (liquid forms), bitter taste. Rare: Rash. May enhance
absorption of mineral oil (avoid combination).',
contraindicationsExpanded: 'Absolute: Intestinal obstruction, fecal
impaction, acute abdominal pain, nausea and vomiting (may indicate obstruction). Relative:
Concurrent use with mineral oil (increased absorption of mineral oil). Do not use for more
than 1 week without medical advice.',
drugInteractions: 'Mineral oil: Avoid - docusate increases absorption of
mineral oil (toxicity risk). May increase absorption of other drugs (theoretical). Generally
safe with most medications.',
nursingConsiderations: '1) Assess bowel patterns and stool consistency. 2)
Educate that effect takes 1-3 days - not for acute relief. 3) Ensure adequate fluid intake. 4)
Assess for signs of obstruction before administering. 5) Common component of post-operative
and post-MI bowel protocols. 6) Do not give with mineral oil.',
patientEducation: 'This is a stool SOFTENER, not a stimulant laxative - it
takes 1-3 days to work. Drink plenty of water (8+ glasses daily). Not for immediate relief of
constipation. Best used to prevent constipation, not treat it. May be taken daily for patients
at risk. Do not use for more than 1 week without consulting a doctor.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE', pregnancy: 'SAFE - often recommended', hemorrhoids: 'SAFE -
reduces straining', post_MI: 'SAFE - prevents straining' }
}
},
{
id: 'calcium-carbonate',
name: 'Calcium Carbonate',
ph_brands: ['Tums', 'Calcimate', 'Caltrate', 'Calcium Supplement', 'Os-Cal',
'Calci-Aid'],
uses: 'Antacid, heartburn, calcium supplementation, osteoporosis prevention',
origin: 'Natural calcium compound used both as antacid and mineral
supplement',
whenToGive: 'As antacid: chew after meals; as supplement: take with food for
absorption',
contraindications: 'Hypercalcemia, kidney stones (calcium), severe renal
impairment, digoxin use (caution)',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['antacid','calcium','supplement','heartburn','bones'],
additionalInfo: {
genericNames: ['Calcium Carbonate', 'CaCO3', 'Precipitated Chalk',
'Calcite'],
drugClass: 'Antacid, Calcium Supplement, Phosphate Binder',
usesExpanded: 'Antacid for heartburn, acid indigestion, GERD symptoms.
Calcium supplementation for osteoporosis prevention/treatment. Hyperphosphatemia in chronic
kidney disease (as phosphate binder). Hypocalcemia. Pregnancy supplementation.',
mechanismOfAction: 'As antacid: Neutralizes gastric acid (CaCO3 + 2HCl →
CaCl2 + H2O + CO2). Quick onset but short duration. As supplement: Provides eleite calcium for
bone health, muscle function, nerve transmission. As phosphate binder: Binds dietary phosphate
in GI tract.',
originExpanded: 'Calcium carbonate is a naturally occurring compound found
in limestone, marble, and shells. One of the oldest antacids used. Contains 40% elemental
calcium (highest among calcium salts). Tums introduced as antacid in 1930.',
pharmacokinetics: 'Antacid effect: Onset 5-10 minutes, duration 20-60
minutes. Calcium absorption: Best absorbed in acidic environment - take with food. 15-40% of
calcium absorbed. Requires adequate vitamin D for optimal absorption. Excreted renally.',
dosing: 'Antacid: 500-1500mg chewed after meals and at bedtime (max
7500mg/day). Supplement: 500-600mg elemental calcium per dose, 2-3 times daily with meals (max
2500mg/day). Adjust for age, dietary intake, and vitamin D status.',
whenToGiveExpanded: 'As antacid: Chew tablets thoroughly after meals or
when symptoms occur. As supplement: Take with food (stomach acid aids absorption). Divide
doses (max 500-600mg per dose for optimal absorption). Do not take with high-fiber meals or
iron supplements.',
sideEffects: 'Common: Constipation, bloating, gas (due to CO2 release).
Excessive use: Hypercalcemia (nausea, vomiting, confusion), milk-alkali syndrome (rare),
rebound acid hypersecretion. May cause kidney stones with chronic high doses.',
contraindicationsExpanded: 'Absolute: Hypercalcemia, hypercalciuria,
severe kidney impairment, calcium-containing kidney stones. Relative: Digoxin therapy
(hypercalcemia increases digoxin toxicity), achlorhydria (poor absorption), chronic use as
antacid.',
drugInteractions: 'Tetracyclines, fluoroquinolones: Reduced absorption
(separate by 2-4 hours). Iron supplements: Reduced iron absorption. Thyroid hormones: Reduced
absorption. Digoxin: Hypercalcemia increases toxicity. Bisphosphonates: Reduced absorption
(separate doses). Thiazide diuretics: Increased hypercalcemia risk.',
nursingConsiderations: '1) Distinguish between antacid and supplement use.
2) For supplements, assess dietary calcium intake first. 3) Monitor for constipation. 4) Check
calcium and vitamin D levels in chronic users. 5) Many drug interactions - review medication
list. 6) Educate on proper timing with other medications. 7) Contains 40% elemental calcium.',
patientEducation: 'As antacid: Chew tablets well, take after meals. As
supplement: Take with food in divided doses. May cause constipation - increase fiber and
water. Do not take with iron or certain antibiotics (separate by 2-4 hours). Contains highest
amount of calcium among supplements. Ensure adequate vitamin D for absorption. Do not exceed
recommended dose (can cause kidney stones).',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'CAUTION - use as phosphate binder may be appropriate', pregnancy:
'SAFE - often recommended', osteoporosis: 'SAFE - first-line supplement', digoxin_use: '⚠️
CAUTION' }
}
},
{
id: 'ferrous-sulfate',
name: 'Ferrous Sulfate',
ph_brands: ['Iberet', 'Feromin', 'Sangobion', 'Fer-In-Sol', 'Feosol',
'Ferro-Gradumet'],
uses: 'Iron deficiency anemia, iron supplementation, pregnancy
supplementation',
origin: 'Iron salt supplement for treating and preventing iron deficiency',
whenToGive: 'For iron deficiency; take on empty stomach if tolerated, or with
food if GI upset occurs; vitamin C enhances absorption',
contraindications: 'Hemochromatosis, hemosiderosis, hemolytic anemia, repeated
blood transfusions',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'SAFE' },
tags: ['iron','anemia','supplement','blood'],
additionalInfo: {
genericNames: ['Ferrous Sulfate', 'Iron(II) Sulfate', 'FeSO4', 'Ferrous
Sulfate Heptahydrate'],
drugClass: 'Iron Supplement, Hematinic, Essential Mineral',
usesExpanded: 'Iron deficiency anemia (treatment and prevention),
pregnancy supplementation, postpartum anemia, chronic blood loss (menorrhagia, GI bleeding),
post-gastrectomy iron deficiency, pediatric growth periods, vegetarian/vegan supplementation',
mechanismOfAction: 'Provides ferrous iron (Fe2+) which is absorbed in the
duodenum and upper jejunum. Iron is incorporated into hemoglobin for oxygen transport,
myoglobin for muscle oxygen storage, and various enzymes. Absorption is enhanced in acidic
environment and by vitamin C.',
originExpanded: 'Ferrous sulfate has been used for iron deficiency for
over 200 years. Contains 20% elemental iron (325mg tablet = 65mg elemental iron). The most
commonly prescribed and cost-effective iron supplement. Green vitriol was historically used
for anemia before its active component was identified.',
pharmacokinetics: 'Absorption: 10-15% absorbed (increases to 20-30% in
iron deficiency). Best absorbed on empty stomach in acidic environment. Peak serum iron: 2-4
hours. Distribution: Bound to transferrin. Storage: As ferritin/hemosiderin in liver, spleen,
bone marrow. No excretion mechanism - balance maintained by absorption regulation.',
dosing: 'Adults (treatment): 325mg (65mg elemental) 2-3 times daily.
Prevention: 325mg once daily. Pregnancy: 30-60mg elemental iron daily. Children: 3-6mg
elemental/kg/day in divided doses. Take on empty stomach; with food if GI upset (reduces
absorption by 40%). Vitamin C enhances absorption.',
whenToGiveExpanded: 'Take on empty stomach (1 hour before or 2 hours after
meals) for best absorption. If GI upset occurs, take with food (reduces absorption but
improves tolerance). Take with vitamin C (orange juice) to enhance absorption. Avoid taking
with calcium, antacids, or dairy products.',
sideEffects: 'Common (dose-related): Nausea, constipation, diarrhea,
abdominal pain, dark stools (normal), metallic taste. Rare: Hemosiderosis (chronic excess),
stained teeth (liquid forms). GI effects main reason for non-compliance.',
contraindicationsExpanded: 'Absolute: Hemochromatosis, hemosiderosis,
hemolytic anemia (increases iron without deficiency), thalassemia (unless concurrent iron
deficiency), repeated blood transfusions (iron overload). Relative: Peptic ulcer disease,
inflammatory bowel disease, parenteral iron preparations.',
drugInteractions: 'Antacids, calcium, dairy: Reduced iron absorption.
Tetracyclines, fluoroquinolones: Mutual absorption reduction (separate by 2-4 hours).
Levodopa, methyldopa: Reduced absorption. PPIs/H2 blockers: Reduced absorption. Tea, coffee:
Tannins reduce absorption. Vitamin C: Enhanced absorption.',
nursingConsiderations: '1) Assess for signs of iron deficiency (pallor,
fatigue, tachycardia, koilonychia). 2) Check hemoglobin/hematocrit and reticulocyte count. 3)
Educate about GI side effects (major cause of non-compliance). 4) Warn about dark stools
(normal). 5) Check for drug interactions. 6) Monitor response (reticulocyte increase in 5-10
days, Hgb increase in 2-4 weeks). 7) POISON RISK IN CHILDREN - keep out of reach.',
patientEducation: 'Take on empty stomach if possible, or with food if
stomach upset. Take with vitamin C (orange juice) for better absorption. Avoid taking with
milk, antacids, calcium, tea, or coffee. Stools will turn dark/black - this is normal. May
cause constipation - increase fiber and water. Keep away from children - iron overdose is
dangerous. Treatment usually continues 3-6 months to replenish iron stores.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'SAFE - monitor iron status', pregnancy: 'SAFE - routinely
recommended', thalassemia: '⚠️ CAUTION - only if iron deficient', hemochromatosis: '⚠️
CONTRAINDICATED' }
}
},
{
id: 'multivitamins',
name: 'Multivitamins',
ph_brands: ['Enervon', 'Centrum', 'Stresstabs', 'Cherifer', 'Conzace', 'Myra
E', 'Sangobion'],
uses: 'Nutritional supplementation, vitamin deficiency prevention, general
health maintenance',
origin: 'Combination of essential vitamins and minerals for daily
supplementation',
whenToGive: 'For general supplementation; take with food; not a substitute for
balanced diet',
contraindications: 'Hypervitaminosis (excess of specific vitamins), iron
overload conditions',
conditionSafety: { hypertension: 'SAFE', diabetes: 'SAFE', asthma: 'SAFE',
copd: 'SAFE', ckd: 'CAUTION' },
tags: ['vitamin','supplement','multivitamin','nutrition'],
additionalInfo: {
genericNames: ['Multiple Vitamins', 'Multivitamin Supplement', 'Vitamin
and Mineral Supplement', 'MVI'],
drugClass: 'Nutritional Supplement, Vitamin Supplement, Dietary
Supplement',
usesExpanded: 'Prevention of vitamin deficiencies, nutritional
supplementation for inadequate dietary intake, pregnancy and lactation support, recovery from
illness, elderly supplementation, vegetarian/vegan diets, malabsorption syndromes,
post-bariatric surgery',
mechanismOfAction: 'Provides essential vitamins (A, B-complex, C, D, E, K)
and often minerals (iron, zinc, calcium, etc.) that serve as cofactors for enzymatic
reactions, antioxidants, and structural components. Each vitamin has specific functions:
B-vitamins for energy metabolism, Vitamin C for collagen synthesis, Vitamin D for calcium
absorption, etc.',
originExpanded: 'First multivitamin tablets introduced in the 1940s.
Development followed discovery of individual vitamins in early 20th century. Popular
Philippine brands include Enervon (B-complex + C), Centrum (complete), Stresstabs (B-complex +
C + E), Cherifer (with growth factors), and Conzace (antioxidant combination).',
pharmacokinetics: 'Varies by vitamin: Water-soluble vitamins (B-complex,
C) - absorbed in small intestine, excess excreted in urine, require daily intake. Fat-soluble
vitamins (A, D, E, K) - require dietary fat for absorption, stored in liver and adipose
tissue, risk of accumulation with excess intake.',
dosing: 'Usually 1 tablet daily with food. Take with meals to enhance
absorption (especially fat-soluble vitamins). Some formulations designed for specific
populations: prenatal, pediatric, senior, men\'s, women\'s. Do not exceed recommended dose.',
whenToGiveExpanded: 'Take with food to enhance absorption of fat-soluble
vitamins and reduce GI upset. Best taken at same time daily. Not a substitute for balanced
diet - supplements fill nutritional gaps, not replace food. Consider specific deficiencies
before choosing formulation.',
sideEffects: 'Generally well tolerated at recommended doses. May cause:
Nausea, upset stomach (especially on empty stomach), constipation (if iron-containing), bright
yellow urine (riboflavin - normal). Excess fat-soluble vitamins can accumulate (A, D
toxicity).',
contraindicationsExpanded: 'Absolute: Hypervitaminosis A or D,
hemochromatosis (if iron-containing). Relative: Kidney disease (may need to avoid certain
minerals), specific vitamin sensitivities. Avoid megadose formulations unless prescribed.',
drugInteractions: 'Vitamin K: Antagonizes warfarin. Iron: Reduces
absorption of levothyroxine, tetracyclines, fluoroquinolones. Calcium: Interferes with iron
and some antibiotics. Vitamin C: May interfere with certain lab tests. Folic acid: May mask
B12 deficiency.',
nursingConsiderations: '1) Assess dietary intake and nutritional status.
2) Identify specific deficiencies before recommending. 3) Educate that supplements don\'t
replace balanced diet. 4) Check for interactions with medications (especially warfarin). 5)
Recommend appropriate formulation for patient population. 6) Monitor for signs of vitamin
toxicity with excessive intake. 7) Special considerations for pregnancy (avoid excess Vitamin
A).',
patientEducation: 'Take with food for better absorption. Not a substitute
for healthy eating. One tablet daily is usually sufficient - more is not better. Fat-soluble
vitamins (A, D, E, K) can accumulate if taken in excess. Bright yellow urine is normal
(B2/riboflavin). If taking blood thinners, consult doctor (Vitamin K interaction). Store away
from children (iron-containing vitamins are poisoning risk). Choose appropriate formula for
your needs.',
conditionSafetyExpanded: { hypertension: 'SAFE', diabetes: 'SAFE', asthma:
'SAFE', copd: 'SAFE', ckd: 'CAUTION - avoid high mineral content', pregnancy: 'Use PRENATAL
formula', liver_disease: 'CAUTION - avoid excess Vitamin A', warfarin_use: '⚠️ CAUTION -
Vitamin K interaction' }
}
}
];
const otcListEl = document.getElementById('otc-list');
const otcDetailEl = document.getElementById('otc-detail');
const otcSearch = document.getElementById('otc-search');
function escapeRegex(s){ return s.replace(/[.*+?^${}()|[\\]\\]/g, "\\$&"); }
function highlight(text, term){
if(!term) return text;
const re = new RegExp(escapeRegex(term), 'ig');
return text.replace(re, m => `<strong style="font-weight: 800; color:
#22d3ee;">${m}</strong>`);
}
// State for OTC list preview - incremental loading
let otcVisibleCount = 3;
const OTC_INCREMENT = 3;
function renderOTCList(filter){
const q = (filter||'').trim().toLowerCase();
otcListEl.innerHTML = '';
const matches = otcDatabase.filter(item => {
if(!q) return true;
if(item.name.toLowerCase().includes(q)) return true;
if(item.ph_brands.join(' ').toLowerCase().includes(q)) return true;
if(item.uses.toLowerCase().includes(q)) return true;
if((item.tags||[]).some(t=>t.includes(q))) return true;
return false;
});
if(matches.length === 0){
otcListEl.innerHTML = `<div class="text-slate-400 text-sm">No matches
found.</div>`;
return;
}
// If searching, show all results; otherwise respect the visible count limit
const isSearching = q.length > 0;
const itemsToShow = isSearching ? matches : matches.slice(0, otcVisibleCount);
const hiddenCount = matches.length - otcVisibleCount;
itemsToShow.forEach((item, idx) => {
const searchTerm = q;
const title = highlight(item.name, searchTerm);
const trade = highlight(item.ph_brands.join(', '), searchTerm);
const usesPreview = highlight(item.uses, searchTerm);
const card = document.createElement('button');
card.className = 'w-full text-left rounded-xl border transition';
card.style.backgroundColor = '#1e293b';
card.style.borderColor = '#1e293b';
card.style.padding = '0.25rem 0.5rem';
card.innerHTML = `<div class="flex flex-col sm:flex-row justify-between
items-start gap-0 sm:gap-2">
<div class="flex-1">
<p class="font-bold text-white text-sm">${title}</p>
<p class="text-[11px] text-slate-300 mt-0">${trade}</p>
<p class="text-[11px] text-slate-400 mt-0.5">${usesPreview}</p>
</div>
<div class="text-xs text-slate-500 whitespace-nowrap">More</div>
</div>`;
card.onclick = () => showOTCDetail(item);
otcListEl.appendChild(card);
});
// Show "Show More" button if not searching and there are more items to show
if (!isSearching && hiddenCount > 0) {
const showMoreBtn = document.createElement('button');
showMoreBtn.className = 'w-full mt-3 py-3 px-4 rounded-xl font-semibold
text-sm transition flex items-center justify-center gap-2';
showMoreBtn.style.background = 'linear-gradient(135deg, #0891b2, #0e7490)';
showMoreBtn.style.color = 'white';
showMoreBtn.style.border = '1px solid #06b6d4';
const nextBatch = Math.min(OTC_INCREMENT, hiddenCount);
showMoreBtn.innerHTML = `<span>▼</span> Show ${nextBatch} More <span
class="ml-1 px-2 py-0.5 bg-white/20 rounded-full text-xs">${hiddenCount} remaining</span>`;
showMoreBtn.onclick = () => {
otcVisibleCount += OTC_INCREMENT;
renderOTCList('');
};
otcListEl.appendChild(showMoreBtn);
}
// Show "Show Less" button if showing more than initial amount
if (!isSearching && otcVisibleCount > OTC_INCREMENT) {
const showLessBtn = document.createElement('button');
showLessBtn.className = 'w-full mt-2 py-2 px-4 rounded-xl font-semibold
text-sm transition flex items-center justify-center gap-2';
showLessBtn.style.background = 'linear-gradient(135deg, #475569, #334155)';
showLessBtn.style.color = '#cbd5e1';
showLessBtn.style.border = '1px solid #475569';
showLessBtn.innerHTML = `<span>▲</span> Show Less`;
showLessBtn.onclick = () => {
otcVisibleCount = OTC_INCREMENT;
renderOTCList('');
otcListEl.scrollIntoView({behavior:'smooth', block:'start'});
};
otcListEl.appendChild(showLessBtn);
}
}
function showOTCDetail(item){
// TLDR (short) content - always uses the short fields
const tldrContent = `
<div class="space-y-2 text-sm text-slate-300">
<div><strong class="text-slate-200">Uses:</strong> ${item.uses}</div>
<div><strong class="text-slate-200">Origin:</strong> ${item.origin}</div>
<div><strong class="text-slate-200">When to Give:</strong>
${item.whenToGive}</div>
<div><strong class="text-red-400">Contraindications / Cautions:</strong>
${item.contraindications}</div>
</div>
`;
// Check if this medicine has additional info
const hasAdditionalInfo = item.additionalInfo;
// Additional Information (expanded) content - only if additionalInfo exists
let additionalContent = '';
if (hasAdditionalInfo) {
const info = item.additionalInfo;
additionalContent = `
<div class="space-y-3 text-sm text-slate-300">
${info.genericNames ? `<div><strong class="text-cyan-400">Generic
Names:</strong> ${info.genericNames.join(', ')}</div>` : ''}
${info.drugClass ? `<div><strong class="text-cyan-400">Drug
Class:</strong> ${info.drugClass}</div>` : ''}
<div><strong class="text-slate-200">Uses:</strong> ${info.usesExpanded
|| item.uses}</div>
${info.mechanismOfAction ? `<div><strong
class="text-emerald-400">Mechanism of Action:</strong> ${info.mechanismOfAction}</div>` : ''}
<div><strong class="text-slate-200">Origin:</strong>
${info.originExpanded || item.origin}</div>
${info.pharmacokinetics ? `<div><strong
class="text-blue-400">Pharmacokinetics:</strong> ${info.pharmacokinetics}</div>` : ''}
${info.dosing ? `<div><strong class="text-amber-400">Dosing:</strong>
${info.dosing}</div>` : ''}
<div><strong class="text-slate-200">When to Give:</strong>
${info.whenToGiveExpanded || item.whenToGive}</div>
${info.sideEffects ? `<div><strong class="text-orange-400">Side
Effects:</strong> ${info.sideEffects}</div>` : ''}
<div><strong class="text-red-400">Contraindications /
Cautions:</strong> ${info.contraindicationsExpanded || item.contraindications}</div>
${info.drugInteractions ? `<div><strong class="text-pink-400">Drug
Interactions:</strong> ${info.drugInteractions}</div>` : ''}
${info.nursingConsiderations ? `<div><strong
class="text-green-400">Nursing Considerations:</strong> ${info.nursingConsiderations}</div>` :
''}
${info.patientEducation ? `<div><strong class="text-blue-300">Patient
Education:</strong> ${info.patientEducation}</div>` : ''}
</div>
`;
}
let html = `
<h3 class="font-bold text-xl text-amber-300 mb-1">${item.name}</h3>
<p class="text-xs text-slate-400 mb-3">Philippine Brand Names:
${item.ph_brands.join(', ')}</p>
${hasAdditionalInfo ? `
<!-- Tab Buttons -->
<div class="flex gap-2 mb-4">
<button id="tldr-tab" onclick="switchOTCTab('tldr')" class="px-4 py-2
text-sm font-semibold rounded-lg transition" style="background: linear-gradient(135deg,
#06b6d4, #0891b2); color: white;">
📋 TLDR
</button>
<button id="additional-tab" onclick="switchOTCTab('additional')"
class="px-4 py-2 text-sm font-semibold rounded-lg transition" style="background: #334155;
color: #94a3b8;">
📚 Additional Info
</button>
</div>
<!-- Tab Content -->
<div id="tldr-content">${tldrContent}</div>
<div id="additional-content" style="display: none;">${additionalContent}</div>
` : tldrContent}
`;
otcDetailEl.innerHTML = html;
// On mobile: hide list, show detail container full width
const isMobile = window.innerWidth < 768;
if (isMobile) {
document.getElementById('otc-list-container').classList.add('hidden');
document.getElementById('otc-detail-container').classList.remove('hidden');
document.getElementById('otc-detail-container').scrollIntoView({behavior:'smooth',
block:'start'});
} else {
otcDetailEl.scrollIntoView({behavior:'smooth', block:'nearest'});
}
}
function hideOTCDetail() {
// On mobile: show list again, hide detail container
document.getElementById('otc-list-container').classList.remove('hidden');
document.getElementById('otc-detail-container').classList.add('hidden');
document.getElementById('otc-list-container').scrollIntoView({behavior:'smooth',
block:'start'});
}
function switchOTCTab(tab) {
const tldrTab = document.getElementById('tldr-tab');
const additionalTab = document.getElementById('additional-tab');
const tldrContent = document.getElementById('tldr-content');
const additionalContent = document.getElementById('additional-content');
if (tab === 'tldr') {
tldrTab.style.background = 'linear-gradient(135deg, #06b6d4, #0891b2)';
tldrTab.style.color = 'white';
additionalTab.style.background = '#334155';
additionalTab.style.color = '#94a3b8';
tldrContent.style.display = 'block';
additionalContent.style.display = 'none';
} else {
additionalTab.style.background = 'linear-gradient(135deg, #f59e0b, #d97706)';
additionalTab.style.color = 'white';
tldrTab.style.background = '#334155';
tldrTab.style.color = '#94a3b8';
tldrContent.style.display = 'none';
additionalContent.style.display = 'block';
}
}
otcSearch.addEventListener('input', (e) => {
renderOTCList(e.target.value);
});
// initial render
renderOTCList('');
renderOTCSidebar();
</script>
<!-- Service Worker Registration for PWA offline support -->
<script>
if ('serviceWorker' in navigator) {
window.addEventListener('load', () => {
navigator.serviceWorker.register('/sw.js', { scope: '/' })
.then((registration) => {
console.log('✅ Service Worker registered successfully:',
registration.scope);
registration.update();
// In standalone mode, ensure app functions work
if (window.navigator.standalone === true ||
window.matchMedia('(display-mode: standalone)').matches) {
console.log('📱 Running in standalone mode - app fully
functional');
// Ensure all event listeners are active
if (typeof liveAnalyze !== 'undefined') {
console.log('✅ Analysis functions loaded');
}
}
})
.catch((error) => {
console.error('⚠️ Service Worker registration failed:', error);
});
});
// Handle SW update notifications
navigator.serviceWorker.addEventListener('controllerchange', () => {
console.log('🔄 Service Worker updated');
// Reload to get latest version
window.location.reload();
});
} else {
console.log('⚠️ Service Workers not supported - app will work in browser only');
}
// Check if app was launched from home screen
const isInStandaloneMode = () =>
(window.navigator.standalone === true) ||
(window.matchMedia('(display-mode: standalone)').matches);
if (isInStandaloneMode()) {
console.log('📱 App running in standalone mode (installed PWA)');
console.log('✅ All offline features available');
}
</script>
<!-- Persistent Simulation Mode Footer -->
<div style="position: fixed; bottom: 0; left: 0; right: 0; background:
linear-gradient(90deg, #92400e, #b45309, #92400e); color: white; padding: 8px 16px;
text-align: center; font-size: 11px; font-weight: bold; z-index: 9999; border-top: 2px solid
#f59e0b; letter-spacing: 1px; text-transform: uppercase;">
📚 Simulation Mode: Verify All Outputs with Faculty & Prescribed Textbooks
</div>
<!-- Add padding to body to prevent content being hidden behind fixed footer -->
<style>
body { padding-bottom: 50px !important; }
</style>
</body>
</html>
===============================================================================
=
 --- COMPLETE SOURCE CODE FILE ---
 sw.js (Service Worker)
 --- CATEGORY: Class N Computer Program ---
===============================================================================
=
// --- SOURCE CODE FILE: sw.js ---
// --- CATEGORY: Class N Computer Program ---
const CACHE_NAME = 'nursepath-dean-demo-v1.1';
const OFFLINE_URL = '/index.html';
// Files to cache for offline use
const STATIC_ASSETS = [
 '/',
 '/index.html',
 '/manifest.json',
 '/image-192.png',
 '/image-512.png'
];
// Install: cache all static assets
self.addEventListener('install', (event) => {
 console.log('🚀 NursePath Service Worker installing...');
 event.waitUntil(
 caches.open(CACHE_NAME).then((cache) => {
 console.log('📦 Caching app for offline use...');
 return cache.addAll(STATIC_ASSETS)
 .catch((err) => {
 console.warn('⚠️ Some assets failed to cache:', err);
 });
 }).then(() => {
 console.log('✅ Service Worker installed - app available offline!');
 self.skipWaiting();
 })
 );
});
// Activate: clean old caches
self.addEventListener('activate', (event) => {
 console.log('🔄 Service Worker activating...');
 event.waitUntil(
 caches.keys().then((cacheNames) => {
 return Promise.all(
 cacheNames
 .filter((name) => name !== CACHE_NAME)
 .map((name) => {
 console.log(`🗑️ Deleting old cache: ${name}`);
 return caches.delete(name);
 })
 );
 }).then(() => {
 console.log('✅ Service Worker activated');
 return self.clients.claim();
 })
 );
});
// Fetch: CACHE-FIRST strategy for offline academic use
self.addEventListener('fetch', (event) => {
 const { request } = event;

 // Skip non-GET requests
 if (request.method !== 'GET') {
 return;
 }
 event.respondWith(
 caches.match(request).then((cachedResponse) => {
 if (cachedResponse) {
 // Serve from cache (works offline!)
 console.log('📦 Serving from cache:', request.url);

 // Background update for next time
 fetch(request).then((networkResponse) => {
 if (networkResponse && networkResponse.ok) {
 caches.open(CACHE_NAME).then((cache) => {
 cache.put(request, networkResponse.clone());
 });
 }
 }).catch(() => {});

 return cachedResponse;
 }
 // Not in cache - try network
 return fetch(request).then((networkResponse) => {
 if (networkResponse && networkResponse.ok) {
 // Cache for future offline use
 const responseToCache = networkResponse.clone();
 caches.open(CACHE_NAME).then((cache) => {
 cache.put(request, responseToCache);
 });
 }
 return networkResponse;
 }).catch(() => {
 // Network failed - return offline page for navigation
 if (request.mode === 'navigate') {
 return caches.match(OFFLINE_URL);
 }
 });
 })
 );
});
console.log('🏥 NursePath Service Worker loaded - Ready for offline academic reinforcement!');
--- END SERVICE WORKER ---
INTELLECTUAL PROPERTY ASPECTS (sw.js):
• Proprietary cache versioning strategy
• Offline-first service worker implementation
• Background update mechanism
• Custom error handling for offline scenarios
• Selective asset caching logic
===============================================================================
=
 --- COMPLETE SOURCE CODE FILE ---
 manifest.json (PWA Manifest)
 --- CATEGORY: Class N Computer Program ---
===============================================================================
=
// --- SOURCE CODE FILE: manifest.json ---
// --- CATEGORY: Class N Computer Program ---
{
 "id": "https://block9nurseapp.vercel.app/",
 "name": "NursePath - Academic Learning Companion",
 "short_name": "NursePath",
 "description": "Interactive calculators and study references for nursing education — offline-capable academic
support for student nurses.",
 "start_url": "/index.html",
 "scope": "/",
 "display": "standalone",
 "orientation": "portrait",
 "theme_color": "#0f172a",
 "background_color": "#0f172a",
 "categories": ["medical", "productivity"],
 "prefer_related_applications": true,
 "related_applications": [
 {
 "platform": "play",
 "url": "https://play.google.com/store/apps/details?id=com.block9.nurse",
 "id": "com.block9.nurse"
 }
 ],
 "icons": [],
 "screenshots": []
}
--- END MANIFEST ---
TECHNICAL SIGNIFICANCE (manifest.json):
• Enables mobile app installation ("Add to Home Screen")
• Defines PWA identity and branding
• Specifies standalone display mode (full-screen app experience)
• Establishes vercel domain as canonical app location
• Enables app discovery through PWA stores
===============================================================================
=
 LICENSE INFORMATION
===============================================================================
=
--- SOURCE CODE FILE: LICENSE.txt ---
This software is the intellectual property of Rance Adriel M. Pascua.
Academic Use License: This application is provided for educational purposes
and academic evaluation by faculty at Universidad de Dagupan.
Restrictions:
- This is a non-commercial student project
- Use is restricted to educational/academic contexts
- Commercial use, redistribution, or modification requires written permission
- Attribution to Rance Adriel M. Pascua is required in any derivative works
For questions regarding licensing or usage rights, contact:
Rance Adriel M. Pascua
adrielrancepascua@gmail.com
===============================================================================
=
 APPENDIX: REGISTRATION SUMMARY
===============================================================================
=
INTELLECTUAL PROPERTY REGISTRATION FOR IPOPHL
Category: Class N - Computer Program
WORK IDENTIFICATION:
Title: NursePath: Clinical Learning Progressive Web Application
Author/Developer: Rance Adriel M. Pascua
Institution: Universidad de Dagupan
Program: Bachelor of Science in Nursing
Year Completed: 2026
Version: 1.1
TECHNICAL SPECIFICATIONS:
- Language: JavaScript, HTML5, CSS3
- Architecture: Progressive Web Application (PWA)
- Offline Capability: Service Worker
- Data Persistence: localStorage
- Runtime: Client-side JavaScript (no backend server)
- Deployment Platform: Vercel
- Total Lines of Code: Approximately 2,800+
FUNCTIONAL COMPONENTS:
1. Clinical Calculation Engine
 - IV Flow Rate (mL/hr, gtt/min)
 - Age of Gestation & EDD (Naegele's Rule)
 - BMI (Body Mass Index)
 - Vital Signs Interpretation
2. Educational Database
 - 34 OTC Medications with Philippine brands
 - Vital Signs Reference (age-stratified)
 - Pregnancy-specific vital signs ranges
 - Condition-specific medication safety ratings
3. Offline Infrastructure
 - Service Worker caching strategy
 - Offline asset management
 - Background update mechanism
4. User Interface
 - Responsive design (mobile, tablet, desktop)
 - Tab navigation system
 - Interactive calculators
 - Searchable databases
 - Simulation mode agreement system
EVIDENCE OF ORIGINAL AUTHORSHIP:
✓ Custom software architecture (no templates used)
✓ Proprietary vital signs assessment algorithm
✓ Original OTC medication database curation
✓ Custom calculation implementations
✓ Original responsive UI/UX design
✓ Service Worker implementation for offline functionality
CONTENT VERIFICATION:
All medical/nursing content verified against:
- Brunner & Suddarth's Textbook of Medical-Surgical Nursing
- Kozier & Erb's Fundamentals of Nursing
- Lippincott's Nursing Drug Guide
- Philippine National Drug Formulary
- Pillitteri's Maternal & Child Health Nursing
DEPLOYMENT INFORMATION:
Primary URL: https://block9nurseapp.vercel.app/
Repository: https://github.com/adrielrancepascua-dev/block9nurseapp
Current Version: 1.1
Last Updated: April 8, 2026
PRIOR DISCLOSURES:
This is an original student academic project with no previous registration.
The application has been developed for academic evaluation by faculty.
===============================================================================
=
 CONTACT INFORMATION
===============================================================================
=
Developer: Rance Adriel M. Pascua
Email: adrielrancepascua@gmail.com
Phone: [09454903281]
Institution: Universidad de Dagupan
Program: Bachelor of Science in Nursing
Year: 2025-2026
For IPOPHL Registration Inquiries:
This documentation package contains all necessary source code, technical
specifications, and intellectual property evidence required for Copyright
Registration (Class N - Computer Program) with the Intellectual Property
Office of the Philippines.
===============================================================================
=
Document Prepared: April 8, 2026
Content Status: Complete and Ready for IPOPHL Submission
Total Source Code Lines: 2,800+
Files Included:
 ✓ Complete README.md (technical manual)
 ✓ Complete index.html (main application - 2,700+ lines)
 ✓ Complete sw.js (Service Worker - 76 lines)
 ✓ Complete manifest.json (PWA Manifest - 21 lines)
 ✓ LICENSE.txt (Usage terms)
===============================================================================
=
END OF IPOPHL COPYRIGHT REGISTRATION DOCUMENTATION
===============================================================================
=